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The 3D structure of a protein can be fundamentally useful for understanding protein function. In 
the absence of an experimentally determined structure, the most common way to obtain protein 
structures is to use homology modeling, or the mapping of the target sequence onto a closely 
related homolog with an available structure. However, despite recent efforts in structural biology, 
the 3D structures of many proteins remain unknown. Recent advances in genomic and 
metagenomic sequencing coupled with coevolution analysis and protein structure prediction have 
allowed for highly accurate models of proteins that were previously considered intractable to 
model due to the lack of suitable templates. Structural models obtained from homology modeling, 
coevolution-based modeling, or crystallography can then be used with other computational tools 
such as small molecule docking or molecular dynamics (MD) simulations to help understand 
protein function, dynamics, and mechanism. 
 
Here coevolution-based modeling was used to build a structural model of the HgcAB complex 
involved in mercury methylation (Chapter I). Based on the model it was proposed that conserved 
cysteines in HgcB are involved in shuttling mercury, methylmercury, or both. MD simulations and 
docking to a homology model of E. coli inosine monophosphate dehydrogenase (IMPDH) 
provided insights into how a single amino acid mutation could relieve inhibition by altering protein 
structure and dynamics (Chapter II). Coevolution-based structure prediction was also combined 
with docking, and experimental activity data to generate machine learning models that predict 
enzyme substrate scope for a series of bacterial nitrilases (Chapter III). Machine learning was also 
used to identify physicochemical properties that describe outer membrane permeability and efflux 
in E. coli and P. aeruginosa and new efflux pump inhibitors for the E. coli AcrAB-TolC efflux 
pump were identified using existing physicochemical guidelines in combination with small 
molecule docking to a homology model of AcrA (Chapter IV). Lastly, quantum 
mechanical/molecular mechanical simulations were used to study the mechanism of a key proton 
transfer step in Toho-1 beta-lactamase using experimentally determined structures of both the apo 
and cefotaxime-bound forms. These simulations revealed that substrate binding promotes catalysis 
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Protein structures can provide valuable insights into enzymatic function. The overall fold, domain 
architecture, and spatial arrangement of residues involved in substrate recognition and catalysis all 
provide useful clues. In the absence of an experimentally determined structure, modeling is an 
alternative approach. When suitable templates are available, homology modeling is often the 
method of choice. However, the accuracy of the modeled structure depends on various factors, 
including scoring functions and conformational sampling strategies.1 Homology model accuracy 
also depends on the quality of the template as well as the sequence similarity to the query sequence. 
However, templates are not available for many proteins. In the absence of suitable templates, 
models can be generated by using coevolutionary information obtained from large multiple 
sequence alignments of homologs to the target protein. Here, pairs of amino acids that are found 
to coevolve in sequence space are expected to be in close proximity to one another in the folded 
protein. Using this information, contact restraints can be derived and used to generate accurate 
structural models that reach homology level accuracy.2-6 
 
Structural models and experimentally determined structures generated by any or all of these 
approaches can then be further studied with other computational tools to address questions 
pertaining to the structure, dynamics, functions, and mechanisms of various bacterial proteins. For 
example, molecular dynamics (MD) simulations can be used to investigate conformational 
changes in a protein upon mutation. Meanwhile, docking of small molecule ligands can be used to 
identify substrates for an enzyme and quantum mechanical/molecular mechanical (QM/MM) 
simulations can be used to study enzyme mechanisms in detail.  
HgcAB 
 
The hgcAB gene pair has been identified anaerobic bacteria and archaea that methylate mercury 
(Hg). 7-10 The hgcAB gene pair occurs in only ~1.4% of sequenced microbial genomes and deletion 
of hgcA, hgcB, or both has been show to completely eliminate methylmercury (MeHg) 
production.11 Despite the rare occurrence of hgcA and hgcB in sequenced genomes, 
microorganisms with these genes are found throughout the world in highly diverse anaerobic 
settings. However, bacteria that methylate Hg are no less susceptible to Hg toxicity than those that 
do not, suggesting that it is not a mechanism for Hg detoxification.12 
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Through protein sequence analysis, HgcA was predicted to consist of an N-terminal corrinoid (i.e., 
vitamin B12) binding protein (CBD) homologous to the corrinoid iron-sulfur protein (CFeSP) 13-15  
and a C-terminal transmembrane domain (TMD) that consists of five helices.7 Similar to CFeSP, 
HgcA was also predicted to have a “cap helix” that interacts non-covalently with the corrinoid. 
This helix contains several highly conserved residues, including a strictly conserved Cys that is 
absent in the CFeSP sequence. This Cys residue has been suggested to bind to the corrinoid 
cofactor based on observations from homology modeling. Site-directed mutagenesis experiments 
revealed that Ala or Thr mutations of this Cys (Cys93 in Desulfovibrio desulfuricans ND132) 
abolished Hg methylation, while mutation to His retained some activity.16 Unlike the CBD, the 
TMD of HgcA lacks detectable sequence homology to any available protein structures. This 
domain has been shown to be essential for Hg methlylation activity, as  C-terminal truncation 
mutants that removed the TMD are unable to methylate Hg.16 
 
Bioinformatics analysis has suggested that HgcB is a bacterial ferredoxin with two separate 
CxxCxxCxxxCP motifs. These motifs are known to bind [4Fe-4S] clusters. HgcB also contains a 
strictly conserved Cys (Cys73 in D. desulfuricans ND132), located near the second [4Fe-4S]-
binding motif. Mutation of this residue to Ala has been shown to eliminate Hg methylation in 
vivo.10 There are also two additional Cys residues (Cys94 and Cys95 in D. desulfuricans ND13) 
at the C-terminus. For both of these Cys residues, Ala mutations have been shown to abolish Hg 
methylation activity, but single Cys mutants were not affected, suggesting that at least one of these 
Cys residues is required. Sequence homologs of HgcB have variable sequence length and number 
of C-terminal Cys residues. 
 
HgcA and HgcB are expressed at very low levels,17,18 making it particularly challenging to isolate 
and purify sufficient quantities of these proteins from the native host. Heterologous overexpression 
is difficult as Hg methylating microorganisms are obligate anaerobes and exposure to oxygen stops 
MeHg production.19 In addition, the uptake of corrinoids is tightly regulated20 and the iron-sulfur 
clusters require the proper machinery for assembly.21 The TMD also poses a challenge in structure 
determination, as transmembrane proteins are difficult to crystallize. Lastly, structure 
determination of transmembrane proteins such as the TMD remains challenging for X-ray 
crystallography, nuclear magnetic resonance, and cryo-EM. 
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Structural models of the HgcAB complex would provide valuable insight into the biochemical 
mechanism of Hg methylation. These structures can be obtained using coevolution analysis. This 
method requires a large multiple sequence alignment and the massive amount of sequence data 
available provide a large number of diverse protein sequences. Recently, it was shown that highly 
accurate structures can be obtained using coevolution analysis on sequences obtained from 
metagenomes.22 Due to the rarity of these genes in sequence genomes and the large number of 
sequences required to generate accurate contacts from coevolution analysis, metagenomes can be 
crucial for generating accurate models of the HgcAB complex. In Chapter I this complex is 
confirmed to bind corrinoid and iron-sulfur clusters, as predicted previously and models of the 
HgcAB complex were generated using metagenome sequences for coevolution analysis (Figure 
1A).  In addition, the relevant cofactors are incorporated to generate a complete model of the 
complex that is used to provide mechanistic insights into how microorganisms methylate Hg. 
IMPDH 
 
Microbes are able to utilize a wide array of compounds as carbon and energy sources. By 
expanding the range of compounds, a particular organism can use, new environmental niches can 
be accessed, and microbes can be engineered to use new feedstocks. In nature, horizontal gene 
transfer (HGT) allows for transfer of catabolic pathways between bacterial strains. In the 
laboratory setting metabolic engineering can be used for transferring pathways.23, 24 However, 
these engineered pathways often fail to function properly in the host, requiring optimization to 
minimize deleterious interactions.25,26, 27 
 
Pathways for catabolism of lignin-derived aromatic compounds are found to be widespread in 
nature28, and often undergo HGT.29 Previous metabolic engineering efforts have attempted to 
generate strains of Escherichia coli that use lignin-derived compounds (i.e., 4-hydroxybenzoate, 
4-HB) as sole energy sources.30, 31 However, introduction of the relevant pathways was not enough 
to enable growth. To overcome this issue, directed evolution was used to select for strains with 
improved growth in order to identify causal mutations that improve function of this engineered 
pathway. An extension of this work optimized these pathways for phenylpropanoid catabolism in 
E. coli and point mutations in the host were able to readily alleviate limitations in pathway activity. 
In one of these pathways, 4-hydroxybenzaldehyde, a pathway intermediate, inhibited purine 
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nucleotide biosynthesis. Interestingly, this inhibition was relieved by single amino acid 
replacements in the enzyme inosine-5′-monophosphate dehydrogenase (IMPDH). In Chapter II 
homology models of IMPDH were generated for small molecule docking to predict the inhibitor 
binding site followed by MD simulations to understand the structural and dynamic changes 
between the wild-type and mutant enzyme that lead to inhibition relief (Figure 1B). 
Nitrilase  
 
Enzymes are often able to accept multiple molecules as substrates and knowledge about the 
repertoire of substrates a given enzyme prefers (also known as substrate scope) can provide 
information about biological pathways and insights for metabolic engineering. Sequenced based 
methods are effective at predicting information about the broad categories of molecules that may 
act as substrates for a given enzyme to provide valuable information about potential protein 
function (i.e. active site residues, gene ontology terms, conserved domains), but are unable to 
predict the substrate scope. BRENDA32  is a manually curated database of ~84,000 enzymes that 
contains information about substrate specificity, but is limited to only experimentally verified 
systems. The ability to predict the substrate scope of an enzyme based on limited experimental 
data would be beneficial to studying enzyme function. 
 
Several efforts have been used to predict substrate specificity. For example, the substrate 
specificity of an enoyl-acyl carrier protein reductase was predicted using small molecule docking 
of putative substrates to an available crystal structure.33 As mentioned previously, structural 
modeling (i.e., homology or coevolution-based modeling) can be used in the absence of an 
available crystal structure. These models can then be used for computational docking of ligands.34-
36 However, docking studies often are unable to differentiate between ligands with similar 
scaffolds and docking also neglects to account for chemical reactivity, making it challenging to 
predict enzymatic activity.37 Combining information from structural modeling, docking, and other 
sources such as physicochemical properties of the ligand and the enzyme active site is expected to 
help overcome some of these limitations observed from docking to structural models of proteins. 
 
Machine learning (ML) has recently been applied to a variety of problems in fields such as 
quantum mechanics, physical chemistry, and biophysics. For example, channelrhodopsin was 
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engineered with higher light sensitivity using directed evolution in combination with information 
from protein sequence and contact maps generated from crystal structures.38 ML has also shown 
to be a promising way to predict substrate specificity.39, 40 Recently, a decision tree-based classifier 
that incorporated sequence information and physicochemical properties of substrate donor and 
acceptor molecules with experimental activity data was able to accurately predict enzymatic 
activity (~90%).41An extension of this approach would be to directly incorporate 3D structural 
information. 
 
Nitrilases are a family of enzymes that hydrolyze nitrile compounds to their corresponding 
carboxylic acids and ammonia. This enzyme family has a broad scope and is found in a wide range 
of organisms. These enzymes are involved in a variety of biological processes in addition to 
degradation of toxic nitrile compounds.42 In plant-microbe interactions these enzymes are of 
interest for improving food crop production, as they are thought to be involved in hormone 
synthesis, nutrient assimilation, detoxification, and modulation of plant development and 
physiology.43 In addition, nitriles are of interest in drug design.44, 45 In general, nitrilases fall into 
three categories of substrate specificities: aliphatic, arylaceto-, and aromatic nitrilases.43, 46 
However, existing sequence-based annotations are limited in their ability to classify nitrilases. 
 
Functional screening of microbial metagenomes has led to the identification of a diverse collection 
of nitrilases and reactivity toward specific substrates was found to be strongly correlated with 
phylogenetic relationships.44 To evaluate a large number of putative nitrilases, a high-throughput 
method is essential. Various fluorogenic or chromogenic activity assays are available to do so.45, 
47, 48 Recently, a chromogenic method was developed to screen nitrilases produced in crude cell 
extracts which alleviates purification steps and facilitates screening.49  
 
Shifts in substrate specificity were observed within specific subfamilies, suggesting that subtle 
changes in sequence can noticeably alter their substrate scope.44  Chapter III describes an 
integrated and modular approach that combines experimental activity assays with coevolution-
based protein structure prediction, small molecule docking, and calculation of physicochemical 
properties of a series of 12 bacterial nitrilases and a set of 20 nitriles (Figure 1C). This information 
is then used to train various machine learning classifiers to predict enzyme substrate scope. 
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Antibiotic outer membrane permeability and efflux 
 
Bacteria are developing resistance to antibiotics at an alarming rate through an arsenal of resistance 
mechanisms and understanding these various resistance mechanisms is important for developing 
strategies to overcome multi-drug resistance and restore antibiotic effectiveness. The presence of 
multidrug resistant strains in clinics often leave clinicians with no therapeutic options and the 
discovery of new antibiotics that are active against these pathogens is a major challenge.50 
 
Compared to Gram-positive bacteria, Gram-negative bacteria are more resistant to antibiotics. 
Gram-negative cell envelopes are comprised of the outer membrane (OM) that provides protection 
from toxic molecules and enzymatic attacks. The OM is an asymmetric bilayer of 
lipopolysaccharides and phospholipids along with both substrate-specific channels and non-
selective porins.51, 52 The inner membrane is a phospholipid bilayer that contains multidrug efflux 
pumps that protect intracellular functions by expelling small, toxic molecules from the cell.53 The 
low-permeability of the OM coupled with active efflux in the inner membrane provides two 
synergistic barriers that are responsible for antibiotic resistance in Gram-negative bacteria. In 
particular, efflux is considered a major bottleneck in addressing multidrug resistance54 and the 
discovery of new antibiotics is hindered by the lack of practical rules to maximize OM 
permeability and minimize active efflux.55, 56 
 
Separation of these two barriers allows for  different sets of rules to be established that define OM 
permeation and efflux.57 To investigate efflux in the absence of the OM barrier, a hyperporination 
approach can be used that facilitates control of OM permeability in Gram-negative cells through 
inducible expression of a chromosomally encoded open pore.58 The deletion of efflux pumps 
allows for OM permeability to be characterized without concern for the effect of efflux. Different 
classes of antibiotics can also be used to further investigate the individual and synergistic 
contributions of these two barriers. b-lactams (BLs) and fluoroquinolones (FQs) have been 
extensively developed and remain the major antibiotics administered in clinics. FQs target DNA 
replication by inhibiting DNA topoisomerases. Thus, to be effective, these antibiotics must 
penetrate both the outer and inner membranes and evade efflux pumps. In contrast, BLs act in the 
periplasm. The different targets for BLs and FQs allow for further investigation into the barriers 
limiting antibiotic activity in Gram-negative bacteria. 
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Pseudomonas aeruginosa and E. coli are two Gram-negative pathogens that differ significantly in 
their permeability barriers, despite having similar OM lipid compositions.51, 59, 60 These two species 
differ in the composition and structure of their major general porins. E. coli has~200,000 copies 
per cell of OmpF/C porins, which have a molecular mass cutoff of ~600 Da, allowing for a 
significant portion of antibiotics to permeate.61 In contrast, P. aeruginosa only utilizes substrate-
specific porins to take up small compounds.62 P. aeruginosa has shown susceptibility to FQs and 
some BLs, suggesting alternate routes of OM permeation. Fortunately, hyperporination negates 
the differences in OM permeability in these two species. 57, 58 
 
AcrAB-TolC is the main efflux pump in E. coli, which, which consists of three main components, 
AcrB, AcrA and TolC that assemble in 3:6:3 stoichiometry to span the entire cell envelope.63 AcrB 
is a homotrimer with an integral membrane domain, a periplasmic porter domain that binds and 
extrudes substrates, and a docking domain that interacts with AcrA.64, 65 AcrA consists of α-
hairpin, lipoyl, β-barrel, and membrane-proximal domains. TolC is a trimeric protein that consists 
of a b-barrel domain embedded in the OM and a periplasmic a-helical coiled-coil domain.66  
 
An effective efflux pump inhibitor must first bypass the OM. Recently, random forest ML was 
used to help determine that small-molecule compounds containing amine functional groups were 
most likely to accumulate in E. coli, and incorporation of a primary amine into the Gram-positive 
antibiotic deoxynybomycin resulted in a new antibiotic with broad-spectrum activity against 
multidrug-resistant Gram-negative bacteria.67 In addition to containing an amine, antibiotics that 
were polar, amphiphilic, relatively rigid, and had low globularity were found to be more likely to 
permeate. In Chapter IV (Figure 1D) random forest classification is used to identify molecular 
properties of antibiotics that are associated with their activities, measured as minimum inhibitory 
concentrations in P. aeruginosa and E. coli strains with controlled permeability barriers. 
Physicochemical property guidelines are then used to identify novel efflux pump inhibitors. 
b-lactamase 
 
Enzymatic inactivation is often the preferred mechanism of resistance, as enzymes can catalyze 
chemical transformations that inactivate an entire class of antibiotics. The most extensively studied 
enzymatic inactivation mechanism is the inactivation of BL antibiotics by β-lactamase enzymes. 
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Since their introduction into the clinic, BLs have revolutionized medicine.68, 69 However, the 
development of antibiotic resistance is inevitable. Despite the wide variety of BL antibiotics 
available today, resistant strains pose a threat to public health.  
 
Sequence homology is used to divide β-lactamases into four classes (A-D).70 Typical class A β-
lactamases include extended-spectrum β- lactamase (ESBL) cefotaxime-resistant (CTX) M-type 
enzymes. CTX-M-type CTX-M ESBLs can inactivate monobactam antibiotics  and all generations 
of cephalosporins.70-72 Toho-1 is a class A CTX-M-type ESBL β-lactamase composed of two 
highly conserved domains.73 All class A β-lactamases, including Toho-1, utilize a serine 
nucleophile to cleave the β-lactam bond. Several detailed mechanisms have been proposed for this 
reaction.74-77 One way to differentiate between these mechanisms is to unambiguously identifying 
key protonation states and hydrogen-bonding interactions of the catalytically important residues 
and the substrate. Neutron crystallography is ideally suited to experimentally determine 
protonation states as it allows for hydrogen atom positions to be determined. 
 
QM/MM calculations can provide key mechanistic insights that are complementary to 
crystallographic experiments by allowing for detailed inspection of short-lived intermediates and 
transition states and the quantification of reaction energetics of enzymatic reactions. 
Configurational sampling is required to provide information about free energies and can be 
achieved using umbrella sampling by running a series of restrained simulations along the reaction 
coordinate, in this case a hydrogen atom transfer. However, the computational cost of QM/MM 
umbrella sampling with density functional theory is high as it requires calculations at the quantum 
mechanical level at each timestep. Instead, semiempirical QM methods are often used to perform 
these calculations. Previous QM/MM studies of class A β-lactamases have focused on the 
acylation78-81and deacylation steps82, 83, and have helped establish likely mechanisms for BL 
inactivation. However, the effect the substrate has on this mechanism has not yet been investigated. 
In Chapter V X-ray and neutron crystallography is combined with QM/MM simulations to address 





Figure 1. Schematic overview of chapters. (A) In Chapter I coevolution-based structural modeling is used to build a model of the HgcAB complex 
involved in mercury methylation. (B) In Chapter II homology modeling, docking, and molecular dynamics (MD) simulations are used to investigate 
how a single amino acid mutation relieves inhibition of E. coli inosine monophosphate dehydrogenase (IMPDH) by 4-hydroxybenzaldehyde (C) 
Chapter III describes the use of coevolution-based structure prediction, docking, and machine learning to predict the enzyme substrate scope of a 
series of bacterial nitrilases. (D) In Chapter IV machine learning is also used to identify physicochemical properties that define antibiotic permeability 
and efflux in E. coli and P. aeruginosa. Physicochemical property filters are then used to discover novel efflux pump inhibitors (EPIs) for the E. coli 
AcrAB-TolC efflux pump by docking to AcrA. (E) Chapter V describes the use of MD and quantum mechanical/molecular mechanical (QM/MM) 
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Abstract 
Bacteria and archaea possessing the hgcAB gene pair methylate inorganic mercury (Hg) to form 
highly toxic methylmercury. HgcA consists of a corrinoid binding domain and a transmembrane 
domain, and HgcB is a dicluster ferredoxin. However, their detailed structure and function have 
not been thoroughly characterized. We modeled the HgcAB complex by combining metagenome 
sequence data mining, coevolution analysis, and Rosetta structure calculations. In addition, we 
overexpressed HgcA and HgcB in Escherichia coli and confirmed spectroscopically that they bind 
cobalamin and [4Fe-4S] clusters, respectively, and incorporated these cofactors into the structural 
model. Surprisingly, the two domains of HgcA do not interact with each other, but HgcB forms 
extensive contacts with both domains. The model suggests that conserved cysteines in HgcB are 
involved in shuttling HgII, methylmercury, or both. These findings refine our understanding of the 







Anaerobic bacteria and archaea possessing the hgcAB gene pair methylate inorganic mercury (Hg) 
to form methylmercury (CH3Hg+),7-10 a potent neurotoxin. Deletion of hgcA, hgcB, or both 
completely abolishes the ability of microorganisms to make methylmercury. These genes are 
distributed somewhat sporadically among various Proteobacteria (Deltaproteobacteria), 
Firmicutes, and Euryarchaeota. They are also found in some Chloroflexi (Dehalococcoides), 
Chrysiogenetes, Nitrospirae, and others.  
 
The hgcAB gene pair is relatively rare, occurring in only ~1.4% of sequenced microbial genomes.11 
Nevertheless, microorganisms harboring these genes are distributed worldwide in highly diverse 
anaerobic settings including soils, sediments, periphyton, rice paddies, invertebrate digestive 
tracts, and various extreme environments. It is not known why microorganisms methylate Hg, but 
this process is generally not thought to be a Hg detoxification mechanism because microorganisms 
harboring hgcAB genes are apparently no less susceptible to Hg toxicity than those lacking them.12 
 
Protein sequence analysis revealed that HgcA (a subset of the CO dehydrogenase/acetyl-CoA 
synthase delta subunit family, PF03599) is a corrinoid (i.e., vitamin B12-dependent) protein 
consisting of an N-terminal corrinoid binding domain (CBD) and a C-terminal transmembrane 
domain (TMD) with five TM helices.7 The CBD of HgcA bears homology to the C-terminal 
domain of the large subunit of the corrinoid iron-sulfur protein (CFeSP) from the Wood-Ljungdahl 
pathway in acetogenic bacteria.13-15  
 
HgcA was predicted to include a “cap helix” in its CBD similar to that in CFeSP.13 The cap helix 
in CFeSP interacts noncovalently with the a face of the corrinoid cofactor. In HgcA, the putative 
cap helix region includes several highly conserved residues, one of which is a strictly conserved 
Cys residue (Cys93 in Desulfovibrio desulfuricans ND132), that is not present at the corresponding 
position in the sequence of CFeSP. On the basis of its position in a homology model of the CBD, 
this Cys residue was predicted to bind the corrinoid cofactor in a cobalt-thiolate, or “Cys-on” 
configuration.7 Findings from in vivo site-directed mutagenesis experiments are consistent with 
Cys-on cofactor binding.16 Mutation of Cys93 to Ala or Thr resulted in a complete loss of Hg 
methylation activity, but a His mutant, which can presumably still coordinate with Co, retained 
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partial activity. In addition, substitution of several amino acids in the cap helix region with a helix-
breaking Pro residue drastically reduced or completely abolished activity. A quantum chemical 
study showed that Cys-on coordination promotes the exchange of one organometallic (Co–C) bond 
for another (Hg–C).84 Recently, the first example of Cys-on coordination in a protein was observed 
for the bacterial vitamin B12 transporter BtuM co-crystallized with cobalamin.85  
 
The TMD of HgcA has no detectable sequence homology (i.e., BLAST E-value < 10) to any 
structurally characterized protein. C-terminal truncation mutants of HgcA in which the TMD was 
deleted by introducing a stop codon after the nucleotides encoding either amino acid 166 or 187 
were both unable to methylate Hg, indicating that this domain is essential for activity.16 
 
HgcB is a 10.2 kDa bacterial ferredoxin (Pfam entries PF13237 and PF00037) that includes two 
CxxCxxCxxxCP motifs, which are known to bind [4Fe-4S] clusters. In addition, HgcB includes 
another strictly conserved Cys (Cys73 in D. desulfuricans ND132), located ~12 residues 
downstream of the second [4Fe-4S]-binding motif, and up to four additional Cys residues at its C-
terminus. Two cysteines are present at the C-terminus of ND132 (Cys94 and Cys95). Homologs 
of HgcB have variable sequence length, in particular in the tail region near the C-terminus. 
Mutation of Cys73 to Ala completely abolished Hg methylation in vivo.10 Mutation of either C-
terminal cysteine (Cys94 or Cys95) individually to Ala did not affect Hg methylation activity, but 
mutation of both residues simultaneously to Ala led to a 95% reduction in activity compared to the 
wild-type. Thus, at least one Cys is required at the C-terminus for maximal Hg methylation 
activity. 
 
In a proteomics study of Geobacter sulfurreducens PCA, another confirmed Hg-methylating 
bacterium, HgcA and HgcB were not detected due to low protein abundance.17 In a subsequent 
study of D. desulfuricans ND132, HgcA was detected in low abundance but HgcB was again not 
detected.18 Thus, isolation and purification of sufficient quantities of protein from a native host are 
expected to be challenging. Heterologous overexpression of HgcA and HgcB is complicated by a 
number of factors. For example, many Hg-methylating organisms are obligate anaerobes. Based 
on the proposed Hg methylation cycle, maintaining a low redox potential is essential for the 
function of HgcA and HgcB. It has been demonstrated that exposure to oxygen inhibits MeHg 
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formation in cell lysates of D. desulfuricans ND132.19 In addition, incorporation of the corrinoid 
cofactor and [4Fe-4S] clusters is nontrivial in heterologous hosts such as Escherichia coli because 
the uptake of corrinoids is tightly regulated20 and overexpression of recombinant proteins increases 
the demand on the machinery required to assemble iron-sulfur clusters.21 Lastly, although 
tremendous progress has been made in recent years, structure determination of transmembrane 
proteins with X-ray crystallography, nuclear magnetic resonance, or cryo-electron microscopy 
remains a challenge. 
 
In the absence of an experimentally determined structure, structural modeling is a viable means 
for obtaining mechanistic insight into protein function. Homology modeling is generally the 
method of choice, provided that suitable template structures are available. When templates are 
lacking, however, models can be generated by leveraging coevolution information inferred from a 
multiple sequence alignment. Pairs of amino acids that coevolve are likely to be in close spatial 
proximity in the folded protein. Thus, by imposing contact restraints derived from coevolution 
analysis with ab initio protein modeling, accurate structural models can be obtained.2-6 
 
Coevolution analysis requires as input a multiple sequence alignment with a large number of 
sequences. The massive amount of data available in public repositories such as the UniRef100 
database86 and the DOE Joint Genome Institute (JGI) metagenome database87 provide a rich source 
of diverse protein sequences. Recently, it was shown that the combination of metagenome 
sequences, coevolution analysis and Rosetta protein structure calculations can produce highly 
accurate structures.22 For a multiple sequence alignment, when the effective number of sequences 
divided by the square root of the sequence length L is greater than 64 (where the effective number 
of sequences is defined as 1 over the number of sequences within 80% identity), then homology 
model-level accuracy or better can be obtained. 
 
Structural models of HgcA and HgcB would provide valuable insight into the biochemical 
mechanism of Hg methylation. Here we express HgcA and HgcB individually in E. coli and show 
by UV-visible spectroscopy that they indeed bind corrinoid and iron-sulfur cofactors, as predicted 
from previous bioinformatics analyses. We then combine metagenome-based protein structure 
calculations to generate models of the individual domains of HgcA and of HgcB. We then show 
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how these domains assemble to form the HgcAB complex and incorporate a vitamin B12 corrinoid 
cofactor and two [4Fe-4S] clusters into the model. In addition, we analyze more than 4,300 
genomic and metagenomic sequences of HgcA to show that the evolution of this enzyme family 
has been marked by extensive horizontal gene transfer. A large diversity of HgcA is present in 
organisms that have not yet been cultured. 
 
Methods 
For experimental details see: 
Cooper, C.J., Ovchinnikov, S., Zheng, K., Rush, K.W., Podar, M., Pavlopoulos, G., Kyrpides, 
N.C., Johs, A., Ragsdale, S.W., and Parks, J.M. Structure determination of the HgcAB complex 
using metagenome sequence data: insights into the mechanism of mercury methylation. Commun. 
Biol. 2020. DOI: 10.1038/s42003-020-1047-5. 
 
MSA generation and coevolution analysis 
The sequences of HgcA and HgcB from D. desulfuricans ND13288 (UniProt IDs: F0JBF0 and 
F0JBF1, respectively) were selected for 3D structural modeling. In microbial genomes, hgcB is 
nearly always located immediately downstream of hgcA, which facilitated generation of the paired 
multiple sequence alignment. Initial alignments were generated by searching the UniProt20 
database (2015_06) with hhblits89 from HH-Suite90 and then filtering the results with hhfilter to 
remove sequences with >90% identity and columns with more than 50% gaps. A hidden Markov 
model (HMM) was then generated from the alignment with hmmbuild from HMMER version 
3.1b1 with default parameters, and hmmsearch was used to search a combined database consisting 
of JGI metagenomes (IMG/M)87 and the UniRef100 database.86 Filtering was performed to 
generate the final paired alignment. GREMLIN91, 92 was used to perform the coevolution analysis 
and predict intra- and interdomain contacts. A single GREMLIN calculation was performed on the 
paired multiple sequence alignment. The GREMLIN output provides predicted contacts that are 
ranked based on the strength of the coevolution signal between residue pairs. These raw contacts 
were then normalized and reweighted according to a previously described model that estimates the 
contact prediction accuracy from the normalized GREMLIN scores, the number of sequences in 




hhsearch from HH-Suite was used to search the PDB70 database of hidden Markov models 
(HMMs) for homologous proteins with known structures using the HgcAB query HMM as input. 
For the resulting list of potential templates, HH∆ was calculated to determine if the multiple 
sequence alignment was closer to the query protein than a given structural homolog.91 
Ab initio modeling 
The approach used to generate the model has been described previously.22 Briefly, individual 
domains were folded with the standard Rosetta ab initio structure prediction method using 
restraints derived from the coevolution analysis. For each domain, we generated 10,000 models 
with sigmoidal restraints, 10,000 models with sigmoidal restraints and bounded restraints (with 
bounded restraints applied only during the centroid stage), and 4,000 map_align models with 
sigmoidal and bounded restraints. The program map_align22 identifies structural homologs by 
aligning contact maps predicted from coevolution analysis with contacts in experimentally 
determined structures, in this case a subset of the Protein Data Bank with a maximum of 30% 
mutual sequence identity.93 
 
The first nine residues of HgcA were excluded from the model because they are not highly 
conserved. The last ten residues of HgcB were not included in initial modeling but were added 
after the complex was assembled. Models were ranked by the sum of their Rosetta energy94 and 
restraint score (scaled by a factor of 3). A diverse set of 30 top-scoring models selected on the 
basis of their pairwise TMscore95 was then used as input for iterative hybridization.1 The 
RosettaScripts interface96 was used for both the map_align models and for iterative hybridization. 
Modeling of [4Fe-4S] clusters 
Consistent with the expected Cys coordination patterns from other dicluster ferredoxins, such as 
that from Clostridium acidurici (PDB entry 2FDN),97 preliminary de novo models of HgcB with 
coevolution restraints suggested that one [4Fe-4S] cluster is bound to Cys20, Cys23, Cys26, and 
Cys60 and another is bound to Cys50, Cys53, Cys56, and Cys30. Thus, after a preliminary model 
of the HgcAB complex was generated, additional restraints were included in subsequent hybrid 
modeling to enforce geometries consistent with cluster binding. The C-terminal tail of HgcB was 
also introduced at this step. All Cys restraints were generated on the basis of the 0.94 Å resolution 
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crystal structure of ferredoxin from C. acidurici (PDB entry 2FDN) and were the average values 
for the corresponding residues in each cluster. Harmonic distance restraints of 6.4 +/- 0.5 Å were 
applied to all pairs of Sg atoms among the four cysteines coordinated to each [4Fe-4S] cluster. 
Harmonic angle restraints were applied to Ca-Cb-Sg angles in each Cys residue as follows: Cys20 
and Cys50, 114.6 +/- 1 deg; Cys23 and Cys53, 116.9 +/- 1 deg; Cys26 and Cys56, 112.9 +/- 1 deg; 
Cys30 and Cys60, 108.9 +/- 1 deg. Circular harmonic restraints were applied to the C-Ca-Cb-Sg 
dihedrals in each cysteine as follows: Cys20 and Cys50, 56.1 +/- 2.3 deg; Cys23 and Cys53, -52.7 
+/- 2.3 deg; Cys26 and Cys56, -71.6 +/- 2.3 deg; Cys30 and Cys60, 58.4 +/- 2.3 deg. Explicit [4Fe-
4S] clusters were placed into the final model by aligning the Sg atoms of cluster-binding cysteines 
of the model with those in 2FDN. 
Modeling of the corrinoid cofactor 
The specific corrinoid cofactor used by HgcA differs from organism to organism. For example, 
the corrinoid used by most species of Geobacter is 5-hydroxybenzimidazolyl cobamide. However, 
the cofactor used by ND132 is not known, so B12 was used. The cofactor was first placed in the 
binding pocket by superposing the CBD onto an X-ray structure of CFeSP. Polar residues in the 
CBD of CFeSP that interact with the B12 cofactor are conserved in HgcA. Thus, the following 
harmonic distance restraints were applied to facilitate cofactor binding in the HgcAB model: Thr60 
(Og1)–B12 (N3B), 2.9 +/- 0.1 Å; Thr66 (Og1)–B12 (O4), 2.7 +/- 0.2 Å; Val91 (N)–B12 (O4), 3.0 +/- 
0.05 Å; Ala153 (N)–B12 (O6R), 3.1 +/- 0.2 Å. Cys93 in HgcA was modeled as a chemically 
modified residue consisting of a coordinating bond between Sg and the Co center in vitamin B12 
with a harmonic distance restraint of 2.5 +/- 0.1 Å and a Cb-Sg-Co harmonic angle restraint of 108 
+/- 5 degrees. We then generated 1,500 models with the Rosetta Relax application.98 The model 
with the lowest Rosetta score was selected as the final model. The Dali web server99 was used to 
identify structures in the PDB with folds that are similar to those of the HgcA and HgcB models. 
Figures were generated with PyMOL version 2.2.0.100 
Phylogenetic analysis 
HgcA sequences identified in UniRef100 and IMG/M included 296 sequences from genomes of 
isolated bacteria and archaea and from taxonomically assigned uncultured organisms (assembled 
genomes from single cells or metagenomes), as well as ~4,200 sequences (after filtering to a 90% 
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identity cutoff) identified in bulk metagenomes. The sequences were aligned with Muscle (v. 
3.8.425)101 in Geneious (version 10)102 and the alignment trimmed to eliminate highly variable 
positions (<30% overall similarity). A phylogenetic tree was constructed using FastTree (v. 
2.1.12)103 and visualized in iTOL.104 
Results  
We cloned and expressed full-length HgcA from D. desulfuricans ND132 heterologously in E. 
coli as an N-terminal His-tagged construct (His-HgcA) (Figure 2A in Appendix I).105 Similarly, 
HgcB was produced separately as a maltose-binding protein fusion construct (MBP-HgcB). 
Electronic spectra of HgcA and HgcB 
After purifying each protein, we obtained UV-visible spectra to confirm cofactor binding. The 
characteristic UV-visible peaks of dicyanocobalamin are 367, 540 and 580 nm.106, 107 We obtained 
a spectrum from KCN and heat-treated His-HgcA (95 °C for 20 min) and compared it to that of 20 
µM dicyanocobalamin dissolved in the same phosphate buffer (Figure 2B). Both spectra show the 
characteristic peaks of dicyanocobalamin, demonstrating that HgcA indeed binds cobalamin. 
Sodium dithionite (1 mM) was added to 12.5 µM HgcB (25 µM [4Fe-4S] cluster), quenching the 
absorbance in the 300-500 nm region, as is characteristic of reduced [4Fe-4S] cluster proteins 
(Figure 2C). 
 
Lack of suitable templates for homology modeling 
Structural models of HgcA published to date are limited to the core of the CBD.7, 108 To determine 
whether including coevolutionary information is likely to provide more information for structural 
modeling of HgcA and HgcB than homology modeling, we searched a nonredundant subset of 
structures in the Protein Data Bank and calculated HH∆ for potential templates. HH∆ values less 
than 0.5 for a query and template sequence are generally considered to be good candidates for 
template-based modeling, whereas those with values greater than 0.5 are not. The lowest HH∆ 
value for the paired alignment of HgcA and HgcB is 0.77 (Table 1 in Appendix I), with the top 
hit corresponding to an X-ray structure of the corrinoid iron-sulfur protein CFeSP (PDB entry 
4DJD).14 However, only the core of the CBD is covered by the template. No structures in the PDB 
were identified by hhsearch that could serve as templates for the TMD of HgcA. The lowest HH∆ 
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value for a template that covers HgcB is 0.92 for the Fe hydrogenase from D. desulfuricans (PDB 
entry 1HFE).109 
Multiple sequence alignments and contact map predictions 
To obtain a sufficient number of sequences for coevolution analysis, we searched a large master 
database comprising JGI metagenomes and the UniRef100 database for sequence homologs of 
HgcA and HgcB. Initial searches identified 7,505 and 19,317 putative HgcA and HgcB sequences, 
respectively. We then exploited co-occurrence and adjacency to generate a paired alignment of 
HgcA and HgcB. After pairing of HgcA and HgcB sequences based on whether two hits were from 
the same metagenomic contig, we obtained 3,025 sequences. We used 90% identity filtering to 
remove redundant sequences (2,432), but later reweighted by 80% identity to obtain the effective 
number of sequences (1,783). From the paired alignment, the estimated contact prediction 
accuracy is Nf = seq/√len = 87.1 for the 419 amino acids in HgcA and HgcB remaining after 
trimming regions at the N- and C-termini that are not well constrained by predicted contacts. This 
Nf value indicates that HgcA and HgcB are excellent candidates for structural modeling guided by 
coevolution-based contact restraints. 
Structural modeling 
Intra- and interdomain residue-residue contacts were predicted by performing a coevolution 
analysis of the HgcAB paired alignment. Surprisingly, the contact map includes very few predicted 
contacts between the two domains of HgcA (Figure 3). Gly33 is predicted to interact with Val186, 
and Leu32 is predicted to interact with Tyr189. In addition, Val173 and Thr174 are both predicted 
to interact with Glu179, but these residues are located near the boundary between the two domains. 
However, there is clear evidence for several contacts between the CBD of HgcA and HgcB. 
CBD of HgcA  
Rosetta modeling guided by coevolution analysis revealed that the core of the CBD of HgcA 
adopts a Rossmann fold with five b sheets, four major a-helices and two short helical regions 
(Figure 4). An additional a-helix is present near the N-terminus. A search of the Protein Data 
Bank with the Dali web server revealed several proteins with structural similarity to the CBD 
model (Table 2). As expected, the protein with the greatest structural similarity to the CBD of 
HgcA is CFeSP (PDB entry 2YCL, Z-score = 14.2). The sequence identity between the CBD of 
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HgcA (residues 15-166) and CFeSP (residues 291-445) is only 27%, but the binding pocket that 
accommodates the nucleotide tail of the cofactor is similar in the two proteins.7 Besides the four 
conserved hydrogen bonds that were used as distance restraints (see Methods), the B12 cofactor 
forms hydrogen bonds with several other residues in the model (Figure 4 and Table 2). 
TMD of HgcA 
The TMD consists of five TM helices, with helix 4 forming a central stalk that is mostly surrounded 
by helices 1, 2, 3 and 5 (Figure 5). Helices 1 and 2 are the longest, both consisting of 31 residues. 
Helix 5 includes 29 residues and helix 4 includes 24. Helix 3 is the shortest, comprising 21 
residues. Based on the coevolution analysis, all adjacent pairs of helices in the model are predicted 
to be in contact with each other except for helices 1 and 5 (Figure 5B). A search of the Protein 
Data Bank with the Dali web server identified structural similarity between the TMD of HgcA and 
several membrane proteins (Table 4). Interestingly, the top hit is an X-ray structure of the 
homodimeric Mg2+ transporter MgtE from Thermus thermophilus (PDB entry 2YVX, Z-score = 
6.8).110 
HgcB 
HgcB consists of an N-terminal core domain with a typical [4Fe-4S] ferredoxin fold111 followed 
by an a-helical extension and a disordered tail at its C-terminus (Figure 6). The core domain of 
HgcB (residues 12-68) displays the same two-fold pseudosymmetry as the bacterial ferredoxin 
from Clostridium acidurici97 and other ferredoxins. In addition, it is structurally similar to 
numerous proteins including heterodisulfide reductase, tungsten formylmethanofuran 
dehydrogenase subunit FwdA, photosystem I subunit PsaC, and adenylylsulfate reductase (Table 
5). A similar a-helical extension is present in some ferredoxins, such as that from Thauera 
aromatica.112 However, the additional disordered tail at its C-terminus appears to be unique to 
HgcB.  
 
Cysteine residues 20, 23, 26 and 60 bind cluster A and residues 50, 53, 56, and 30 bind cluster B. 
The strictly conserved Cys73 in HgcB is located at the beginning of the a-helical extension and is 
located ~13 Å from the nearest Fe atom in cluster B in the model (Figure 6B). The number of 
cysteines and the total number of residues in the disordered tail vary among HgcB orthologs. Of 
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the 2432 sequences in the paired alignment, 1943 have at least one additional Cys located 
downstream of Cys73 and 1317 have two or more C-terminal cysteines. The majority of these 
sequences were obtained from metagenomes, so it is likely that some are truncated at their termini. 
Thus, these counts represent a lower bound for the number of cysteines located at or near the C-
terminal tail of HgcB. 
Assembly and analysis of the HgcAB complex 
Using the top predicted interdomain contacts to guide docking of the individual domains together 
(Figure 7A), we generated a model of the HgcAB complex. Based on the ratio of the number of 
contacts in the model to those expected from the coevolution analysis given the number of 
sequences in the paired alignment and the GREMLIN score,6 the estimated accuracy of the model, 
Rc, is 0.87. Rc values for native proteins range from 0.7 to 1.2. Thus, in general the HgcAB 
structural model fits the predicted contact set well (Figure 7B). 
Interfacial residues 
In the assembled complex (Figure 8), residues in the CBD of HgcA interact with the core of HgcB 
via several polar contacts: Gly96 (O)–Arg58 (NE), Gly132 (N)–Asn59 (OD1), Thr131 (OG1)–
Asn59 (OD1), Arg136 (NH1)–Pro61 (O), Gly132 (O)–Ser25 (OG), Glu168 (OE2)–Lys2 (NZ), 
and Val (N)–Pro31 (O) (Figure 9 and Table 6). Polar contacts between residues in the TMD of 
HgcA and HgcB include: Asn245 (O)–Arg5 (NH1), Arg250 (NH2)–Arg5 (O), Arg250 (N)–Asp8 
(OD2), and Tyr303 (O)–Asp8 (N). The a-helical extension of HgcB interacts with TM helices 4 
and 5 in HgcA, which protrude above the expected position of the membrane head groups. All 
contacts between the C-terminal extension and the TM helices of HgcA are nonpolar. 
 
The distance between the closest Fe atom in cluster B and Co in the assembled model is 14.9 Å. 
The strictly conserved Cys73 in HgcB is located at the beginning of the C-terminal extension and 
is oriented away from the corrinoid in the CBD (Figure 8). The C-terminal cysteines in HgcB 
(Cys94 and Cys95) are located at the end of a long, disordered tail, which is likely to be highly 
flexible. Both Cys73 and the B12 cofactor are accessible by Cys94 and Cys95, suggesting a possible 




Several pieces of evidence suggested that HgcAB could function as a dimer of heterodimers, i.e., 
(HgcAB)2: (i) Helices 1 and 5 in the TMD are not predicted to contact each other (Figure 5), which 
suggests that the TMD may not form a tight, cylindrical bundle but may instead be more open or 
splayed out and may interact with another protein. (ii) The closest structural homolog to the TMD 
model identified by the Dali server is a homodimeric Mg2+ transporter (PDB entry 2YVX).110 (iii) 
There appears to be self-complementarity in the shape of the HgcAB subunit, particularly in the 
TMD. (iv) Three functionally important residues in HgcB, Cys73, Cys94 and Cys95 are all 
oriented away from the B12 cofactor in the HgcAB model (Figure 8), but these residues in one 
HgcB protomer would be oriented toward the corrinoid in the opposite HgcA protomer in a dimer 
of heterodimers model. (v) Some of the predicted contacts, particularly in the TMD, are relatively 
long in the model and could potentially be interpreted as inter-oligomeric contacts. We therefore 
explored this possibility by performing symmetric docking113 of two copies of HgcAB using 
ambiguous restraints. However, we found that the inter-oligomeric contacts were all longer and 
therefore less favorable than those in the original HgcAB model (Figure 7). Thus, the present 
coevolution analysis appears to support a 1:1 rather than a 2:2 oligomerization state. 
Phylogenetic analysis 
In addition to providing input for coevolution analysis, the deep multiple sequence alignment 
obtained in this work enables an unprecedented phylogenetic analysis of HgcA diversity in nature. 
It has been shown previously that the phylogeny of HgcAB is not congruent with that of Bacteria 
and Archaea species, suggesting the genes have been horizontally transferred across the different 
microbial lineages.11 The more than tenfold expansion of the number of available sequences based 
on more recent metagenomes and additional cultured organisms provides much deeper insight into 
the diversity of Bacteria and Archaea that we predict to be able to methylate mercury, in a variety 
of environments. Although HgcA sequences from methanogens appear to remain confined to a 
single major clade, the genes from important methylating bacteria such as Deltaproteobacteria and 
Firmicutes are distributed across three or four distinct clades, suggesting multiple horizontal gene 
transfer events followed by independent diversification (Figure 11). The various groups of HgcA 
also include sequences from a variety of cultured bacterial phyla (including Chloroflexi, 
Nitrospirae, Spirochaetes, Bacteroidetes) but also phyla with few or no cultured representatives 
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(e.g., Raymondbacteria, Saganbacteria, Lentispherae). Several archaeal phyla with no cultured 
representative also appear to include potential methylators, such as Heimdallarchaeota and 
Theionarchaea. Interestingly, distinct sequence clades composed of dozens of metagenomic 
sequences cannot be assigned to any specific microbial taxa, suggesting we still have much to learn 
about the diversity of bacteria and archaea that can methylate mercury. 
 
Discussion 
We have combined coevolution-based contact prediction and Rosetta modeling to generate a 
model of the HgcAB complex, which is responsible for Hg methylation in anaerobic 
microorganisms. This system is challenging to model because HgcA includes a transmembrane 
domain with no detectable sequence homology to any structurally characterized protein, and the 
complex consists of a unique heterodimeric structure in which the two domains of HgcA do not 
interact with each other but are instead bridged by interactions with HgcB. In addition, both 
proteins bind complex metal cofactors, which we have confirmed experimentally through 
heterologous expression and UV-visible spectroscopic characterization. These cofactors, vitamin 
B12 and two [4Fe-4S] clusters were incorporated into the model, which is consistent with available 
data from in vivo site-directed mutagenesis experiments targeting highly conserved residues in 
both HgcA and HgcB.16 
 
Some of the predicted residue-residue contacts in the fully assembled model are longer than 
expected (Figure 7), suggesting that structural rearrangements (i.e., domain motions) may occur 
during catalysis.114 The closest Fe atom from [4Fe-4S] cluster B is ~15 Å from the Co center in 
the B12 cofactor. However, it is likely that the CBD can move slightly closer to enable efficient 
electron transfer. Corrinoid-dependent enzymes with Rossmann domains often bind to (β/α)8 
triosephosphate isomerase (TIM) barrel proteins to perform tightly controlled radical chemistry.115 
In addition, the CBD of the closest known homolog of HgcA, the corrinoid/iron-sulfur protein 
(CFeSP), is known to undergo large-scale conformational rearrangements, as revealed by X-ray 
co-crystal structures with its methyltransferase, a TIM barrel protein.14 In the HgcAB model, the 
CBD is oriented toward the expected location of the membrane surface (Figure 8). Such a 
conformation would preclude the approach and binding of a relatively large TIM barrel protein, 
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suggesting that movement of the CBD would be required to accommodate a TIM barrel protein as 
a methyl donor. 
 
The C-terminal tail of HgcB from D. desulfuricans ND132 includes a pair of cysteine residues 
(Cys94 and Cys95). Pairs of cysteines are commonly observed in proteins and enzymes involved 
in metal trafficking and detoxification, such as the proteins and enzymes encoded by the mer 
operon in Hg-resistant bacteria.116 For example, the mercuric reductase (MerA), which catalyzes 
the reduction of HgII to Hg0, includes two Cys residues at its C-terminus that acquire HgII and then 
transfer it to another pair of Cys residues in the active site. Whereas a double mutant of MerA in 
which both C-terminal Cys residues were substituted with Ala retained less than 0.1% of wild-
type activity, a single Ala mutant maintained the same activity as the wild-type enzyme when an 
exogenous small-molecule thiol was present.117 These findings suggest that when one of the Cys 
residues in the pair is replaced with Ala, a small molecule thiolate can substitute for the missing 
Cys to satisfy the valence of HgII. However, loss of both Cys residues completely eliminates the 
tether that binds and properly positions HgII, resulting in a major reduction in activity.  
 
Formation of MeHg by HgcAB has been previously proposed to proceed through a multi-step 
reaction involving (i) reduction of the corrinoid cofactor to form a CoI species, (ii) methylation of 
the CoI center to form a CH3-CoIII species, and (iii) methyl transfer to a HgII substrate to form 
[CH3HgII]+ (Figure 12A).7 The reduction step is presumed to be carried out by HgcB. The 
reduction potentials of the [4Fe-4S] clusters in HgcB and the corrinoid bound to HgcA have not 
been reported. However, parallels to CFeSP, in which a single [4Fe-4S] cluster serves a reductive 
activation role,118, 119 would put the CoII/I couple below -500 mV versus SHE. Loss of the axial 
Cys93 ligand is expected upon reduction to CoI to give a four-coordinate complex, which is 
supported by DFT calculations.84 Subsequent oxidative addition of the methyl group and 
coordination of Cys93 from HgcA by the reduced corrinoid form the proposed active species for 
mercury methylation. The Hg substrate that is then methylated by HgcA to produce methylmercury 
is not known but is assumed to be a HgII bis(thiolato) species. 
 
Our model provides insight into how HgcAB orchestrates the transfer and transformation of Hg. 
Specifically, we propose that Cys94 and Cys95 from HgcB acquire HgII (from an unknown source) 
25 
 
and deliver it to the corrinoid cofactor for methylation (Figure 12B). The Hg methylation step has 
been proposed to proceed through either a methyl anion transfer or radical ligand exchange 
pathway.7, 84 A relativistic DFT study found that the latter pathway is energetically more favorable 
when spin-orbit effects were taken into account.120 Assuming that the reaction proceeds through 
radical ligand exchange, a crosslinked HgcB-Cys94/95(Sg)–CoIII–(Sg)Cys93-HgcA intermediate 
would be formed. Reduction of the Co center to CoI would then release both thiolate ligands and 
allow the C-terminal tail to deliver [CH3Hg]+ to Cys73 from HgcB. Either of the C-terminal 
cysteines (Cys94/95) could facilitate delivery of the [CH3Hg]+ product, as only a single Cys 
thiolate is required to bind this species. An exogenous thiolate, possibly a cysteine residue on a 
protein, would then displace Cys73 to liberate [CH3Hg]+ from HgcB, completing the reaction 
cycle. We expect that this structural model of HgcAB will facilitate the development of hypotheses 







Table 1. HHsearch results for HgcAB 
PDB ID Coverage Prob (%) HH∆ Description 
4DJD_C 0.37 100 0.77 5-methyltetrahydrofolate corrinoid/Fe-S protein  
2H9A_A 0.37 100 0.78 CO dehydrogenase/acetyl-CoA synthase, Fe-S 
protein 
1HFE_L 0.22 99.5 0.92 Fe-only hydrogenase 
3GYX_B 0.19 99.4 0.93 adenylylsulfate reductase 
1DWL_A 0.13 99.3 0.93 ferredoxin I 
1F2G_A 0.13 99.3 0.93 ferredoxin II 
1JNR_B 0.19 99.3 0.93 adenylylsulfate reductase 
1XER_A 0.07 99.3 0.93 ferredoxin 
4ID8_A 0.14 99.3 0.93 putative ferredoxin 





Table 2. Top ten Dali results for the CBD of HgcA versus PDB25 
PDB ID Z-score RMSD (Å) N_res %ID Description 
2YCL_A 14.2 2.7 442 27 CO dehydrogenase corrinoid/iron-sulfur 
protein 
3D0K_B 5.9 3.1 293 9 putative poly(3-hydroxybutyrate) 
depolymerase LpqC 
2DST_A 5.5 3.5 122 16 hypothetical protein TTHA1544 
3B48_F 5.1 3.2 135 5 uncharacterized protein 
3GDW_B 4.9 3.6 138 5 sigma-54 interaction domain protein 
2XDQ_A 4.8 3.8 425 7 light-independent protochlorophyllide 
reductase 
3LFH_B 4.7 3.4 144 11 phosphotransferase system 
1CVR_A 4.6 3.1 433 7 gingipain R 
6HSW_A 4.6 3.5 422 14 carbohydrate esterase family 15 domain 
protein 





Table 3. Interactions between the B12 cofactor and residues in the CBD of HgcA 
B12 atom CBD atom Distance (Å) 
N3B Thr60 (OG1) 2.9a 
N3B Ala61 (N) 3.3 
O4 Thr66 (OG1) 3.0a 
O2 Thr66 (OG1) 3.2 
N52 Gly88 (O) 2.8 
O51 Asn90 (N) 2.7 
O3 Asn90 (ND2) 2.8 
O4 Val91 (N) 3.0a 
O5 Trp92 (N) 2.9 
O39 Lys97 (NZ) 2.9 
O7R Gln127 (O) 3.0 
O6R Ala153 (N) 3.2a 
O8R Ala153 (N) 3.1 





Table 4. Top ten Dali results for the TMD of HgcA versus PDB25 
PDB ID Z-score RMSD (Å) N_res %ID Description 
2YVX_A 6.8 3.8 442 12 Mg2+ transporter MgtE 
4TQ4_D 6.5 4.9 290 9 prenyltransferase 
6IU4_A 5.6 3.7 225 10 iron transporter VIT1 
5YCK_A 5.6 7.3 449 5 multidrug efflux transporter 
6FV7_A 5.5 7.9 421 6 multidrug resistance transporter Aq_128 
5EDL_A 5.4 4.5 197 6 
S-component of ECF transporter, Putative 
HMP/thiamine permease protein YkoE 
3FNB_A 5.4 4.9 374 6 acylaminoacyl peptidase, hydrolase 
5WEO_A 5.3 5.5 989 5 
glutamate receptor 2, voltage-dependent 
calcium channel 
4IDN_B 5.3 4.7 423 3 atlastin-1, hydrolase 





Table 5. Top ten Dali results for HgcB versus PDB25 
PDB ID Z-score RMSD (Å) N_res %ID Description 
5ODC_A 8.0 6.2 653 27 heterodisulfide reductase 
5T5M_F 7.9 3.4 342 31 tungsten formylmethanofuran dehydrogenase  
5T5I_P 7.8 1.3 81 39 tungsten formylmethanofuran dehydrogenase  
5OY0_c 7.8 2.9 81 27 photosystem I trimer 
3GYX_B 7.7 4.3 166 33 adenylylsulfate reductase 
5C4I_E 6.9 2.3 312 24 oxalate oxidoreductase subunit alpha 
1SIZ_A 6.7 2.1 66 26 ferredoxin 
3J16_B 6.4 6.9 608 24 ribosomal protein 
1XER_A 6.2 1.4 103 35 ferredoxin 






Table 6. Polar interactions between HgcA and HgcB in the HgcAB model 












Gly96 (O) Arg58 (NE) 
Thr131 (OG1) Asn59 (OD1) 
Gly132 (O) Ser25 (OG) 
Gly132 (N) Asn59 (OD1) 
Arg136 (NH1) Pro61 (O) 
Glu168 (OE2) Lys2 (NZ) 












 Asn245 (O) Arg5 (NH1) 
Arg250 (NH2) Arg5 (O) 
Arg250 (N) Asp8 (OD2) 









Figure 2. Purification and UV-visible spectroscopy of HgcA and HgcB. (A) SDS-PAGE gel of 
purified HgcA. The bands enclosed in the red rectangle are HgcA in elution buffer and after buffer 
exchange, respectively, as verified by western blot analysis using an antibody against the His-tag. 
(B) UV-visible spectrum of dicyanocobalamin (orange) and cofactor extracted from purified, His-
tagged HgcA by heating to 95 °C with KCN (blue). HgcA was dissolved in phosphate buffer (50 
mM K2HPO4, 100 mM NaCl, 10% glycerol, 2 mM BME, 10 mM imidazole, pH 7.4). (C) UV-
visible spectrum of oxidized, as-isolated MBP-HgcB (HgcBox) and MBP-HgcB after reduction 






Figure 3. HgcAB contact map predicted from coevolution analysis of the paired multiple sequence 
alignment. Contacts are shown in shades of blue (darker blue = higher probability) and contacts 
from X-ray structures of homologs are shown in grey. Individual domains are labeled and 





Figure 4. Model of the corrinoid binding domain of HgcA. (A) predicted contacts shown as yellow 
bars and residues colored according to sequence conservation (dark blue = highest) and (B) model 







Figure 5. Model of the transmembrane domain of HgcA. (A) Predicted contacts are shown as 
yellow bars and residues are colored according to sequence conservation (dark blue = highest). (B) 
Model rotated ~90 degrees forward to show a ‘top’ view from the cytoplasmic side. Each helix is 





Figure 6. Model of HgcB. (A) Predicted contacts are shown as yellow bars and residues colored 
according to sequence conservation (dark blue = highest). (B) Location of conserved Cys residues 







Figure 7. Assembly of the HgcAB model. (A) Top interdomain contacts (yellow) in the HgcAB 
complex predicted from the coevolution analysis. (B) Interdomain contacts in the assembled 
HgcAB complex after docking. Colors: Dark blue, CBD of HgcA; light blue, TMD of HgcA; light 
green, core of HgcB; dark green, C-terminal extension of HgcB. (C) Predicted contacts in the 
HgcAB model color coded by Ca-Ca distance. Colors: green (<5 Å), yellow (5-10 Å), red (>10 
Å). Residues with distances >10 Å are labeled. All labels refer to the residue from HgcA followed 























Figure 10. Oligimerization state of HgcAB. (A) Dimer-of-heterodimers model generated by 
applying ambiguous restraints during symmetric docking of two HgcAB heterodimers. One 
HgcAB heterodimer is shown in dark gray and the other is shown in light gray. Predicted residue-
residue contacts within a single HgcAB dimer are shown as yellow lines. Only contacts with 
probability >0.99 are shown. Representative examples of contacts that could potentially be 
satisfied between two separate heterodimers are shown as orange and red lines. (B) Stacked bar 
chart of possible contacts. The contacts are ordered by predicted probability with the highest on 
the left. In all cases the contacts within a single HgcAB heterodimer were shorter and therefore 
more favorable than inter-heterodimeric restraints, suggesting that the coevolution analysis 































Figure 12. Mechanistic insights. (A) Proposed Hg methylation cycle from refs 7, 84 and 120. (B) 
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Abstract 
A microbe’s ecological niche and biotechnological utility are determined by its specific set of co-
evolved metabolic pathways. The acquisition of new pathways, through horizontal gene transfer 
or genetic engineering, can have unpredictable consequences. Here we show that two different 
pathways for coumarate catabolism failed to function when initially transferred into Escherichia 
coli. Using laboratory evolution, we elucidated the factors limiting activity of the newly acquired 
pathways and the modifications required to overcome these limitations. Both pathways required 
host mutations to enable effective growth with coumarate, but the necessary mutations differed. In 
one case, a pathway intermediate inhibited purine nucleotide biosynthesis, and this inhibition was 
relieved by single amino acid replacements in IMP dehydrogenase. A strain that natively contains 
this coumarate catabolism pathway, Acinetobacter baumannii, is resistant to inhibition by the 
relevant intermediate, suggesting that natural pathway transfers have faced and overcome similar 
challenges. Molecular dynamics simulation of the wild type and a representative single-residue 
mutant provide insight into the structural and dynamic changes that relieve inhibition. These 
results demonstrate how deleterious interactions can limit pathway transfer, that these interactions 
can be traced to specific molecular interactions between host and pathway, and how evolution or 




Microbes can use a wide variety of compounds as carbon and energy sources. Expanding the 
breadth of compounds that a strain can catabolize can allow access to new environmental niches 
or enable engineered microbes to use new feedstocks. Correspondingly, catabolic pathways are 
frequently transferred between strains, either in nature through horizontal gene transfer (HGT) or 
in the laboratory through metabolic engineering.23, 24 However, newly-acquired pathways often 
fail to function effectively in their new host.25 In these cases, productive use of a new pathway 
may require post-transfer refinement to optimize expression and minimize deleterious 
interactions.26, 27 The pathway activity immediately following transfer may be very different from 
the potential activity after optimization, complicating predictions about engineering or HGT. 
 
We have explored this issue using pathways for catabolism of lignin-derived aromatic compounds, 
since these pathways are widespread in nature,28 are often transferred by HGT,29 have 
biotechnological applications,121 and involve challenging biochemistry.122 We previously 
constructed strains of E. coli that grow with the model lignin-derived compounds protocatechuate 
(PCA) and 4-hydroxybenzoate (4-HB) as sole sources of carbon and energy using the 3,4-cleavage 
pathway for protocatechuate catabolism from Pseudomonas putida and a 4-hydroxybenzoate 3-
monooxygenase from P. putida or Paenibacillus sp. JJ-1b.30, 31 Introduction of the relevant 
catabolic pathways was not sufficient to enable rapid growth with either carbon source. We then 
used experimental evolution to select for strains with improved growth. By resequencing the 
evolved variants and reconstructing mutations in the parental strains, we identified causal 
mutations that improved function of the heterologous pathway. 
 
In this work, we extended those pathways to allow growth with a model phenylpropanoid, 
coumarate. There are two known oxidative routes for coumarate catabolism, differing in their 
specific reaction chemistry and resulting intermediates (Figure 13 in Appendix II). These 
pathways are exemplified by the hca pathway from Acinetobacter baylyi ADP1123 and the cou 
pathway from Rhodococcus jostii.124 Both pathways begin by conjugating the phenylpropanoid 
substrate to coenzyme A. The hca pathway then uses a retro-aldol reaction to produce an 
intermediate benzaldehyde derivative, while the cou pathway uses a hydrolytic retro-Claisen 
reaction to produce the benzoate derivative directly. Since these two phenylpropanoid pathways 
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use different biochemistry and intermediates, their interactions with the host may also differ 
substantially.125 Identifying the likeliest pairing of host and pathway, either for engineering or 
HGT, will depend on understanding the specific challenges imposed by each potential pathway 
and the mechanisms to overcome these challenges available to the host. 
 
Using a combination of engineering and evolution, we constructed and optimized both 
representative pathways for phenylpropanoid catabolism in E. coli. We show that pathway activity 
is initially limited due to pathway-specific molecular interactions that can readily be alleviated 
through point mutations to the host. Similar compensatory mechanisms are present in a strain that 
natively contains the appropriate pathway. Molecular dynamics simulations of the wild-type and 
mutant enzymes demonstrate how subtle modifications to the enzyme distant from the active site 
can relieve inhibition while preserving catalysis. Identifying and alleviating the specific molecular 
interactions between an engineered metabolic pathway and its heterologous host will aid our 
efforts to rapidly engineer metabolic capabilities. 
Methods 
For experimental details see: 
 
Close, D.M., Cooper, C.J., Wang, X., Chirania, P., Gupta, M., Ossyra, J.R., Giannone, R.J., Engle, 
N., Tschaplinski, T.J., Smith, J.C., Hedstrom, L., Parks, J.M., and Michener, J.K. Horizontal 
transfer of a pathway for coumarate catabolism unexpectedly inhibits purine nucleotide 
biosynthesis. Mol. Microbiol. 2019, 112, 1784-1797. 
 
Homology modeling 
To generate models of IMPDH from E. coli (accession number P0ADG7) with the corresponding 
cofactors and substrates, HHpred126 was used to search the Protein Data Bank for suitable 
structural templates. Five templates were chosen based on their similarity to the query sequence, 
inclusion of cofactors and substrates, or both (Table 7 in Appendix II). The sequences were 
aligned with MAFFT (L-INS-i)127 (Figure 14) and homology models were generated using 
RosettaCM 128 with fragment files obtained from the Robetta web server.129, 130 The top-scoring 




The flap containing the catalytic dyad (R401 and Y402) is not resolved in most X-ray crystal 
structures of IMPDH but is present in the structure of the phosphate-bound “apoenzyme” from 
Bacillus anthracis (PDB entry 3TSB).131 Thus, we used this structure as a template to generate 
homology models of E. coli IMPDH in the closed conformation and the top scoring model was 
selected to generate a model of the C305-XMP* covalent intermediate for molecular dynamics 
simulations. Sequences were aligned with MAFFT (L-INS-i) (Figure 15). 
Ligand docking 
Structure files in mol2 format for IMP (ZINC04228242), NAD+ (ZINC08214766), and 4-
hydroxybenzaldehyde (ZINC00156709) were obtained from http://zinc.docking.org.132 
RosettaLigand133 was used to dock 4-hydroxybenzaldehyde into the active site of the IMPDH 
model following a previously described protocol.34 Top binding poses were ranked on the basis of 
their ‘interface_delta’ score in Rosetta energy units. 
Molecular dynamics simulations 
Initial coordinates for XMP were extracted from the crystal structure of B. anthracis IMPDH 
complexed with XMP (PDB entry 3TSD), and the covalently bound C305-XMP* complex was 
generated for chain A using the Molefacture plugin in VMD.134 The force field toolkit (ffTK) 
plugin in VMD was used to generate CHARMM-compatible force field parameters for C305-
XMP*. Gaussian09135 was used to perform geometry optimizations, compute Hessian matrices, 
and calculate water interaction energies of the C305-XMP* fragment. NAMD 2.11 was used for 
charge, bond, angle, and dihedral optimization.136 
 
The CHARMM36 force field137 and TIP3P water model138 were used to describe the protein and 
solvent, respectively. Each system (wild-type and mutant) was solvated in a periodic box of 168 
Å × 168 Å × 104 Å and 0.15 M KCl ions were added using CHARMM-GUI,139 resulting in a 
system of ~274,000 atoms. All-atom molecular dynamics (MD) simulations were performed using 
the OpenMM 7.0 package140 with GPU acceleration using CUDA 7.2. Ten thousand steps of 
energy minimization were performed to eliminate clashes, followed by equilibration in the NPT 
ensemble at 310 K. Temperature was maintained using the Langevin thermostat with a damping 
coefficient of 1 ps-1. To enable a 5-fs time step, which was used in all simulations, all bond lengths 
were constrained to their equilibrium distances and the masses of hydrogens were repartitioned to 
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the parent heavy atoms.140 Five separate runs of 100 ns each were performed for both the wild type 
and mutant IMPDH and the last 50 ns of each run was used for analysis. 
 
Results 
Combining engineering and evolution enabled coumarate catabolism 
We designed and synthesized two constructs containing genes for phenylpropanoid import and 
degradation, each of which converts coumarate into 4-hydroxybenzoate (Figure 13).141 Each 
pathway was introduced into E. coli strains, JME38 and JME50, that had previously been 
engineered to grow with 4-HB using pobA and praI, respectively.31 None of the engineered strains 
acquired the immediate ability to grow with coumarate as the sole source of carbon and energy. 
 
To understand the factors preventing pathway function, we used experimental evolution to select 
for strains with the ability to catabolize coumarate. Three replicate cultures of each engineered 
strain were propagated in minimal medium containing 1 g/L coumarate (~6.1 mM). After 300 
generations, individual mutants were isolated from each population and characterized for growth 
with protocatechuate (PCA), 4-HB, coumarate, and caffeate. Representative isolates were chosen 
for each replicate population for further characterization. All isolates could grow with PCA and 
coumarate, though growth with caffeate and 4-HB varied between replicates.141  
Genome resequencing and reconstruction identified causal mutations 
The genomes of the selected isolates were resequenced to identify new mutations. Several of the 
mutations have previously been described for their effects on catabolism of 4-HB, such as 
synonymous mutations to the gene encoding the 4-hydroxybenzoate monooxygenase pob.A.31 
Among the strains with the hca pathway, five of the six isolates had additional mutations to the 
native gene guaB, encoding inosine monophosphate (IMP) dehydrogenase (IMPDH), and to the 
intergenic region between hcaB and hcaC in the engineered pathway. The exception was JME96, 
which had a mutation to rpoS, encoding the RNA polymerase sigma factor σ38, that is expected to 
be highly pleiotropic.142 
 
In the strains with the cou pathway, the acquired mutations were less consistent across replicates, 
with several mutations to genes that are expected to be pleiotropic. However, parallel mutations 
were observed in JME106 and JME109, with mutations to both couL and nadR. The mutations to 
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couL, which encodes the CoA ligase, were coding mutations, L192R and S134Y. NadR is involved 
in both regulation and catalysis for NAD salvage.143 One of the mutations to nadR led to a 
frameshift that precisely removed the C-terminal ribosylnicotinamide kinase (RNK) domain, 
which converts N-ribosylnicotinamide into β-nicotinamide mononucleotide during NAD 
salvage.143 Similarly, the second nadR mutation also occurred in the RNK domain. The 
physiological consequences of these mutations are unclear. 
To test the causality of the identified mutations, we reconstructed representative mutations in the 
engineered parental strains. We assumed that parallel mutations to a given gene produced similar 
effects, and therefore only tested one representative mutation (e.g. D243G in guaB). Two 
mutations, to pobA and hcaABCK, were necessary for growth with coumarate in JME64, while a 
third mutation to guaB significantly increased growth.141 Similarly, mutations to pobA, 
couLHTMNO, and nadR were all required for growth with coumarate using the cou pathway in 
JME65. 
 
Parallelism of mutations within replicates of a pathway, but divergence between pathways, 
strongly suggests that the mutations are specific to a particular pathway. To test this hypothesis, 
we replaced the hca pathway in JME131 with either the wild-type or evolved cou pathways. 
Neither strain was able to grow with coumarate as the sole source of carbon and energy. 
Inhibitory crosstalk between engineered and native pathways limits function 
A mutation to guaB was necessary for growth with coumarate using the hca pathway. IMPDH, 
encoded by guaB, converts inosine monophosphate (IMP) to xanthosine monophosphate (XMP) 
with the reduction of NAD+ during guanine nucleotide biosynthesis.144 Five independent amino 
acid replacements in IMPDH were identified: A48V, D243G, G330D, L364Q, and P482L. IMPDH 
uses different conformations to catalyze each step of the catalytic cycle: an open conformation for 
hydride transfer that produces a covalent intermediate with the catalytic C305 (E-XMP*) and a 
closed conformation for hydrolysis of the E-XMP* (Figure 16). We generated homology models 
of wild-type E. coli IMPDH in both the closed and open conformations. The mutations are distant 




To understand the consequences of these mutations, we measured metabolite levels in the parent 
and engineered strains during growth with coumarate. Consistent with our genetic analysis above, 
we chose to focus on the D243G mutation. Compared to the D243G guaB mutant (JME131), the 
strain with wild type guaB (JME129) showed higher levels of inosine nucleotides. We 
hypothesized that growth with coumarate led to inhibition of IMPDH and accumulation of IMP, 
and that this inhibition was relieved in the guaB mutants. To determine whether inhibition of 
nucleotide biosynthesis limited growth with coumarate, we supplemented the growth medium with 
guanosine. Addition of guanosine increased growth with coumarate in a strain with the wild-type 
IMPDH, but not the mutant.  
 
Mutations to guaB improved growth with the hca pathway but not with the cou pathway. The hca 
pathway produces an intermediate, 4-hydroxybenzaldehyde, that is not present in the cou pathway 
(Figure 13). To test whether this intermediate was responsible for the inhibition of IMPDH, we 
grew strains containing WT and mutant IMPDH in varying concentrations of 4-
hydroxybenzaldehyde.141 Both strains were inhibited by high concentrations of 4-
hydroxybenzaldehyde, but the mutation to guaB decreased inhibition.  
 
Next, we purified WT and mutant IMPDH and measured inhibition in vitro with 4-
hydroxybenzaldehyde. This compound is a weak inhibitor of WT EcIMPDH, with a Ki,app of 320 
± 20 µM. Introduction of the D243G replacement had little effect on catalytic activity but increased 
the Ki,app to 1250 ± 50 µM, indicating a substantial reduction of inhibition in the mutant. The hca 
pathway that we used came from A. baylyi ADP1, and we hypothesized that the native IMPDH of 
this strain would have faced similar selective pressures to minimize inhibition by 4-
hydroxybenzaldehyde. As a surrogate, we tested the IMPDH of A. baumannii, since this strain 
contains a homologous hca pathway (83-94% amino acid identity) and IMPDH (91% amino acid 
identity). As predicted, the A. baumannii IMPDH has a Ki,app of 720 ± 30 µM, substantially higher 
than that of wild-type EcIMPDH. 
Subtle changes in enzyme dynamics relieve inhibition while maintaining catalysis 
To gain insight into possible mechanisms of inhibition by 4-hydroxybenzaldehyde, we measured 
enzyme activity at varying inhibitor concentrations. 4-hydroxybenzaldehyde is an uncompetitive 
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inhibitor with respect to IMP and a noncompetitive (mixed) inhibitor with respect to NAD+ for 
both wild type and D243G EcIMPDH.141 Similar patterns of inhibition have been observed for 
compounds that bind in the NAD+ site.131 In addition, we computationally docked 4-
hydroxybenzaldehyde to a model of wild-type IMPDH in the open conformation of the apoenzyme 
as well as to IMP-bound and IMP/NAD+-bound states. In both the apoenzyme and IMP-bound 
models, the majority of the top poses of 4-hydroxybenzaldehyde were found to occupy the NAD+ 
binding site, approximately 20 Å from D243 (Figure 18 and Table 8). Therefore, to relieve 
inhibition by 4-hydroxybenzaldehyde, the D243G substitution would need to perturb the structure 
or dynamics of the distant active site. 
 
Understanding the mechanism of this perturbation required additional analysis. The hydrolysis of 
E-XMP* is the slow step in the IMPDH reaction, so E-XMP* is the predominant enzyme 
complex.144 Therefore, a decrease in the affinity of 4-hydroxybenzaldehyde for E-XMP* can 
account for resistance to inhibition. Hydrolysis of E-XMP* requires a conformational change 
wherein a mobile protein flap folds into the cofactor binding site. We assessed the effect of the 
D243G mutation on the active site by performing MD simulations of wild-type and D243G mutant 
IMPDH in the covalently bound E-XMP* state using the closed conformation model, since the 
flap is disordered in crystal structures of the open conformation. In the simulations of the wild-
type E. coli IMPDH, D243 forms stable hydrogen bonds with the side chains of K87 and R219 
and also with the backbone of V220 (Figure 19A). In the absence of this hydrogen bonding 
network in the mutant (Figure 19B), G243 adopts two different conformations, one that resembles 
the wild type in which G243 is close to but not interacting with K87, R219, and V220, and another 
in which G243 is positioned farther away from these residues when a new hydrogen bond is formed 
with Q272 (Figure 19C). However, it was not obvious how these local changes around the 
mutation site propagate to the active site, which is located on the opposite side of the b-barrel.  
 
To identify changes in protein dynamics resulting from the D243G mutation, we calculated root-
mean-squared fluctuations (RMSFs) for chain A in both the wild-type and mutant. In both systems, 
high RMSFs were observed over the entire flap region (Figure 20). Upon inspection of specific 
interactions of flap residues, we found that the mutation leads to changes in hydrogen-bonding 
interactions with other residues on chain A or the adjacent chain D (Figure 21 and Figure 22). 
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These interactions resulted in reorientation of a loop on the flap that could alter inhibitor binding. 
R386 interacts with D50 and D410 interacts with H432 on chain D more frequently in the wild 
type than in the mutant. Interestingly, other interactions between flap residues are observed more 
frequently (i.e. R386-E418, S399-D410, S405-D410) in the mutant. S405 and D410 also have 
additional hydrogen bonding interactions with residues on chain D that differ between the wild-
type and mutant. S405 forms a hydrogen bond with N26 on chain D more frequently in the mutant 
than the wild type. In contrast, D410 forms a hydrogen bond with R439 on chain D more frequently 
in the wild type than the mutant. In addition, the covalent intermediate also forms a hydrogen bond 
with the side chain of E415 more frequently in the mutant than the wild type. Despite these changes 
in flap conformations and dynamics, the catalytic dyad remains in close proximity to the covalent 
intermediate, poised for catalysis (Figure 23).  
 
RMSF analysis also revealed that helix a2 (residues 76-89) and helix a8 (residues 230-241) 
fluctuate more in the mutant than in the wild type (Figure 20). Helix a8 is downstream of the 
mutation site (Figure 24A). Therefore, the higher fluctuations of this helix and the adjacent helix 
a2 in the mutant are likely due to the loss of the hydrogen bonding network formed by D243 with 
K87, R219, and V220 as well as the formation of a new hydrogen bond between G243 and Q272 
in the mutant. The N-terminal end of helix a2 and the C-terminal end of helix a8 are located near 
the NAD+ binding site, which is also the predicted binding site for 4-hydroxybenzaldehyde based 
on docking to the open conformation model (Figure 18). Therefore, these perturbations to helices 
α2 and α8 represent another mechanism for the D243G mutation to affect inhibitor binding.  
 
To understand the mechanism by which helix dynamics could affect inhibitor binding, we 
combined these MD results with our previous docking studies. In six of the top 10 docking poses, 
the phenolic hydrogen of the inhibitor forms hydrogen-bonding interactions with either the side 
chain or backbone of D248. The carbonyl oxygen of the inhibitor also interacts with the side chain 
of S250 (Figure 24B). D248 and S250 are located on the b-sheet (b11) downstream of the 
mutation site and are in close proximity to helices a2 and a8 as well as the loop on the flap that 
showed different interactions in the wild-type and mutant simulations. Thus, changes in the 
structure and dynamics of these regions around the NAD+ binding site likely disrupt inhibitor 




In this work, we have recapitulated the process of HGT and demonstrated the necessity for host 
adaptations to accommodate the hca pathway in both E. coli and A. baumannii. We identified a 
novel interaction between the newly introduced pathway and the endogenous metabolism, as well 
as the physiological and biochemical consequences of this interaction. Finally, we demonstrated 
how single point mutations to an essential host protein alter its conformational dynamics to prevent 
binding of the novel inhibitor while still preserving catalysis.  
Highly similar hca pathways are present in various beta- and gamma-proteobacteria. Further HGT 
of this pathway would require either a host with an IMPDH homolog that is resistant to inhibition 
by 4-hydroxybenzaldehyde, or post-transfer selection for mutations that relieve inhibition. 
Understanding these types of limitations on HGT, and the mechanisms by which organisms evolve 
to avoid them, will aid in our ability to predict and manipulate horizontal gene transfer.26, 27 
 
In combination, our results suggest that introduction of the hca pathway allowed only limited 
growth with coumarate because accumulation of 4-hydroxybenzaldehyde inhibited the native E. 
coli IMPDH. This inhibitory crosstalk results in nucleotide starvation and impairs growth and 
phenylpropanoid catabolism. Mutations to guaB prevent inhibition by 4-hydroxybenzaldehyde and 
allow growth with coumarate. There is no a priori reason to expect that a pathway for degradation 
of an aromatic compound would interact with a native pathway for nucleotide biosynthesis. 
Phenolic amides such as feruloyl amide have been shown to inhibit a different step in nucleotide 
biosynthesis,145 but neither the substrate nor products of coumarate degradation are toxic at the 
relevant concentrations.30, 31 These types of inhibitory cross-talk are likely to be common with 
heterologous engineered metabolic pathways, though they are rarely identified and alleviated.125, 
146, 147  
 
In particular, inhibition of microbial growth by aldehydes is commonly observed, though the 
mechanisms of toxicity can rarely be traced to a specific interaction.148-150 Enzymatic pathways 
have frequently evolved to limit the release of free aldehydes, for example through enzymatic 
channeling.151 It is unclear whether channeling between HcaA and HcaB limits the release of free 
aldehydes in either the native or heterologous hosts. Mutations that increase tolerance to free 
aldehydes generally do so either by increasing export of the toxic compound or by performing 
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redox chemistry to remove the aldehyde functionality.152 In this work, we have shown an example 
of aldehyde toxicity that acts through a single protein and can be relieved by point mutations to 
the associated gene. For the D243G mutant, biochemical assays revealed mixed inhibition that was 
relieved through mutation. Other examples of nonspecific toxicity may prove to be similarly 
specific when characterized fully. 
 
MD simulations provided insight into how a single amino acid substitution distant from the active 
site could relieve inhibition while maintaining catalysis. The mutation is located at the N-terminal 
end of b11, which is near the NAD+ binding site where the inhibitor was predicted to bind based 
on docking calculations. The simulations showed local changes in the hydrogen bonding networks 
at the mutation site, which led to changes in the dynamics of the catalytic flap and helices a2 and 
a8 near the inhibitor binding site. In addition, the catalytic dyad showed only minor perturbations 
and remained poised for catalysis.  
 
Across the replicate populations, many mutations were highly pleiotropic, including large 
insertions and deletions flanked by insertion sequences as well as mutations to core transcriptional 
machinery such as rho and rpoB. Duplications frequently spanned the insertion sites for engineered 
operons, suggesting that expression of the heterologous genes was limiting. By comparing across 
replicates, we were able to identify a set of point mutations that allowed growth with coumarate 
as the sole source of carbon and energy. However, a reconstructed strain containing these 
mutations does not grow as quickly with coumarate as the evolved isolates, suggesting that some 
of the remaining mutations provided additional fitness benefits.141  
 
The two 4-HB monooxygenases, praI and pobA, are 60% identical at the nucleotide level, and the 
associated enzymes have 54% amino acid identity. We previously demonstrated that these 
enzymes required different optimization solutions to enable growth with 4-HB.31 In contrast, in 
this experiment, the evolutionary solutions were very similar. Even in the optimized strain, 
JME131, the growth rate with coumarate was lower than the growth rate with PCA. We 
hypothesize that the conversion of coumarate into 4-HB is the rate-limiting step, and that the 




Multiple mutations were identified in the heterologous cou and hca pathways. In the hca pathway, 
these mutations served to increase expression of the pathway, either through pathway duplication 
or by intergenic mutations that affected translation, specifically increasing expression of the CoA 
ligase HcaC. The cou pathway mutations were coding mutations to a single gene, the couL that 
encodes a CoA ligase, and decrease expression of that enzyme.141 These differential evolutionary 
responses could arise from different initial expression levels of the two CoA ligases, for example 
due to the placement of couL at the beginning of an operon and hcaC at the end. Further 
biochemical analysis will be required to precisely identify the consequences of these mutations. 
 
We have described the use of experimental evolution to identify and alleviate deleterious 
interactions between engineered metabolic pathways for coumarate catabolism and native 
pathways for nucleotide biosynthesis and cofactor salvage. Many engineered pathways place a 
substantial burden on the production host yet understanding and accommodating these interactions 
remains challenging. Evolution can simplify this optimization process by directly selecting for 
mutations that eliminate the inhibition. As we did with guaB, researchers can then work backwards 
from the evolutionary solutions to understand the factors that were initially limiting productivity 
and the biochemical solutions to overcome those problems. By solving more problems of this sort, 
we will develop design rules for future forward engineering of metabolic pathways and better 






Table 7. Templates used to model the open and closed conformations of E. coli IMPDH 
State PDB ID Organism Resolution (Å) E-value % ID Cofactors 




1.90 9.8e-55 56 IMP 
5AHN Pseudomonas 
aeruginosa 
1.65 4.8e-59 66 IMP 
2CU0 Pyrococcus horikoshii 2.10 2.9e-47 49 XMP 
1VRD Thermotoga maritima 2.18 8.3e-47 56 n/a 





Table 8. Binding energies for the top five poses obtained from docking 4-hydroxybenzaldehyde 
to the apoenzyme, IMP-bound, and IMP/NAD+-bound states of IMPDH 
interface_delta (Rosetta energy units) 
apoenzyme IMP-bound IMP/NAD+-bound 
-11.5 -12.4 -10.3 
-11.0 -12.2 -9.4 
-10.6 -12.1 -9.3 
-10.6 -12.1 -8.9 







Figure 13. Two routes to convert the phenylpropanoid coumarate to 4-HB (the hcaABC pathway 
from A. baylyi ADP1 and the couLMNO pathway from R. jostii). 4-HB is then oxidized to PCA. 





Figure 14. MAFFT (L-INS-i) multiple sequence alignment of IMPDH from A. baumannii, E. coli, 
and multiple template sequences used for structural modeling of the open conformation of E. coli 







Figure 15. MAFFT (L-INS-i) alignment of E. coli IMPDH with the B. anthracis template 
sequence of the closed conformation that contains the catalytic flap (PDB entry 3TSB). Selected 





Figure 16. IMPDH mechanism. IMPDH transitions between two conformations, an open 
conformation for rapid substrate binding and hydride transfer and a closed conformation for the 







Figure 17. Beneficial mutations to IMPDH are distant from the active site. (A) Structural model 
of E. coli IMPDH colored by chain. (B) Chain A of IMPDH in the closed conformation, 







Figure 18. Top 5 predicted docking poses for 4-hydroxybenzaldehyde to the open conformation 
model of IMPDH in various enzyme states. (A) Apoenzyme, (B) IMP-bound, and (C) IMP/NAD+-
bound IMPDH. The top five docking poses are shown in each case. 4-hydroxybenzaldehyde 
carbons are shown in cyan. All other carbons are shown in yellow. Molecules in transparent 
representation are shown for reference but were not included in the docking. All hydrogens are 







Figure 19. A beneficial mutation to IMPDH affects enzyme structural dynamics. Hydrogen bond 
network around the D243G mutation site for (A) wild-type and (B) mutant IMPDH from MD 





Figure 20. RMSF analysis of wild-type and mutant IMPDH. (A) RMSF of the chain A core 
domain of wild-type and mutant IMPDH from MD simulations. CBS domains and termini are 
highly dynamic and were excluded. The helix residues are indicated with grey boxes. Residues 






Figure 21. The D243G mutation alters the conformation of several residues on the catalytic flap. 
Hydrogen bond network around the catalytic flap for (A) wild-type and (B) mutant IMPDH from 
MD simulations. (C) Heavy atom distance distributions from the individual, independent 





Figure 22. Changes in the conformation of residues on the catalytic flap in MD simulations of (A) 
wild type and (B) mutant IMPDH in the closed conformation. (C) Heavy atom distance 
distributions for residues near the catalytic dyad and C305-XMP* loop of chain A that have 
different interactions with other chain A residues or with residues on chain D between the wild-












Figure 24. Summary of wild-type and mutant IMPDH simulations. (A) Selected snapshots of the 
flap from MD simulations of wild-type and mutant IMPDH in the closed conformation. Ca atoms 
of key residues whose interactions differ between wild type and mutant simulations (D50, R386, 
S399, S405, D410, E418) are shown as spheres and labeled. A selected docking pose is shown for 
4-hydroxybenzadehyde in the IMP-bound open conformation after superposition with the closed 
conformation snapshots. (B) Selected docking pose showing 4-hydroxybenzaldehyde interactions 
with residues D248 and S250. Flap residues were omitted as they were not resolved in the 
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Abstract 
Predicting the range of substrates accepted by an enzyme from its amino acid sequence is 
challenging. Although sequence- and structure-based annotation approaches are often accurate for 
predicting broad categories of substrate specificity, they generally cannot predict which specific 
molecules will be accepted as substrates for a given enzyme, particularly within a class of closely 
related molecules. Combining targeted experimental activity data with structural modeling, ligand 
docking, and physicochemical properties of proteins and ligands with various machine learning 
models provides complementary information that can lead to accurate predictions of substrate 
scope for related enzymes. Here we describe such an approach that can predict the substrate scope 
of bacterial nitrilases, which catalyze the hydrolysis of nitrile compounds to the corresponding 
carboxylic acids and ammonia. Each of the four machine learning models (logistic regression, 
random forest, gradient-boosted decision trees, and support vector machines) performed similarly 
(average ROC = 0.9, average accuracy = ~82%) for predicting substrate scope for this dataset. The 
approach is intended to be highly modular with respect to physicochemical property calculations 





Many enzymes are capable of accepting multiple molecules as substrates. Knowledge of the 
repertoire of substrates for a given enzyme, often referred to as substrate scope, is informative for 
elucidating biochemical pathways and also for metabolic engineering. Standard sequence-based 
annotation methods are generally highly effective at identifying (super)family membership, 
conserved domains, sequence signatures, active site residues, and assigning gene ontology (GO) 
terms for sequences with detectable homology to proteins of known function but fall short of 
predicting substrate scope. The BRENDA enzyme database currently contains manually curated 
information on ~84,000 enzymes including classification nomenclature, biochemical reaction, 
substrate specificity, structure and other attributes, but is limited to experimentally verified 
systems.32  
 
Beyond the primary amino acid sequence, protein structures provide insight into enzymatic 
function. The overall protein fold, domain architecture, and spatial arrangement of residues 
involved in substrate recognition and catalysis all provide useful clues to function. Homology 
modeling is often used to generate structural models of proteins when suitable templates are 
available. However, the accuracy of modeled structures depends on various factors, including the 
similarity between the query sequence and the template(s). Scoring functions and conformational 
sampling strategies also play a role in model accuracy.1  
 
A combination of molecular docking of putative substrates to an available X-ray crystal structure, 
QM calculations of substrate reactivity, and experimental enzyme activity assays predicted 
substrate specificity of an enoyl-acyl carrier protein reductase (FabI).33In the absence of a crystal 
structure, homology modeling can be used in the context of ligand docking.34-36 However, 
molecular docking studies often struggle to differentiate between ligands with similar scaffolds 
due to inaccuracies in the models and in scoring functions. In addition, docking is insufficient to 
predict enzymatic activity because it does not account for chemical reactivity.37 Some of these 
limitations can be overcome by combining complementary information from modeling, docking 
and other sources. For example, a combined analysis of genomic context, homology modeling and 
metabolite docking was used to identify substrate specificities of multiple enzymes encoded in a 
bacterial gene cluster.153 
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Machine learning (ML) is widely applicable to a variety of problems from fields such as quantum 
mechanics, physical chemistry, biophysics, and physiology. For example, a Gaussian process 
model that incorporated information from protein sequence and contact maps derived from crystal 
structures was used in combination with directed evolution to engineer channelrhodopsin with high 
light sensitivity.38 ML has also shown promise in predicting substrate specificity. For example, a 
support vector machines (SVM) approach was used to predict substrate specificity of adenylation 
domains in non-ribosomal peptide synthases from physicochemical properties of active site amino 
acids.39A related method extended this approach to predict specificity by incorporating active site 
structural information from sequence alignments to a template from a homologous structure.40 
Using SVM coupled with an active learning approach to prioritize compounds for experimental 
testing to provide maximal benefit to the model, substrates were predicted for four different 
enzymes with an accuracy of ~80%.154 Enzymatic activity of 107 glycosyltransferase superfamily 
1 (GT1) sequences from Arabidopsis thaliana was predicted with an accuracy of ~90% using a 
decision tree-based classifier that incorporated local sequence information, physicochemical 
properties of substrate donor and acceptor molecules, and experimental activity data.41 
 
Nitrilases are a family of the carbon-nitrogen hydrolase superfamily that catalyze the hydrolysis 
of nitrile compounds to their corresponding carboxylic acids and ammonia (Eq. 1). They are an 
example of an enzyme family with broad scope and are found in a range of eukaryotic and 
prokaryotic organisms. Nitrilases play an important role in many biological processes, such as the 
degradation of toxic nitrile compounds, metabolism and generation of hormones, and synthesis of 
signaling molecules.42 In the context of plant-microbe interactions, they are believed to play a role 
in hormone synthesis, nutrient assimilation, detoxification, and modulation of plant development 
and physiology, making them attractive for improved food crop production.43In addition, nitriles 
are desirable for their use in efficient chemo- and enantioselective synthesis of carboxylic acids, 
making them attractive for drug design.44, 45 Typically, nitrilases are classified into three categories 
according to their substrate specificities: aliphatic, arylaceto-, and aromatic nitrilases.43, 46 In terms 
of chemistry and reactivity, Enzyme Commission numbers have been assigned for aliphatic (EC 
3.5.5.7) and arylacetonitrilases (EC 3.5.5.5). However, no broad category of aromatic nitrilases 






Various nitrilase activity assays have been described and are based on either fluorogenic or 
chromogenic substrates or pH indicator methods.45, 47, 48 Recently, a chromogenic method was 
developed as a convenient means to screen recombinantly produced nitrilases in crude cell 
extracts.49 Alleviating purification steps facilitates high-throughput screening and evaluation of 
diverse, potential substrates. 
 
High-throughput methods are essential for evaluating the large number of putative nitrilases being 
identified through genome sequencing techniques. For example, functional screening of microbial 
metagenomes from a wide range of environments has led to the identification of a diverse 
collection of nitrilases. These efforts have facilitated characterization of the relationship between 
gene sequence and substrate specificity based on experimental evaluation of the hydrolysis of 
diverse nitrile substrates.44Three substrates, mandelic acid, phenyl lactic acid and 4-cyano-3-
hydroxybutyric acid, were of particular interest due to their potential use in stereospecific 
pharmaceutical biosynthesis. Reactivity toward specific substrates as well as enzymatic 
stereoselectivity were found to be strongly correlated with the phylogenetic groupings of 
individual nitriles in sequence clades or clusters. Because most tested nitrilases were identified in 
metagenomic libraries and affiliation to specific organisms could not be determined, it is unknown 
if substrate specificity is linked to microbial taxonomy. More in depth analysis of some of the 
nitrilase subfamilies identified positive selective pressure for evolving novel substrate specificities 
and enantioselectivity, suggesting that these enzymes can undergo subtle site changes that alter 
their repertoire of accepted substrates.155 Because shifts in substrate specificity and 
enantioselectivity were found associated with distinct sequences in specific subfamilies previously 
characterized for several substrates, we selected nine nitrilases from that study for in-depth 
enzymatic characterization and structural modeling. We also included two closely related putative 





Here we describe an integrated and modular approach in which we combine protein structural 
modeling, ligand docking, and physicochemical property calculation with experimental activity 
assays. We use this information to train several machine learning classifiers to predict enzyme 
activity for a set of bacterial nitrilases toward a library of 20 nitrile substrates. For this dataset, 
cross-validation revealed that that all four ML methods showed similar performance in predicting 
substrate scope. 
Methods 
For experimental details see: 
Mou, Z., Eakes, J., Cooper, C.J., Foster, C.M., Standaert, R.F., Podar, M., Doktycz, M.J., Parks, 
J.M. Structure-based prediction of enzyme substrate scope with machine learning: Application to 
bacterial nitrilases. DOI: https://doi.org/10.22541/au.158888180.03951231 
 
Phylogenetic analyses 
Nitrilase sequences were selected for structural and enzymatic analyses based on prior substrate 
specificity data and were aligned along with related sequences from sequenced microbial genomes 
using Muscle v3.8101 in Geneious v9.102 Nitrilase sequences from plants were also included as an 
outgroup. A phylogenetic tree was constructed using FastTree v. 2.1.12.103  
Structural modeling 
The amino acid sequences of 12 target nitrilases were aligned with Clustal Omega (Figure 26).157 
The GREMLIN web server91 was used to search the UniProt20 database for sequence homologs 
of each nitrilase, perform coevolution analysis, and identify potential structural templates from the 
Protein Data Bank. We used the 3.1 Å X-ray crystal structure of a bacterial nitrilase (Nit6803) 
from Synechocystis sp. PCC6803 (UniProt ID Q55949, PDB entry 3WUY) as a template and to 
generate a Rosetta symmetry file.158 For all 12 putative nitrilases, the top template was 3WUY and 
the sequences were all covered well by the full Synechocystis sp. PCC6803 sequence (>81%). 
Structural modeling was supplemented with residue-residue contact restraints obtained from the 
coevolution analysis. We used map_align (https://github.com/gjoni/map_align) to align the 
contact maps to the top ten templates22 identified by hhsearch. Due to the presence of inter-
oligomeric contacts, dimer symmetry was defined based on 3WUY and this crystal structure was 
used as the master template for modeling. Fragments were obtained from the Robetta server. 
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RosettaCM128 was then used to generate at least 5,000 models of each protein. We selected the top 
ten models based on the sum of the Rosetta energy and coevolution restraint score and aligned the 
models to the template dimer. For each protein, we selected the model with the lowest Rosetta 
score that had a low (< 3.5 Å) backbone RMSD to the 3WUY dimer and an “open” active site in 
which the volume of the active site (residues within 10 Å of Ca of the catalytic Cys) calculated 
with POVME 2.0159 was greater than 50 Å3. 
Docking and docking descriptors 
Three-dimensional structures of each nitrile were obtained from the ZINC database.160 The 
geometry of each nitrile was optimized using density functional theory at the B3LYP/6-31G(d,p) 
level of theory in the gas phase.161, 162 All quantum mechanical (QM) calculations were performed 
with Gaussian 16, revision A.03.135 Restrained electrostatic potential (RESP) charges163 were 
calculated at the HF/6-31G(d) level of theory in the gas phase. The optimized geometries and 
RESP charges were then used for docking with Rosetta Ligand.133, 164 The REF2015 score 
function165 was used for both homology modeling and docking. The center of mass of Sg from 
Cys, Oe2 from Glu and Nz from Lys in the catalytic triad was used as the initial docking site. We 
generated 5,000 docked models for each nitrile-nitrilase combination and selected the final docked 
pose based on the docking energy (interface_delta). Additional components of the Rosetta docking 
score were also included as descriptors for RF. These components included the following 
interfacial interaction energy terms: full-atom vdW attraction (fa_atr), electrostatics (fa_elec), 
vdW repulsion (fa_rep), hydrogen bonding terms (hbond_bb_sc and hbond_sc), and solvation 
energy (fa_sol). 
Physicochemical descriptors 
“Classical” 2D and 3D physicochemical descriptors were calculated with MOE.166 QM descriptors 
included atomic partial charges computed from natural population analysis167 and Merz-Singh-
Kollman (MK) charges168, 169 the C and N atoms of the cyano group, highest occupied molecular 
orbital (HOMO) energy, lowest unoccupied molecular orbital (LUMO) energy, molecular dipole 
moment, and molecular volume.  
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Active site descriptors 
The active site of each enzyme-ligand pair was defined as all protein and ligand atoms within 10 
Å of the Cα atoms of the catalytic triad. ProtDCal170 was used to calculate active-site descriptors 
including thermodynamic indices of the folded and extended protein state, topographic indices, 
physicochemical and structural composition indices. 
Machine learning and statistical analysis  
The scikit-learn package (version 0.22) was used to perform the binary classification analysis 
using four ML methods including two decision tree-based ensemble methods: random forest 
(RF)171 and gradient boosted decision trees (GBDT)172, as well as a kernel-based method, support 
vector machines (SVM)173, and logistic regression (LR). For this analysis, experimentally 
measured activities of < 2 mM ammonia were considered inactive and descriptors with high 
correlation to other descriptors (≥ 0.9) were removed. All statistical analyses and plotting were 
performed with Python 3.7 using Pandas, Numpy, and Matplotlib. 
 
Results 
We reasoned that protein structural modeling and ligand docking combined with physicochemical 
properties that describe the ligand and its reactivity could be used synergistically to predict 
substrate preferences. Structural modeling provides insight into overall protein folds and the 
arrangement of residues in the active site. Docking scores provide approximations of binding 
affinities but do not account for reactivity, which can be instead quantified by computing QM 
properties of the nitriles that depend on electron density and molecular orbitals. Additional 
molecular properties of the nitriles can be taken into account by calculating classical 
physicochemical descriptors (e.g., van der Waals surface area and related quantities). As a test 
case we selected bacterial nitrilases, which catalyze the hydrolysis of nitriles to form the 
corresponding carboxylates and ammonia (Eqn. 1). To create an effective training set, we selected 
a set of 12 nitrilase sequences (Figure 27) and evaluated their activity computationally and 
experimentally against a set of representative aliphatic, aromatic and arylaliphatic nitriles. The 
various descriptors and experimentally determined activity data were then used the machine 




Sequence selection and structural modeling 
Standard sequence-based approaches generally cannot assign substrate preferences at the 
individual molecule level. Thus, we developed a structure- and property-based ML approach to 
predict substrate scope using bacterial nitrilases as a test case. Previously, 137 unique nitrilase 
sequences were identified by screening more than 600 environmental samples from terrestrial and 
aquatic environments.44 The enzymes were then expressed heterologously and assayed for their 
ability to catalyze the enantioselective hydrolysis of three pharmaceutically relevant nitriles, 3-
hydroxyglutaronitrile (3HGN), mandelonitrile (MA), and phenylacetaldehyde cyanohydrin 
(PAC), to form the corresponding carboxylic acids. Phylogenetic analysis of these sequences 
identified six distinct sequence clades that exhibited varying reactivities and enantioselectivities 
toward the three substrates. For example, nitrilase 1B15 hydrolyzed all three substrates with an 
enantiomeric excess for the corresponding R isomeric product ranging from 33 to 100%. In 
contrast, 1B16 exhibited S enantioselectivity toward 3HGN and PAC, but did not hydrolyze MA. 
From this set of 137 nitrilases, we selected a small representative set of nine enzymes from among 
three sequence clades. Greater emphasis was placed on two adjacent subclades (1A and 1B), but 
we also selected one sequence each from clades 2 and 3.  
 
To date, only a few structures of nitrilases have been determined with X-ray crystallography. One 
such structure is that of Nit6803 from Synechocystis sp. PCC6803 (PDB entry 3WUY)158, which 
is a member of sequence clade 1B (Figure 27). This enzyme hydrolyzes a broad range of nitriles, 
including aliphatic and aromatic mono- and dinitriles. In addition, we included two putative 
nitrilases identified in the genomes of plant rhizosphere-associated bacteria. These enzymes were 
selected on the basis of their similarity to sequences from subclade 1A and also to the structural 
template Nit6803. These 11 sequences have varying degrees of sequence identity to Nit6803 and 
range from 32-71% with a sequence coverage of at least 81%. We used the structure of Nit6803 
as a template to generate homology models of a selected set of 20 nitriles (Figure 25) from among 
these substrate categories based on previous data sets44, 49 and docked them to each enzyme model 
and also to the Nit6803 crystal structure (Figure 28). We then calculated various QM and classical 




Enzyme activity assays  
Target nitrilases were expressed heterologously in E. coli and were prepared as crude extracts.174 
These enzyme-containing extracts were added to solutions containing a selected nitrile and 
enzymatic activity was measured using a semi-quantitative colorimetric assay optimized for crude 
extracts based on a previously described method.49 
 
All 12 enzymes were active toward at least one nitrile (Figure 29). In general, catalytically active 
enzymes tend to hydrolyze multiple nitriles with no obvious patterns in activities. Not surprisingly, 
docking scores do not correlate with enzymatic activity (Figure 30). We observed negligible 
activity (i.e.,  < 2) toward all aliphatic nitriles except for 2-methylglutaronitrile. Interestingly, 
1B15 and 1A8 were the only enzymes that did not display activity toward this nitrile. Furthermore, 
1B15 was the only enzyme that had no activity toward aliphatic or aromatic nitriles. Thus, 1B15 
is specific for arylaliphatic nitriles but is only moderately active for 3-phenylpropionitrile and 
cinnamonitrile. No appreciable activity was measured for any enzyme with 2-aminobenzonitrile 
or 2,6-dichloroaminobenzonitrile. 2A6 was active toward all arylaliphatic nitriles except 
cinnamonitrile and was the only enzyme that hydrolyzed mandelonitrile and a-methylbenzyl 
cyanide. 
Prediction workflow  
Having obtained the experimental activity assay data, structural models, docked ligand, and 
calculated descriptors, we trained various binary classification ML models to predict substrate 
scope for bacterial nitrilases. Because the activity assays are semi-quantitative, we used a binary 
classification approach to predict whether a given enzyme is active or inactive toward a given 
nitrile according to a chosen activity threshold. We considered four different activity thresholds 
(1, 2, 3 and 4 mM) for classifying nitrilase activity and selected a threshold of 2 mM ammonia to 
define enzyme-substrate pairs with negligible activity as being essentially inactive. Thus, activities 
below 2 mM were considered inactive. 
 
To determine whether the use of oversampling techniques could be used to generate better models, 
a variety of synthetic minority oversampling technique (SMOTE)175 methods were tested. For grid-
search hyperparameter tuning and cross-validation we used an 80/20 training/test set split. We 
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further tested the robustness of the models by performing leave-n-protein-out tests, which were 
conducted by randomly and phylogenetically leaving out n = 1, 2, 3, 4 or 6 proteins during training 
and then using them as test sets. 
 
We analyzed the performance of four different ML methods that are generally considered suitable 
for datasets of this size. These methods included random forest (RF), gradient-boosted decision 
trees (GBDT), logistic regression (LR), and support vector machines (SVM). For this dataset, 
which has a ratio of inactive:active substrates of 2:1 using a cutoff of 2 mM ammonia, 
oversampling did not significantly improve model performance. All four ML methods perform 
similarly as evaluated by performing tenfold cross-validation (Figure 31A). The average areas 
under the ROC curve (ROC_AUC) were all ~0.90 and the models had average accuracies of 79-
83%. The methods also performed similarly for the test set with the exception of the recall metric, 
for which GBDT did not perform as well as the others (Figure 31B). Although the test set was 
used to assess classification predictions on completely unseen data, it only reflects a single, 
randomly chosen subset of the data. Thus, model performance from the test set does not necessarily 
reflect the overall robustness of the model.  
 
We further assessed the robustness of the different ML methods by leaving out one enzyme at a 
time, training separate models on the remaining eleven enzymes, and then predicting the substrate 
scope for the left-out enzyme (Figure 31C). All four ML methods performed similarly for 
ROC_AUC, accuracy, and precision. However, RF performed the best for F1 and recall. We then 
randomly removed two, three, four, and six of the twelve proteins and observed that RF 
performance was similar the other methods and for some metrics outperformed GBDT, LR, and 
SVM.174 In addition to randomly leaving out proteins, we also removed two, three, four, and six 
proteins according to their order and proximity in the phylogenetic tree to investigate the 
contribution of phylogenetic relationships on model performance. As observed for the random 
leave-out tests, RF generally performed similar to or outperformed the other methods in some 
metrics. 
Discussion 
Here we have developed an approach for predicting substrate scope for enzymes by combining 
structural modeling, docking, physicochemical properties and various machine learning methods 
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(Figure 32). Rather than generating a large training set, we sought to explore the limits of accuracy 
of the model by training the ML model on a relatively small amount of targeted in vitro enzyme 
assay data. The time and expense involved with generating and screening enzymes demands 
effective in silico approaches. Here, the use of crude extracts that contain heterologously produced 
enzymes combined with an automated, colorimetric activity assay facilitated construction of an 
effective training set. Our approach enables accurate predictions of substrate scope for a series of 
aliphatic, aromatic, and arylaliphatic nitriles by including descriptors for the enzymes, substrates 
and their interactions in ML models.  
 
Given a phylogenetic tree and sparse activity data, it may be difficult to identify trends in substrate 
scope. In some cases, sequences that have high sequence identity show similar trends in substrate 
preference. For example, 1A1 and 1A2 are closely related (85% identical) and their substrate 
scopes differ only for the substrate 4-(dimethylamino)benzonitrile (Figure 29). 1B16 and 3WUY 
are also closely related (71% identical) and show similar patterns in activity (90% overlap in 
substrate scope). However, PMI28 and 1A8 are 88% identical but differ markedly in their 
respective substrate scopes. PMI28 displays activity toward 12 of the 20 nitriles spanning all three 
classes, making it one of the most active enzymes tested. In contrast, 1A8 is only active toward 
two aromatic nitriles. In other cases, distantly related sequences share similar substrate 
preferences. For example, 1A17 and 3WUY (51% identical) have the same substrate scope except 
that 4-nitrophenylacetonitrile is not hydrolyzed by 3WUY. Therefore, predictions of the substrate 
scope of an enzyme often cannot be made based on phylogenic analysis alone. In addition, subtle 
changes in the amino acid composition of the active site or in the chemical structure of the substrate 
may lead to differences in activity. In the present case, active enzymes tend to have high activity 
for many nitriles. However, in other cases it will not be known beforehand how much of the 
specificity space will be covered by the proteins or the substrate library. In such cases, active 
learning approaches in which the training data are augmented iteratively to optimize model 
performance, are expected to be particularly useful.154 
 
Substituent effects play an important role in determining reactivity. For example, 2-
aminobenzonitrile and 2,6-dichloroaminobenzonitrile are both aromatic nitriles with substituents 
that are ortho to the cyano group. In contrast to the other aromatic nitriles, these two molecules 
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were not hydrolyzed by any of the nitrilases tested. This large difference in reactivity may be due 
to the steric hindrance of the ortho functional groups or substituent effects. The two dinitriles were 
readily hydrolyzed by most enzymes, with the exceptions of 1A8 and 1B15 toward 2-
methylglutaronitrile and 1A1, 1A2, and 1B15 toward isophthalonitrile. These dinitriles have high 
activities compared to the mononitriles, suggesting that both nitrile groups in the dinitriles were 
hydrolyzed. In a dinitrile, the conversion of one nitrile substituent to a carboxylate will alter the 
solubility and electrostatic properties of the resulting intermediate, which could affect the binding 
affinity and reactivity of the secondary substrate.  
 
In a previously proposed catalytic mechanism for nitrilases176, the first step of the reaction consists 
of a series of proton transfer steps involving the catalytic Cys, the cyano group, and an ordered 
water molecule, resulting in the formation of a thioimidate intermediate. Geometries of catalytic 
residues across a given enzyme family tend to be well conserved (i.e. RMSD < 0.5 Å) and it has 
been shown that incorporating this information in the form of geometric constraints can improve 
model quality.177 Furthermore, docking results can potentially be improved by including additional 
restraints that account for specific interactions between the enzyme and putative substrates (i.e., 
selecting for catalytically relevant orientations). As enzymes preferentially bind transition states 
over ground states of substrates, it could be beneficial to include information about transition states 
in the docking calculations. Performing docking with a transition state mimic is a promising 
approach that can provide improved accuracy compared to ground state docking.178 Most of the 
nitrile substrates considered in the present work are relatively rigid and extensive conformational 
sampling was not required. However, for other cases with more flexible ligands, conformational 
sampling may be critical and should therefore be included. 
 
RF models performed as well as, or in some cases better than, the other three ML methods. Unlike 
kernel-based methods (i.e., SVM), decision tree-based methods (i.e., RF) allow for calculation of 
variable importance of each descriptor. For the nitrilase example, we used an 80:20 split of the 
data and calculated the variable importance for 20 independent runs initiated with different random 
seeds. Descriptors from all four categories were present in the top 10 most important descriptors 
over the 20 runs (Figure 33). Thus, including complementary information from each category 
indeed contributes to the predictive value of the model. QM descriptors do not appear frequently 
70 
 
in the top 10, suggesting that descriptors intended to account for chemical reactivity are not as 
important as other properties for obtaining accurate predictions. In the present case, the QM 
descriptors are all similar among the 20 nitriles. For example, the natural population analysis 
(NPA) partial charge on the nitrile carbon ranges from 0.25 to 0.3. In contrast, MOE descriptors 
capture more global properties of the substrate molecules and are therefore more informative for 
classification. Although there are more ligand descriptors (MOE and QM) than those that contain 
information about the ligand in the context of the protein from the docked pose, docking and 
ProtDcal descriptors comprise the majority of the top 10 lists (Figure 33). Thus, for this system 
the descriptors that encode information from the structural models and docked poses are 
informative for accurately predicting substrate scope. 
 
The approach developed here was designed to be highly modular, with readily swappable 
computational components. For example, protein modeling could be performed with other 
software such as I-TASSER179-181, MODELLER182,SWISS-MODEL183, and others. Similarly, 
ligand docking could be performed with software such as Glide184, AutoDock Vina185, and many 
others. Alternatives for calculating physicochemical descriptors include Rcpi186, 
PaDEL187,Mordred188 and essentially any quantum chemistry software. As expected, single amino 
acid substitutions can cause large changes in reactivity or specificity that would not be identified 
based on a phylogenetic analysis of the full sequence. In principle, our approach can capture these 
subtle effects if they lead to substantial changes in active site properties. Compared to sequence-
based approaches189, the modular, structure-based machine learning approach described here is 
more flexible, and should be readily extensible to enable prediction of substrate scope for many 
classes of enzymes. In addition, the experimental assays used are scalable for high-throughput 
applications. The application of advanced computational methods will lead to a better 






Figure 25. Nitriles used in this study to screen for nitrilase activity. See ref 174 for additional 

















































































Figure 26. Clustal Omega alignment of target nitrilase sequences. Residues in gray were excluded 





Figure 27. Phylogenetic tree of a family of nitrilases that encompass the enzymes used in this 
study (grey). The scale bar indicates the inferred number of substitutions per site. Enzymes for 
which an X-ray structure is available are indicated with a red star. Two putative nitrilases from 





Figure 28. Nitrilase models and docking. (A) Structural model of a representative nitrilase 
(PMI26) with the catalytic triad of chain A shown as ball and stick and colored by element. (B) 
Residues within 10 Å of the catalytic triad. (C) Selected docked poses of nitriles are shown as 
sticks and colored by element with different colored carbons for each nitrile. Side chain carbons 





Figure 29. Activity data (ammonia concentration in mM) for putative nitrilases with 20 nitrile 
substrates obtained from cell extracts at 50% dilution. Background color to the activity data values 
is added as a visual aid in estimating relative enzyme-substrate activity. See ref 174 for additional 






Figure 30. Experimental nitrilase activity (ammonia concentration in mM) versus Rosetta docking 





















































































































































































2A6 12.5 0.2 1.3 0.1 1.6 0 0 0.1 4.1 0 3.0 0 0 6.3 6.1 6.1 7.0 2.8 0 4.4
3A2 11.6 0 0 0 0 0 0 7.9 2.6 0.9 5.9 2.5 0 8.5 2.9 0 0 0 3.2 0
1B15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.7 0 0 0 2.5 0
1B16 3.7 0 0 0 0 0 0 0.7 1.6 0 2.5 2.2 0 2.2 2.1 0 0 1.2 4.1 0
3WUY 4.2 0.1 0.1 0.1 0.7 0.1 0.1 0.8 4.3 1.7 6.7 5.7 0 4.2 5.2 0 0 2.6 6.7 0
1A27 11.1 0 0.6 0 1.5 0 0 8.0 5.2 6.7 6.3 5.8 2.2 7.2 6.8 0 0 2.3 4.7 0
PMI26 7.6 0 0.1 0 0 0 0 2.9 0.5 1.1 3.0 3.8 0 3.1 1.6 0 0 0.4 4.0 0
1A17 10.7 0 0 0.1 0.8 0 0 0 4.7 0 5.5 4.3 1.3 5.5 5.3 4.6 0 2.4 6.2 0.2
1A8 0.2 0 0.1 0.2 0 0 0 0 2.2 0 0.7 0 0 5.0 0.1 0 0 0 1.8 0
PMI28 12.6 0.8 0.3 1.1 2.0 0 0 8.2 5.6 4.8 5.5 8.2 4.6 10.4 7.8 0 0 2.9 6.4 0
1A2 2.3 0 0.1 0 0.1 0 0 0 3.7 0 5.9 0.5 0.1 0 6.4 0 0 0.2 5.5 0
























Figure 31. Machine learning model metrics. (A) Tenfold cross-validation (B) 80/20 test set and 
(C) leave-one-protein-out tests for a set of bacterial nitrilases and nitrile substrates. Error bars 






Figure 32. Graphical overview of the structure-based approach to predict the substrate scope of 
enzymes. After target selection, structural models are generated for docking and descriptor 
calculation and targets are cloned, expressed, and extracted for screening. The experimental 
activity data and calculated descriptors are then used to train an RF classification model that can 






Figure 33. Analysis of descriptor categories. (A) Number of descriptors per category used for ML 
model building. (B) Descriptor counts for the top 10 features in 20 random seeds. Descriptors are 
colored by category (MOE = orange, QM = gray, docking = blue, ProtDCal = red). Error bars 















MOLECULAR PROPERTIES THAT DEFINE THE ACTIVITIES OF ANTIBIOTICS 
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Abstract 
The permeability barrier of Gram-negative cell envelopes is the major obstacle in the discovery 
and development of new antibiotics. In Gram-negative bacteria, these difficulties are exacerbated 
by the synergistic interaction between two biochemically distinct phenomena, the low permeability 
of the outer membrane (OM) and active multidrug efflux. In this study, we used Pseudomonas 
aeruginosa and Escherichia coli strains with controllable permeability barriers, achieved through 
hyperporination of the OMs and varied efflux capacities, to evaluate the contributions of each of 
the barriers to protection from antibacterials. We analyzed antibacterial activities of β-lactams and 
fluoroquinolones, antibiotics that are optimized for targets in the periplasm and the cytoplasm, 
respectively, and performed a machine learning-based analysis to identify physicochemical 
descriptors that best classify their relative potencies. Our results show that the molecular properties 
selected by active efflux and the OM barriers are different for the two species. Antibiotic activity 
in P. aeruginosa was better classified by electrostatic and surface area properties, whereas 
topology, physical properties, and atom or bond counts best capture the behavior in E. coli. In 
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several cases, descriptor values that correspond to active antibiotics also correspond to significant 
barrier effects, highlighting the synergy between the two barriers where optimizing for one barrier 
promotes strengthening of the other barrier. Thus, both barriers should be considered when 
optimizing antibiotics for favorable OM permeability, efflux evasion, or both. Inhibition of 
multidrug efflux pumps is a promising approach for reviving the efficacy of existing antibiotics. 
Using existing physicochemical property guidelines in combination with computational ligand 
docking, we identified a new class of inhibitors of E. coli AcrAB-TolC. Six molecules with a 





Gram-negative bacteria are notoriously more resistant to antibiotics than Gram-positive bacteria. 
The major reason for this resistance is that Gram-negative cell envelopes comprise two membranes 
of different compositions and functions.55, 190, 191 The outer membrane (OM) is an asymmetric 
bilayer of lipopolysaccharides (LPS) and phospholipids with non-selective porins and substrate-
specific channels embedded therein.51, 52 The major function of the OM is protection from toxic 
molecules and enzymatic attacks in a hostile environment. The inner, or cytoplasmic, membrane 
is a phospholipid bilayer that is responsible for diverse physiological and metabolic functions. It 
also contains multidrug efflux pumps that protect intracellular functions by actively removing 
small, toxic molecules and peptides from the periplasm and cytoplasm.53 The two barriers-the 
passive, low-permeability OM and active efflux in the inner membrane-act synergistically and are 
the major factors that are responsible for the intrinsic resistance of Gram-negative bacteria to a 
broad range of antimicrobial agents.57, 192 In addition, the orthogonal to the OM sieving properties 
of the inner membrane are also thought to affect the intracellular accumulation of antibiotics 191. 
 
The antibiotic resistance of Gram-negative pathogens has become particularly worrisome with the 
emergence of multidrug resistant strains in clinics, which often leave clinicians with no therapeutic 
options.50 The discovery of new antibiotics that are active against these pathogens is hindered by 
low hit rates in screening efforts and by the lack of practical rules to maximize OM permeability 
and minimize efflux.55, 56 The latter problem has been identified as a major bottleneck in addressing 
emerging multidrug resistance in clinics.54 
 
To establish rules based on molecular properties that define antibiotic permeation, the two 
permeability barriers (OM and efflux) must be analyzed separately to define the factors 
contributing to each barrier.57 For this purpose, we developed a hyperporination approach that 
facilitates control of OM permeability in Gram-negative cells through the inducible expression of 
a chromosomally encoded open pore (Pore) with a 2.4-nm internal diameter 58. The expression of 
the Pore effectively and non-selectively allows influx of antibiotics and reduces the barrier 
constant, B, which is defined as the ratio of maximum attainable drug fluxes across the outer 
membrane into the cell and out of the cell via the efflux transporter.192 The overexpression and 
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deletion of efflux pumps, on the other hand, allows manipulation not only of B, but also the efflux 
constant, KE, which measures efflux efficiency for a given antibiotic.192-195 
 
We focused on understanding interactions between the permeability barriers of Gram-negative 
bacteria and the antibacterial activities of b-lactams (BLs) and fluoroquinolones (FQs). 
Representatives of these antibiotic classes have been extensively developed and remain the major 
antibiotics administered in clinics. FQs target DNA replication by inhibiting DNA topoisomerases 
and, hence, to reach their targets must penetrate both the outer and inner membranes and evade 
efflux pumps. In contrast, transpeptidases, which are targeted by BLs, are located in the periplasm 
and these antibiotics are optimized to penetrate only across the OM and to evade efflux from the 
periplasm. Thus, the two classes differ significantly in their structures and physicochemical 
properties and contain determinants that are recognized by these different barriers. 
 
Antibacterial activities were analyzed in two Gram-negative species that differ significantly in 
their permeability barriers: P. aeruginosa and E. coli. Although the lipid compositions of the OMs 
overall are similar between these two species 51, 59, 60, they differ in the composition and structure 
of their major general porins. The OM of E. coli contains ~200,000 copies per cell of OmpF/C 
porins, which have a molecular mass cutoff of ~600 Da. As a result, a significant number of 
antibiotics are active against this species.61 In contrast, P. aeruginosa lacks such large general 
porins and instead utilizes substrate-specific porins of the Occ family to take up small compounds 
such as monosugars and amino acids.62 Nevertheless, this species is susceptible to FQs and some 
BLs, suggesting alternative routes of permeation across the OM. Hyperporination of the OM 
through the expression of large non-specific pores negates the differences in permeabilities of the 
OMs in P. aeruginosa and E. coli and allows evaluation of the contributions of these barriers 
toward antibacterial activities. 57, 58 
 
Cryo-EM structures have been determined for the assembled AcrAB-TolC efflux pump, which 
consists of three main components, AcrB, AcrA and TolC (Figure 34A in Appendix IV). AcrB 
is a homotrimeric protein that consists of an a-helical integral membrane domain, a periplasmic 
porter domain that binds and extrudes substrates, and a docking domain that interacts with AcrA.64, 
65 AcrA is a membrane fusion protein that consists of four domains: α-hairpin, lipoyl, β-barrel, and 
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membrane-proximal (Figure 34B). TolC is a trimeric protein that consists of a b-barrel domain 
embedded in the OM and a periplasmic a-helical coiled-coil domain.66 AcrB, AcrA, and TolC 
assemble in a 3:6:3 stoichiometry196 to form a complex that spans the entire Gram-negative cell 
envelope.63 In E. coli, inactivation of a single gene, tolC, leads to the complete loss of efflux across 
the OMs, because all efflux pumps capable of efflux across the OMs in this species depend on 
TolC. 197-199 In contrast, the major efflux pumps of P. aeruginosa are encoded in the same operons 
as specific tolC homologs, and each pump is functionally independent from the others. 200 Hence, 
multiple pumps must be inactivated to deplete the efflux capacity of P. aeruginosa and the 
differences between the barriers are further evident in the genetic make-up of their respective 
efflux pumps. 
 
Identifying molecular properties that govern antibiotic activity in the presence and absence of the 
two barriers is expected to provide strategic guidelines for optimizing compounds against gram-
negative bacteria. 191 Recently, random forest (RF) machine learning was used establish a set of 
rules for favorable accumulation of antibiotics in E. coli.67, 201, 202 Liquid chromatography with 
tandem mass spectroscopy (LC–MS/MS) analysis revealed that small-molecule compounds 
containing amine functional groups were most likely to accumulate in E. coli cells, with primary 
amines having the highest accumulation.67 Incorporation of a primary amine into the Gram-
positive antibiotic deoxynybomycin (6DNM) resulted in a new antibiotic (6DNM-NH3) that 
exhibited broad-spectrum activity against a panel of multidrug-resistant Gram-negative bacteria. 
In addition to containing an amine, antibiotics that tended to be successful at bypassing the OM 
permeability barrier were polar, amphiphilic, relatively rigid, and had low globularity. 
 
We identify molecular properties of antibiotics that are associated with their activities, measured 
as minimum inhibitory concentrations (MICs), in P. aeruginosa and E. coli strains with controlled 
permeability of the OMs and variable efflux capacities. We also describe the characteristics of 
antibiotics that display activity when both the efflux and OM barriers are removed (P∆6-Pore and 
∆TolC-Pore), when only efflux (P∆6 and ∆TolC) or the OM barrier is removed (PAO1-Pore and 
WT-Pore), and in the corresponding wild-type strains (PAO1 and WT). To establish these 
associations, we use RF classification to extract physicochemical properties of antibiotics that 
separate them based on the contributions of these two barriers. Our results show that molecular 
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properties selected by active efflux and the OM barriers are different for E. coli and P. aeruginosa. 
By combining existing physicochemical rules for OM permeability and efflux in E. coli in with 
computational docking, in vitro binding assays, and in vivo potentiation assays in bacterial strains 
with controllable permeability barriers we identified six molecules with a shared scaffold that 
potentiate the antibiotic activity of erythromycin and novobiocin in hyperporinated E. coli cells 
and in wild-type strains of both A. baumannii and K. pneumoniae. 
 
Methods 
For additional experimental details see: 
 
Cooper, S.J., Krishnamoorthy, G, Wolloscheck, D, Nguyen, J, Walker, J.K., Rybenkov, V.V., 
Parks, J.M. and Zgurskaya, H.I. Molecular properties that define the activities of antibiotics 
in Escherichia coli and Pseudomonas aeruginosa. ACS Infect. Dis. 2018, 4, 1223–1234. 
and 
Green, A.T., Moniruzzaman, M., Cooper, C.J., Walker, J.K., Smith, J.C., Parks, J.M., Zgurskaya, 
H.I. Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold. BBA General 
Subjects. 2020, 1864, 129546. 
 
Experimental MIC and MPC measurements 
All strains201 were grown in Luria-Bertani broth at 37˚C with shaking. Susceptibilities of cells to 
different classes of antibiotics were determined by 2- and 4-fold dilutions as described 
previously.57, 58 Therefore, MIC ratios of 2-4-fold changes are within error of the assay. For RF 
classification of MICs and MIC ratios, the lowest MIC in the range was used. Antibiotics were 
purchased from MicroSource Discovery Systems, Inc. and Sigma-Aldrich. All minimal inhibitory 
concentration (MICs) determinations were done at least twice. For EPIs, minimal potentiating 
concentration (MPC) was defined as a concentration of a compound that decreases the MIC of an 
antibiotic by four (MPC4) or more fold. 
Physicochemical property calculation 
Three-dimensional structures of antibiotics used in RF classification were obtained from the ZINC 
database.132, 203 Marvin calculator plugins204 were used to calculate the most likely tautomeric and 
protonation states at pH 7.4. Geometries were optimized with the Amber12:EHT molecular 
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mechanics force field205 implemented in MOE version 2015.206 MOE was then used to calculate 
>300 2D and 3D molecular descriptors207, and the resulting descriptor values were analyzed with 
respect to the MIC and MIC ratio data. Descriptors with standard deviations equal to zero were 
discarded. Redundant descriptors (i.e., correlation coefficients > 0.85) were identified and 
removed using the findCorrelation function in the R package caret.208 A total of 143 descriptors 
were used for P. aeruginosa, and 142 descriptors for E. coli (Table 9 in Appendix IV). Prior to 
analysis, the descriptor values were scaled and centered so they all had the same variance. 
RF analysis of MICs and MIC ratios 
RF combines the information from numerous decision trees to obtain a consensus classification of 
“high” or “low” activity (MICs) or barrier effects (MIC ratios) from molecular descriptor values. 
At each node of a tree, RF determines which descriptor from a randomly selected subset of 
descriptors best separates the antibiotics in the training set classified as “high” from those that are 
classified as “low”. Each time a descriptor is selected as the best splitter, a best split value, or 
threshold (T), is obtained based on the descriptor values for that subset of antibiotics. The threshold 
values for each descriptor were averaged over all occurrences in each model (Tavg) to obtain 
general guidelines for desirable descriptor values.  
 
R version 3.3.2209 was used to perform the RF analysis of molecular descriptors. RF scripts were 
adapted from Richter et al., and classification was performed with caret using tenfold cross 
validation repeated ten times on a set of 2000 decision trees. The RF classification models were 
assessed with receiver operating characteristic (ROC) curves and confusion matrices. The top 20 
descriptors for each set of response variables (MICs or MIC ratios) were determined by 
quantifying the overall variable importance of the machine learning model using the out-of-bag 
error, i.e., the decrease in classification accuracy when a single descriptor is removed. Scatter plots 
containing the Tavg, Tmin, and Tmax values were generated with ggplot2 for the top 20 descriptors 
with natural log-transformed MICs and MIC ratios. 
Ensemble docking of primary amines to AcrA 
We used the Tranche Browser to search a subset of the ZINC 15 database 160 for 3D representations 
of in-stock primary amines with “standard” reactivity, molecular charge in the range of -2 to 2 at 
pH “ref” or “mid”, log P between 2.5 and 3, and no molecular weight cutoff, resulting in ~1.8M 
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small molecules (as of November 26, 2018). Alternate protonation and tautomeric states at pH 7.4 
were included for each molecule. We then selected for primary amines, resulting in 22,842 
compounds. From this list we selected molecules that are relatively rigid (number of rotatable 
bonds £ 4), polar (dipole moment ³ 5.5 D), amphiphilic (amphiphilic moment ³ 4.0 Å2), and have 
low globularity (£ 0.14).67, 201 Molecular properties were calculated with MOE 2016.206  
 
Previously, we generated a full-length model of AcrA from E. coli, performed a 50-ns molecular 
dynamics simulation of the model, and extracted 29 representative conformations using RMSD 
clustering.210 In the present work, ensemble docking211 to each of these 29 conformations was 
performed at four sites (E67 (site I), K241 (site II), I343 and I252 (site III), and F81 and F254 (site 
IV), Figure 34B) with VinaMPI using a 25 Å x 25 Å x 25 Å docking search space and an 
exhaustiveness of 10.212 Of the resulting ~50 top compounds selected based on docking score at 
any site, commercially available compounds were purchased from ChemBridge (San Diego, CA). 
 
Results and Discussion 
MICs and MIC ratios  
To determine how active efflux and the OM permeability barrier contribute to the activities of 
antibiotics, we selected 64 representatives of the BLs (cephalosporins (CEFs), penicillins (PENs), 
and meropenem) and FQs. These antibiotics differ significantly in their structures and properties, 
ranging in molecular mass from less than 300 Da to 650 Da, with log D7.5 values from -3 to ~4 and 
log P(o/w) values varying from -2 to 3.5. In addition, we included a few representatives belonging 
to other classes of antibiotics that have been analyzed previously57, 58: two macrolides 
(azithromycin and erythromycin), the activities of which were strongly affected both by active 
efflux and OM permeability, chloramphenicol, which was weakly affected by both efflux and the 
OM barrier, and gentamicin, the activity of which was not affected by the OM. 
 
MICs of antibiotics were measured in E. coli WT, the efflux-deficient variant ∆TolC, and the pore-
producing derivatives WT-Pore and ∆TolC-Pore.58 For P. aeruginosa, four strains were also 
analyzed: the wild type PAO1, strain P∆6 lacking six efflux pumps (∆mexAB-oprM, ∆mexCD-
oprJ, ∆mexXY, ∆mexJKL, ∆mexEF-oprN, ∆triABC), and their pore-producing derivatives, PAO1-
Pore and P∆6-Pore, respectively.213 All strains were previously shown not to have significant 
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growth defects, and to differ dramatically in their susceptibilities to various classes of antibiotics. 
All strains were previously shown not to have significant growth defects, and to differ dramatically 
in their susceptibilities to various classes of antibiotics. 
 
For E. coli WT cells, MICs could be measured for all tested antibiotics, whereas the MICs of ~30% 
of the antibiotics were too high to be determined in P. aeruginosa PAO1 cells (Figure 35 and 
Figure 36). However, the MICs of all antibiotics could be determined in P∆6-Pore, highlighting 
the large contribution of the permeability barriers in this species toward antibiotic activities. To 
normalize to the differences in biochemical potency among compounds, our key measured 
parameters were efflux ratios and OM barrier ratios, defined as MICparent/MICmutant, for efflux 
mutants and hyperporinated mutants, respectively. 
 
Cephalosporins 
These antibiotics were relatively potent against E. coli, with the lowest MICs against WT in the 
low nanomolar range, but not against P. aeruginosa, for which the most potent representatives had 
MICs in the mid to low micromolar range (Figure 35 and Figure 36). This gap in CEF potency 
can be attributed to both the species-specific differences in permeability barriers and the expression 
of chromosomal BLs in P. aeruginosa strains.214, 215 The combination of these two factors resulted 
in about half of the analyzed CEFs lacking appreciable activities against the wild-type PAO1 
strain. However, in both species the activities of almost all CEFs were potentiated by 
hyperporination of the OM, inactivation of efflux, or both, albeit to different degrees. As a result, 
besides the BLs, all CEFs had a measurable MIC in the minimal barrier P∆6-Pore strain with the 
most potent activities in the mid nanomolar range. This result suggests that in P. aeruginosa 
strains, the permeability barriers are synergistic with BLs and contribute significantly to resistance 
against these antibiotics.  
 
Interestingly, in both species CEFs were modestly (≤ fourfold) affected by efflux deletions. In P. 
aeruginosa, the exceptions were ceftibuten (8-fold), cefotaxime and cefepime (16-fold) and 
cefmenoxime (64-fold), whereas in E. coli, cefuroxime was potentiated 16-fold upon efflux 
activation (Figure 37). In contrast to efflux, the effect of hyperporination was species-specific. 
With a few exceptions, the hyperporinated E. coli cells were only slightly more susceptible to 
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CEFs (≤ fourfold) than WT cells (Figure 35 and Figure 37). Cefonicid, cefoperazone, and 
cefuroxime were among the most limited (16-fold) by the E. coli OM barrier. In P. aeruginosa on 
the other hand, the effect of hyperporination was more drug specific. Some CEFs were not 
significantly affected by hyperporination in P. aeruginosa (e.g., cefdinir and cefalonium), whereas 
others were significantly limited by the OM barrier (e.g., cefotaxime, and cefmenoxime).  
 
The increased potency of CEFs in the barrierless strains highlights the synergistic effect of active 
efflux and the OM barrier. In most cases, P. aeruginosa P∆6-Pore cells were ≥ 16-fold more 
susceptible to CEFs than the wild-type PAO1 cells, with the exceptions of cefalonium, 
cefoperazone, cefprozil, and cefuroxime. Ceftriaxone and cefmenoxime were the most potentiated 
CEFs (≥ 256-fold). In contrast, most CEFs were not affected significantly (≤ fourfold) by removal 
of the OM barrier and inactivation of efflux in E. coli (e.g., cefepime and cefalonium). Other CEFs 
such as cefdinir and cefuroxime had activities that were potentiated greater than 32-fold upon 
removal of both barriers (Figure 36 and Figure 37). 
 
Penicillins 
Like CEFs, these antibiotics differ significantly in their activities against E. coli and P. aeruginosa 
and are affected by the OM, active efflux, and BLs. In general, the MICs of PENs in both species 
were in the micromolar and millimolar ranges. However, unlike CEFs, the effects of active efflux 
and hyperporination on the activity of PENs spanned orders of magnitude in both species.  
 
PENs were either poor substrates of P. aeruginosa efflux pumps (e.g., penicillin and amoxicillin) 
or excellent substrates (e.g., ampicillin and methicillin) (Figure 35 and Figure 37). Likewise, in 
E. coli PENs were either poor substrates of efflux pumps in E. coli (e.g., amoxicillin and 
ampicillin), or excellent substrates (e.g., cloxacillin and dicloxacillin), the activities of which 
increased by 512-fold upon the removal of efflux compared to WT (Figure 36 and Figure 37). In 
both P. aeruginosa and E. coli, most PENs were significantly limited by the OM barrier. Some 
PENs, such as piperacillin, azlocillin, and nafcillin were minimally affected by hyperporination of 
PAO1-Pore. In contrast, activities of other PENs including ampicillin, methicillin, and cloxacillin 
were all potentiated by ≥ 16-fold. In E. coli, greater than fourfold increases in potentiation were 
observed in hyperporinated cells compared to WT cells for all PENs except ampicillin, 
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carbenicillin, and hetacillin, with maximal increases in activity of 64-fold for piperacillin and 
azlocillin. 
 
P∆6-Pore cells were in general ≥ 16 times more susceptible to all PENs (Figure 37). The activities 
of several PENs were highly limited by both barriers in P. aeruginosa, including carbenicillin, 
nafcillin, and azlocillin (≥ 103-fold). The susceptibility of ∆TolC-Pore cells increased at least 
eightfold compared to WT cells for all PENs, with maximum increases of 512-fold for cloxacillin, 
dicloxacillin, nafcillin, and oxacillin. Thus, the structural differences of PENs and CEFs lead to 
dramatic effects in both the antibiotic permeation across the OM and active efflux avoidance. 
 
Fluoroquinolones 
Unlike BLs, FQs are highly potent against both species, but on average P. aeruginosa PAO1 was 
16-fold less susceptible to these antibiotics than E. coli WT. Accordingly, the FQ MICs in PAO1 
were in the low micromolar to high nanomolar range, whereas in E. coli, with a few exceptions, 
the MICs of FQ were in the sub micromolar range. 
 
FQs were relatively good substrates of efflux pumps in both species. In P aeruginosa, most FQs 
were potentiated by at least 16-fold upon efflux deletion, except for difloxacin (fourfold). In E. 
coli, FQs such as sparfloxacin and nadifloxacin were good substrates of efflux pumps, as 
evidenced by the potentiation of their activities in ∆TolC cells (64-fold and 256-fold, respectively) 
(Figure 35). Other FQs such as prulifloxacin and sarafloxacin only showed a fourfold increase in 
susceptibility upon removal of efflux capabilities. Unlike BLs, most FQs were not significantly 
affected by the removal of the OM barrier (≤ fourfold) in either species. However, the 
susceptibility of PAO1-Pore cells toward moxifloxacin and nadifloxacin increased 16-fold 
compared to PAO1, whereas WT-Pore was 16-fold more susceptible than WT for nadifloxacin 
(Figure 36 and Figure 37).  
 
However, even such small changes in the permeation across the OM contributed significantly to 
the FQ potency when synergized with active efflux. In general, P∆6-Pore cells were ≥ 64 times 
more susceptible to FQs than WT. Furthermore, the activities of certain FQs were potentiated by 
more than a thousand-fold in P∆6-Pore cells compared to PAO1 cells. For example, among the 
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FQs flumequine and nadifloxacin were potentiated ≥ 103-fold. In E. coli ∆TolC-Pore, most FQs 
displayed eightfold or greater potentiation, although norfloxacin, pefloxacin, pazufloxacin, 
prulifloxacin and sarafloxacin were potentiated by only fourfold upon removal of both barriers.  
 
Taken together, these results show that in P. aeruginosa and E. coli strains the MICs of tested 
antibiotics ranged from millimolar to sub-nanomolar values, and their potencies varied 
dramatically depending on the presence or absence of one or both permeability barriers. 
Molecular property fingerprints of MICs and MIC ratios  
We used RF classification to dissect the specific effects of OM permeability and efflux that limit 
antibiotic activity. Specifically, we identified the most important physicochemical properties, i.e. 
those that resulted in the largest decrease in accuracy upon removal, for classifying the relative 
potency of the antibiotics in mutant strains and wild-type strains (as measured by MIC) and the 
dependence of the antibacterial activities on efflux, the OM barrier, or both (as measured by MIC 
ratios). We performed RF classification on 143 descriptors for P. aeruginosa and 142 descriptors 
for E. coli (Table 9). E. coli MICs < 4 µM were classified as low, i.e. active. However, because 
P. aeruginosa shows greater resistance to antibiotics, antibiotics classified as low had MICs < 20 
µM. All other MICs were classified as high (i.e., inactive). For both species, MIC ratios < 4 were 
classified as low, or having no significant barrier effect, and MIC ratios > 4 were considered to 
show a significant barrier effect. 
 
The most important molecular descriptors identified by RF classification provide a “fingerprint” 
that describes the molecular characteristics that best distinguish between high and low 
classifications for each set of MICs or MIC ratios. The descriptors belong to eight aggregate 
categories: charge, connectivity, molecular topology number of selected atom or bond types, 
physical properties, potential energy, shape, and surface area (Table 9). 
 
Charge Properties 
These descriptors quantify electrostatic properties in a molecule or portion of a molecule. Partial 
charges calculated with the partial equalization of orbital electronegativity (PEOE) method216 are 
the most prevalent charge descriptors identified from the RF analysis. Several of these descriptors 
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map charges to specific van der Waals surface area (VSA) regions (e.g., fractional negative, or 
total negative VSA). This category is prominent for both P. aeruginosa and E. coli MICs and MIC 
ratios. Charge properties are abundant in the top descriptors for P. aeruginosa, comprising 8-10 of 
the top 20 descriptors for each strain. However, for E. coli MICs, charge descriptors are less 
abundant (≤ 7 of the 20). Compared to MICs, the MIC ratios feature fewer charge descriptors (4-
8 of the top 20 for P. aeruginosa MIC ratios, and 2-5 for E. coli). For both E. coli and P. 
aeruginosa, efflux ratios (PAO1/P∆6, PAO1-Pore/P∆6-Pore, WT/∆TolC, and WT-Pore/∆TolC-
Pore) include the most charge descriptors, suggesting that electrostatic properties may help in 
distinguishing between antibiotics that are significantly limited by the efflux barrier and those that 
are not. 
 
Atom connectivity, shape, and molecular topology 
Connectivity and topological descriptors represent molecules as graphs in which vertices 
correspond to atoms, and edges correspond to bonds. These descriptors are not abundant in the 
fingerprints of either species. ∆TolC-Pore is the only strain that contains a connectivity descriptor, 
along with the MIC ratios WT-Pore/∆TolC-Pore and PAO1/P∆6-Pore. This category is absent 
from the top 20 list in P. aeruginosa MICs and appears only sparingly among all E. coli strains 
except for ∆TolC-Pore. ∆TolC/∆TolC-Pore, PAO1/P∆6-Pore, PAO1/PAO1-Pore, and PAO1-
Pore/P∆6-Pore also contain shape descriptors. In contrast to shape and connectivity descriptors, 
most MIC or MIC ratio fingerprints contain topological descriptors. Five of the top 20 descriptors 
for WT-Pore are topological, incorporating measures of the partition coefficient, partial charges, 
or polarizability. However, the descriptor fingerprints for other E. coli strains contain two 
topological descriptors. This category is highly abundant in the E. coli ratios WT/∆TolC-Pore and 
WT/WT-Pore, (8 and 7 of the top 20, respectively), indicating that molecular topology may be 
relevant for distinguishing antibiotics that are severely limited by hyperporination in the presence 
and absence of efflux compared WT.  
 
Atom and bond counts 
Examples of these descriptors include the numbers of hydrogen bond donor atoms (adon), aromatic 
rings, and oxygen atoms, as well as measures of flexibility in the form of total and fractional 
rotatable bond counts. The fingerprints for all strains of P. aeruginosa contain a single atom or 
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bond count descriptor, and all E. coli strains include 2-4 descriptors in this category. These 
descriptors are present in the fingerprint of all ratios except for WT/WT-Pore and PAO1/P∆6-
Pore.The top descriptor lists for ∆TolC-Pore and WT-Pore ∆TolC-Pore each include four atom or 
bond count descriptors. Thus, certain descriptors in this category may be useful for classifying 
antibiotic activity in the absence of efflux in E. coli. 
 
Physical Properties 
Physical properties such as molecular weight, solubility coefficient, and partition coefficient, are 
commonly considered in drug design. Descriptors of this type are present for all MICs except P∆6. 
E. coli MIC ratios all list 2-4 descriptors physical property descriptors, and the ratios WT/∆TolC-
Pore and WT/WT-Pore have the most physical descriptors. The trend is similar for P. aeruginosa, 
with PAO1/P∆6-Pore and PAO1/PAO1-Pore having the most physical descriptors among P. 
aeruginosa MIC ratios. Thus, common metrics used in rational drug design classify antibiotics in 
the OM ratios better for E. coli than for P. aeruginosa. 
 
Potential Energy Descriptors 
Potential energy descriptors quantify energetic contributions from, for example, van der Waals 
(VDW) effects or solvation. Similar to physical properties, these descriptors appear in the 
fingerprints for all MICs and MIC ratios in both species at least once. The wild-type and 
hyperporinated strains contain two potential energy descriptors in both species, but the efflux-
deficient strains contain only a single descriptor in this category. 
 
Surface Area Properties 
Surface area (SA) descriptors are the second most abundant descriptor category, with all MIC and 
ratio fingerprints including 2-8 occurrences. Many of these descriptors are based on either the total 
or subdivided VSA of a molecule combined with another property such as lipophilicity (SlogP and 
log P(o/w)), hydrophobicity, shape, or connectivity. Compared to E. coli, the respective ratios in P. 
aeruginosa have more descriptors in this category, highlighting the differences between the two 
species. The descriptor fingerprints for hyperporinated strains in both species contained five SA 
descriptors, suggesting that these descriptors can distinguish active from inactive antibiotics in the 
presence of only the efflux barrier. 
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P. aeruginosa and E. coli permeability barriers select for different molecular properties 
To provide a set of descriptor guidelines that are favorable for antibiotic potency in the presence 
and absence of efflux and OM barriers, we selected from among the top descriptors those that trend 
with MICs and/or MIC ratios. To identify the “optimal” descriptor values for active antibiotics, 
we determined the average best split value or threshold (Tavg) that separates high and low MICs or 
ratios in the RF analysis. As in previous studies, antibiotics were grouped on the basis of how their 
antibacterial activities were affected by the OM barrier and active efflux barriers. 57 
 
The OM barrier 
Antibiotic properties that are favorable for OM permeation were captured in the MIC fingerprints 
of the efflux-deficient PD6 and DTolC strains and in the fingerprints of the MIC ratios for cells 
with hyperporinated and intact OM barriers, i.e., PD6/PD6-Pore, PAO1/PAO1-Pore, 
DTolC/DTolC-Pore and WT/WT-Pore. Antibiotics with high OM barrier ratios were classified as 
being strongly affected by permeation across the OM. This group includes BLs, predominantly 
CEFs.  
 
The properties that trend with changes in MICs in both DTolC and PD6 strains are rigidity and 
VDW potential energy (Evdw) (Table 10). The most potent antibiotics have high values for Evdw, 
with average threshold values of 4.1 kcal mol-1 for DTolC and 4.6 kcal mol-1 for PD6. Molecular 
rigidity was quantified here as the fraction of rotatable bonds (brotR = brotatable/btotal). Rigid antibiotics 
(i.e., brotR below Tavg of 0.2) were more active against both E. coli and P. aeruginosa in the absence 
of efflux, suggesting that less flexible molecules more readily overcome the OM barrier in both 
species. Rigidity was previously found to be important for increasing accumulation in wild-type 
E. coli.217 
 
As mentioned previously, charge properties are more abundant in the P. aeruginosa fingerprints. 
Several charge descriptors trend with antibiotic potencies in PD6 but not in DTolC cells. In general, 
the most effective antibiotics have larger dipole moments (Tavg = 5.5 D), suggesting that molecules 
with greater charge separation more readily permeate the OM in P. aeruginosa. Both fractional 
positive water accessible SA (FASA+) and fractional negative VSA (PEOEVSA FNEG) provide 
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information about favorable charge distributions in these molecules. Antibiotics with a high 
FASA+ (Tavg = 0.5) and a low PEOEVSA FNEG (Tavg = 0.5) generally have low MICs. However, these 
descriptors trend with MICs in other P. aeruginosa strains as well (Table 10), suggesting their 
importance in antibiotic permeation across both barriers. 
 
From the high PAO1/PAO1-Pore ratios, the OM barrier of P. aeruginosa counterselects for 
antibiotics with a high principal moment of inertia in the Y direction (pmiY, Tavg = 2930). PmiY is 
not present in the WT/WT-Pore fingerprint and, therefore, is specific for the P. aeruginosa OM 
barrier. Antibiotics that show a significant barrier effect in PD6/PD6-Pore generally have high 
negative and fractional negative VSA (PEOEVSA NEG, Tavg = 141 Å2 and PEOEVSA FNEG, Tavg = 0.4), 
and low VSA with SlogP values in the range of 0 to 0.1 (SlogPVSA3, Tavg = 62.8 Å2). The same 
trends are evident for PEOEVSA NEG (Tavg = 210 Å2) and SlogPVSA3 (Tavg = 20.5) in the corresponding 
E. coli DTolC/DTolC-Pore ratio.  
 
Thus, several descriptors that trend with MICs or MIC ratios are common for the OM barriers of 
both E. coli and P. aeruginosa. For example, rigid molecules more readily permeate the OM in 
both species. On the other hand, charge and shape descriptors are characteristic only for the OM 
barrier in P. aeruginosa. 
 
The active efflux barrier 
Descriptors that quantify the effect of the active efflux barrier are present in the fingerprints for 
PAO1-Pore and WT-Pore MICs. They are also present in MIC ratios PAO1-Pore/PD6-Pore, 
PAO1/PD6 in P. aeruginosa, and WT-Pore/DTolC-Pore and WT/DTolC in E. coli. In both species, 
FQs are the dominant antibiotics limited by this barrier. Meropenem is known to cross the OM of 
P. aeruginosa using the amino acid-specific channel OprD218. This carbapenem is a substrate of 
the P. aeruginosa efflux pumps. In contrast, in E. coli meropenem potency is strongly limited by 
OM permeation, but not by efflux. 
 
For PAO1-Pore, active antibiotics have a balance of fractional positive and negative SA, with high 
FASA+ (Tavg = 0.5) and low PEOEVSA FNEG (Tavg = 0.5) and a high dipole moment (Tavg = 5.6 D). As 
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observed with the OM barrier, antibiotics with the greatest activity against PAO1-Pore are more 
rigid (brotR Tavg = 0.2).  
 
The top descriptors, that trend with the PAO1/PD6 ratio, are primarily charge descriptors. 
Interestingly, relative positive partial charges (PEOERPC+, Tavg = 0.1) trend with both the PAO1/PD6 
and PAO1-Pore/PD6-Pore efflux ratios, but not with the OM ratios. Thus, P. aeruginosa efflux 
pumps may select for antibiotics with high positive partial charges. In addition, rigid antibiotics 
have higher PAO1/PD6 ratios, suggesting that P. aeruginosa efflux pumps may favor rigid 
molecules. Lipophilicity trends with PAO1-Pore/PD6-Pore ratios. The more lipophilic molecules 
tend to have higher values for this ratio. Thus, a metric such as SlogP (Tavg = -0.53), which is often 
considered for maximizing membrane permeability, may also promote efflux in P. aeruginosa.  
 
In E. coli, active antibiotics in WT-Pore have Evdw values above ~4 kcal mol-1. However, charge 
descriptors are mostly absent for this strain and do not show any notable trends with MICs or ratios 
in E. coli (Table 10). Antibiotics that are significantly limited by active efflux in the presence of 
the OM barrier in E. coli (WT/DTolC) have log P(o/w) and SlogP values greater than 1.3 and -0.7 
respectively, indicating that lipophilicity plays a role in efflux pump specificity. Similarly, 
antibiotics with high WT-Pore/DTolC-Pore ratios have log P(o/w) and SlogP values greater than the 
average thresholds of 1.5 and -0.5, respectively. 
 
Thus, the lipophilic properties identified by RF for active efflux are similar in both species. These 
descriptors may be useful for guiding the prediction of antibiotic potencies and the effects of efflux. 
In addition, partial positive charges in antibiotics are selected by active efflux in P. aeruginosa. 
OM and active efflux synergy 
Some antibiotics are strongly affected both by hyperporination and efflux inactivation. In both 
species, FQs, macrolides and BLs are all included in this group. Antibiotics with activities that 
were significantly affected by the removal of both barriers (PAO1/PD6-Pore and WT/DTolC-Pore) 
generally have positive log P(o/w) values (Table 10). Interestingly, the average threshold for log 
P(o/w) in WT/DTolC-Pore (Tavg =  0.7) is higher than for PAO1/PD6-Pore (Tavg =  -0.9). Lipophilicity 
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(SlogP) values greater than the average threshold are associated with high PAO1/PD6-Pore and 
WT/DTolC-Pore ratios with values of -0.6 and -0.9, respectively. In E. coli, brotR is an important 
feature for describing the differences in antibiotic effectiveness between the maximal and minimal 
barrier strains. In general, rigid molecules have lower WT/DTolC-Pore ratios (Tavg = 0.2), and thus 
antibiotics below this threshold value were often limited by both barriers.  
 
PD6-Pore and DTolC-Pore are minimal-barrier strains in which both barriers have been removed. 
The positive trends of MICs in these strains with the lipophilic descriptors logP(o/w) and SlogP and 
the rigidity descriptor brotR are consistent with the trends in the respective MIC ratios described 
above (Table 10). In addition, FASA+ is also a top descriptor for PD6-Pore, with active antibiotics 
having higher values than Tavg = 0.5.  
 
Taken together, these results show that several top descriptors identified by RF classification trend 
with MICs and/or MIC ratios in P. aeruginosa and E. coli and that these descriptors vary between 
species and barriers. In several cases, optimizing for one barrier promotes strengthening of the 
other barrier, suggesting a synergistic relationship between the OM and efflux barriers. For 
example, rigid antibiotics (e.g., FQs) are more active against PD6 and thus, more readily permeate 
the OM in P. aeruginosa, but these antibiotics are also often excellent substrates of efflux pumps. 
The activity of antibiotics in P. aeruginosa is primarily captured by charge and surface area 
descriptors, whereas properties identified for the E. coli barriers point to the role of topology, 
physical properties, and atom or bond counts. The calculated threshold values of these descriptors 
provide guidelines that may be useful for selecting or designing antibiotics with favorable 
properties to overcome these barriers. 
Chemical structure and descriptor relationships 
The top descriptors described above are sensitive to small changes in the chemical structures of 
antibiotics. For example, the CEFs ceftriaxone and cefepime (Table 11) differ by the cyclic 
substitutions at position 3 of the cephalosporin nucleus. These two antibiotics were active against 
both E. coli and P. aeruginosa, but differed significantly in the effects of efflux and the OM barrier 
(Figure 35 and Figure 36). Cefepime, with a methylpyrrolidine substitution at position 3, was not 
sensitive to efflux or the OM barrier in E. coli but was affected strongly by both barriers in P. 
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aeruginosa. In the case of P. aeruginosa, cefmenoxime, which has a methyltetrazole group at this 
position, was further affected by both barriers with a thousand-fold increase in activity compared 
to WT. Although cefepime and cemenoxime have similar values for FASA+, PEOERPC+, adon, and 
brotR, cefmenoxime has a higher fractional and total negative SA, whereas cefepime has a higher 
dipole moment, Evdw, and lipophilicity (Figure 38). 
 
The aminopenicillins amoxicillin and ampicillin differ by the presence of a hydroxy group at C4 
in the phenyl ring (Table 11). These two aminopenicillins had high MICs in PAO1, but both are 
relatively active against WT (Figure 35 and Figure 36). In E. coli, the activity of these antibiotics 
was mainly limited by the OM barrier. For P. aeruginosa either inactivation of efflux or 
hyperporination was required to obtain a measurable MIC for ampicillin. In contrast, both 
inactivation of efflux and hyperporination was needed to obtain a measurable MIC for amoxicillin. 
These two antibiotics have similar descriptor values for several properties such as brotR, SlogPVSA3, 
and FASA+, but ampicillin has a higher dipole moment, lipophilicity, Evdw, and pmiY (Figure 38). 
Amoxicillin has a higher adon as a result of its additional hydroxyl group, which may decrease the 
effect of the OM barrier, at least in E. coli. 
 
For FQs, difloxacin differs from sarafloxacin by the presence of a methyl group at N4 in the 
piperazinyl ring and sarafloxacin is a stronger base and is more hydrophilic (Table 11). Difloxacin 
has a higher total and fractional negative SA, SlogP, and pmiY, and a lower dipole moment than 
sarafloxacin (Figure 38). In P. aeruginosa both of these antibiotics were affected by the removal 
of both barriers, but only sarafloxacin was significantly limited by efflux alone. In both species 
hyperporination did not greatly limit antibiotic activity (< 4-fold change) (Figure 35). However, 
in E. coli active efflux provided a significant barrier to overcome for difloxacin but not sarafloxacin 
(Figure 36).  
 
The activities of most FQs were mainly limited by active efflux. The exceptions are moxifloxacin 
and nadifloxacin, which also showed OM barrier limitations and an even greater increase in 
activity in the minimal-barrier strains, reflecting the synergy of these barriers (Table 11). Several 
of the top descriptors differ between these two antibiotics. For example, moxifloxacin has a higher 
dipole moment, pmiY, and SlogPVSA3, but nadifloxacin has a higher negative SA and an additional 
98 
 
hydrogen bond donor. Moxifloxacin, a fourth generation FQ belonging to the 6-
hydrogenquinolones, bears a cyclopropyl group at N1 coupled with a C8 methoxy and a 
pyrrolopyridine at C7. The bulky heterocyclic group and overall lipophilicity strongly affect both 
the permeation across the OM and the effect of active efflux. Chemically, nadifloxacin has a 
lipophilic tricyclic benzoquinolizine core, with a 4-hydroxypiperidino moiety at the C8 position. 
This singular moiety lacks a distal basic functionality, which is unusual for a side chain of a 
quinolone, as all marketed quinolones bear side chains with a basic functionality, thereby 
providing two or three ionizable groups compared with only one for nadifloxacin (pKa = 6.8). Thus, 
even small changes in the chemical structures of antibiotics such as a single substituent change can 
significantly affect one or more descriptors that capture the behavior of the OM barrier, active 
efflux, or both. 
Identification of EPIs using physicochemical property filters 
An important feature of OM-permeable compounds is the presence of a cationic amine, with 
primary amines being the most permeable. However, primary amines are relatively rare in 
chemical databases. For example, only ~0.1% of the ChemBridge Microformat Set contains this 
functional group.67 Of the limited number of amines, antibacterials should also be relatively rigid, 
polar, amphiphilic, and have low globularity. To generate a focused library of molecules that could 
potentially serve as efflux pump inhibitors, we searched a subset of the ZINC database and 
performed additional filtering for compounds with appropriate properties. We then docked the 
resulting ~1,400 compounds to an ensemble of conformations of monomeric AcrA at four different 
potential binding sites and selected compounds based on docking score. Of the resulting ~50 top 
predicted binders, 34 commercially available compounds were purchased and tested 
experimentally. 
 
To qualify as EPIs, compounds must satisfy at least three criteria: (i) they must enhance the 
activities of antibiotics that are effluxed in strains containing functioning pumps, (ii) they must not 
significantly potentiate the activities of antibiotics in strains that lack efflux pumps, and (iii) must 
interact with AcrA or AcrB.219, 220 MPC4 values to measure antibiotic potentiation of novobiocin 
and erythromycin and surface plasmon resonance (SPR) were used to identify six compounds that 
meet these criteria. Interestingly, the six compounds that potentiate antibiotics and bind AcrA all 
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are substituted 4(3-aminocyclobutyl)-pyrimidin-2-amine compounds. Each of these six 
compounds has low globularity (0.05-0.12), few rotatable bonds (2-4), relatively high dipole 
moment (5-10 D) and relatively high amphiphilic moment (~4.5-7). The most favorable docking 
score for each compound corresponds to binding at either site II or site III, which flank the b-barrel 
domain of AcrA (Figure 39). 
 
We also tested the six top hits for their ability to potentiate the activity of novobiocin and 
erythromycin in four other Gram-negative pathogens. These compounds did not potentiate 
antibiotic activity in P. aeruginosa or E. cloacae. However, some of these compounds increased 
the efficacy of novobiocin and erythromycin as measured by MPC4 in wild-type cells of both A. 
baumannii (up to 8-fold) and K. pneumoniae (up to 2-fold). This result suggests that these 
compounds have broad-spectrum activity and permeate the OM of A. baumannii better than the 
OM of E. coli.  
Conclusions 
The OM barrier and efflux synergistically limit antibiotic activity in Gram-negative bacteria. In 
the present study, we have used P. aeruginosa and E. coli strains with controlled OM permeability 
and varying efflux capacity to identify trends in the antibacterial activities of CEFs, PENs and 
FQs. In addition to high-affinity target binding, OM permeation should be maximized and efflux 
should be minimized to obtain optimal antibacterial activity. Using RF classification, we have 
identified properties that distinguish between antibiotics with high and low antibiotic activities 
(MICs) in the various strains and identify the properties related to the effect of altering the OM 
permeability and efflux barriers (MIC ratios). 
The top descriptors for P. aeruginosa are dominated by electrostatic properties. Active antibiotics 
have a higher dipole moment and antibiotics with low dipole moments are significantly limited by 
the OM barrier. On the other hand, partial positive charges trend specifically with the efflux ratios. 
Rigid antibiotics and antibiotics with high VDW energies (EVDW) were more active against both E. 
coli and P. aeruginosa. Lipophilicity (log P(o/w) and SlogP) trend positively with efflux ratios in 
both species and classify antibiotics in the OM ratios better for E. coli than for P. aeruginosa, 




The physicochemical properties identified here reflect chemical bias toward CEFs, PENs and FQs. 
However, performing a similar predictive analysis on diverse molecular libraries is expected to be 
beneficial for identifying new antibiotics or EPIs. The differences in rules between P. aeruginosa 
and E. coli suggest that different properties may need to be targeted for optimization of antibiotics 
against different species. Furthermore, we have shown that the properties selected as important for 
the OM barrier ratios differ significantly from those for the efflux ratios and that these two barriers 
can work together to develop resistance to antibiotics. Therefore, we recommend that 
antimicrobials should be optimized to evade efflux and enhance OM permeability simultaneously. 
 
Using existing physicochemical guidelines as filters in combination with ensemble docking, in 
vitro binding studies, and in vivo potentiation assays in bacterial strains with controllable 
permeability barriers, we identified a new class of EPIs with activity against several Gram-
negative bacteria. Six molecules with a shared scaffold were found to potentiate the antibiotic 
activity of erythromycin and novobiocin in hyperporinated E. coli cells and in wild-type strains of 












Table 10. Average threshold values for top descriptors that trend with MICs and MIC ratios 
 
a Descriptor negatively trends with MICs (i.e., active antibiotics generally have descriptor values 
above Tavg) or MIC ratios (i.e., significant barrier effects are often observed in antibiotics with 
descriptor values below Tavg).  
b Descriptor positively trends with MICs (i.e., active antibiotics generally have descriptor values 
below Tavg) or MIC ratios (i.e., significant barrier effects are often observed in antibiotics with 
descriptor values above Tavg).  
c No trend between descriptor and MIC or MIC ratio values.  
Descriptor category
Number of Descriptors
P. aeruginosa E. coli
charge 33 32
connectivity 1 1
molecular topology 18 18
natoms , nbonds 17 16
physical properties 14 14
potential energy 9 10
shape 9 9









































































































Dipole 5.5a 5.6a 5.6a 5.5a
FASA+ 0.5a 0.5a 0.5a 0.5a 0.5b
PEOE_RPC+ 0.1b 0.1b
PEOE_VSA-2 21.9b 17.0b 16.9b 15.3b 30.5b 21b 24.9b 20.4b 17.9c 26.7a
PEOE_VSA_FNEG 0.5b 0.5b 0.4b 0.3b 0.4b 0.39b
PEOE_VSA_NEG 170b 171b 141b 167c 170c 210b 210b
a_don 1.5b 2.3c 2.3a
b_rotR 0.2b 0.2b 0.2b 0.2b 0.2b 0.2a 0.2a 0.2a
logP(o/w) 0.2a -0.9b 0.8b 0.7b -0.1c 1.5b 1.3b
SlogP -0.9a -0.6b -0.5b -0.9b -0.5b -0.7b
E_vdw 4.6a 6.1a 6.6a 4.1a 3.8a 5.4a 8.8b
pmiY 2140c 2930b
SlogP_VSA3 39.4a 48.5a 62.8a 20.5a
MICs MIC ratios
P. aeruginosa E. coli P. aeruginosa E. coli
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Table 11. Example CEFs, PENs, and FQs highlighting how small changes in antibiotic structure 
contribute to differences in MIC ratios and molecular descriptors. See ref 201 for additional 












































cefepime 64 16 16 4 2 2 5.5 0.60 0.07 30.6 0.26 118 2 0.23 -0.3 -1.3 4.7 4136 72.6
cefmenoxime 1024 64 16 8 1 1 3.4 0.49 0.10 40.1 0.40 175 2 0.25 -1.1 -1.8 -5.1 3456 34.5
amoxicillin 64 1 1 8 1 8 3.8 0.49 0.10 19.8 0.53 177 3 0.19 0.6 -1.2 2.7 3021 0
ampicillin > 64 16 > 64 8 1 4 5.2 0.47 0.12 19.8 0.56 182 2 0.19 0.9 -0.9 11.4 3182 0
difloxacillin 16 4 4 16 16 4 6.6 0.60 0.11 0 0.43 161 0 0.09 2.6 1.7 14.1 2104 73.8
sarafloxacin 64 16 1 4 4 1 11.6 0.59 0.12 0 0.39 138 0 0.10 2.3 0.3 13.4 1949 73.8
moxifloxacin 256 64 16 64 16 4 12.4 0.69 0.12 0 0.33 119 0 0.12 2.0 -0.2 12.6 5239 55.3

































































cefepime amoxicillin difloxacin moxifloxacin














Figure 34. Structure of the E. coli efflux pump AcrAB-TolC. (A) Cryo-EM structure of the 
AcrAB-TolC complex (PDB Entry 5NG5) shown in cartoon and surface representations. 
Individual subunits of TolC (purple), AcrA (dark green), and AcrB (blue) are shown. (B) Sites I-
IV on AcrA used for docking are color coded by domain: a-hairpin (light green), lipoyl (orange), 
b-barrel (yellow) and membrane-proximal (red). Residues used to define the center of each site 
are shown as spheres and colored by domain.  
 













Figure 35. Scaled MICs and MIC ratios for antibiotics in P. aeruginosa sorted by antibiotic class 
and PAO1 MIC from lowest to highest within each class. Values were natural log-transformed and 
then scaled between 0 and 1. Gray squares indicate MIC ratios that are outside of the measurable 
range. MICs (green) report on relative potency and MIC ratios (blue) report on the dependence of 
antibiotic activity on efflux, the OM barrier, or both. See ref 201 for additional details on 




Figure 36. Scaled MICs and MIC ratios for antibiotics in E. coli sorted by WT MIC from lowest 
to highest. Values were natural log-transformed and then scaled between 0 and 1. MICs (green) 
report on relative potency and MIC ratios (blue) report on the dependence of antibiotic activity on 





Figure 37. P. aeruginosa and E. coli MIC ratios colored by class (CEF=blue, PEN=orange, 
FQ=gray, other=gold) for (A) the “barrierless” ratio (PAO1/P∆6-Pore), (B) only efflux pump 
deletion (PAO1/P∆6), and (C) only hyperporination (PAO1/PAO1-Pore), (D) the “barrierless” 
ratio (WT/∆TolC-Pore), (E) only efflux pump deletion (WT/∆TolC), (F) only hyperporination 
(WT/WT-Pore). Only MIC ratios with measurable values are shown. The fold changes in MICs 
are shown on the X-axes and the number of antibiotics with the corresponding fold changes in 





Figure 38. Selected top molecular descriptors from RF classification of antibiotics with activity 
against P. aeruginosa and E. coli. Descriptor values were scaled between 0 and 1 and colored blue, 
with darker blue indicating higher descriptor values. Minimal values for a given descriptor are 






Figure 39. Highest-scoring docked pose for the six compounds that bind to AcrA and potentiate 
antibiotic activity (top). Individual snapshots of AcrA were aligned to chain A (colored by domain) 
in the cryo-EM structure of the AcrAB-TolC complex (PDB entry 5NG5), which is shown in 
cartoon and surface representations (green = AcrA, blue = AcrB). Individual docking poses for 
each of the six compounds highlighting interactions with residues in AcrA colored by domain 







SUBSTRATE BINDING INDUCES CONFORMATIONAL CHANGES IN A CLASS A  b-
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Abstract 
The emergence and dissemination of bacterial resistance to β-lactam antibiotics via β-lactamase 
enzymes is a serious problem in clinical settings, often leaving few treatment options for infections 
resulting from multidrug-resistant superbugs. Understanding the catalytic mechanism of β-
lactamases is important for developing strategies to overcome resistance. Binding of a substrate in 
the active site of an enzyme can alter the conformations and pKas of catalytic residues, thereby 
contributing to enzyme catalysis. Here we report X-ray and neutron crystal structures of the class 
A Toho-1 β-lactamase in the apo form and an X-ray structure of a Michaelis-like complex with 
the cephalosporin antibiotic cefotaxime in the active site. Comparison of these structures reveals 
that substrate binding induces a series of changes. The side chains of conserved residues important 
in catalysis, Lys73 and Tyr105, and the main chain of Ser130 alter their conformations, with Nζ 
of Lys73 moving closer to the position of the conserved catalytic nucleophile Ser70. This 
movement of Lys73 closer to Ser70 is consistent with proton transfer between the two residues 
prior to acylation. In combination with the tightly bound catalytic water molecule located between 
Glu166 and the position of Ser70, the enzyme is primed for catalysis when Ser70 is activated for 
nucleophilic attack of the β-lactam ring. Quantum mechanical/molecular mechanical (QM/MM) 
free energy simulations of models of the wild-type enzyme show that proton transfer from the Nζ 
of Lys73 to the Oε2 atom of Glu166 is more thermodynamically favorable than when it is absent. 
Taken together, our findings indicate that substrate binding enhances the favorability of the initial 




Since their fortuitous discovery and introduction into the clinic, b-lactam antibiotics have 
revolutionized medicine.68, 69 With their ability to imitate units of the bacterial cell wall during cell 
wall synthesis, they inhibit cell wall regeneration during the autolysis and rebuilding process in 
the cell, thus causing cell death.70, 221 However, the development of acquired and evolved 
resistance by bacteria is inevitable. Despite the wide variety of β-lactam antibiotics available today, 
there are constantly emerging threats to public health from resistant strains. Four mechanisms are 
used individually or in combination by resistant bacteria to overcome β-lactam antibiotics: (i) 
mutations in the active site of penicillin binding proteins (PBPs) that result in reduced affinity of 
antibiotics for PBPs, (ii) decreased expression of outer membrane proteins that give β-lactams 
access to the cell wall building region in the periplasm, (iii) expression of efflux pumps that expel 
β-lactams and other substances that are harmful to the cell, and (iv) the production of β-lactamases, 
which inactivate β-lactam antibiotics.222 
 
β-lactamases are divided into four classes (A-D) on the basis of sequence homology.70 Apart from 
the class B metalloenzymes, which require two Zn2+ ions in the active site to function70, 223, 224, β-
lactamases are serine-reactive hydrolases. Typical class A β-lactamases include sulfhydryl 
variable (SHV), Temoniera (TEM), and extended-spectrum β- lactamase (ESBL) cefotaxime-
resistant (CTX) M-type enzymes. CTX-M-type β-lactamase enzymes are often encountered in 
bacterial intraabdominal and urinary tract infections. CTX-M ESBLs can inactivate first-, second-
, and third- generation cephalosporins and monobactam antibiotics.70-72 In combination with their 
broad substrate profile, these β-lactamases create challenges for clinical treatment and increase 
mortality rates. 
 
Due to its potent activity against extended-spectrum cephalosporins, drugs that reach the spinal 
fluid in a high enough concentration to treat meningitis, Toho-1 is a class A CTX-M-type ESBL 
β-lactamase of particular interest.225-227 Common to other class A β-lactamases, Toho-1 is 
composed of two highly conserved domains, α/β and α, the interface of which forms the active site 
cavity.73 Like all class A β- lactamases, Toho-1 employs an active site serine nucleophile (Ser70) 
to cleave the β-lactam bond of the substrate in a two- step acylation-deacylation reaction cycle that 
leads to overall hydrolysis (Figure 40 in Appendix V). Various detailed mechanisms have been 
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proposed for the formation of the acyl-enzyme intermediate during catalysis.74-77 Differentiating 
between these mechanisms can be facilitated by unambiguously identifying key protonation states 
and hydrogen-bonding interactions of the catalytically important residues and the substrate. 
Neutron crystallography is ideally suited to experimentally determine protonation states. Our 
previous studies have shown that both Glu166 and Lys73 can undergo changes in protonation state 
upon binding of transition state analogues228 and during the formation of the acyl-enzyme 
intermediate.229, 230  
 
Quantum mechanical/molecular mechanical (QM/MM) calculations can provide key mechanistic 
insights that are complementary to experiments. For example, this approach allows detailed 
inspection of short-lived intermediates and transition states and the quantification of reaction 
energetics of enzymatic reactions. To obtain meaningful results, solvent effects must be properly 
taken into account. Long-range electrostatic effects are known to contribute significantly to the 
structure and properties of biomolecules.231 Most often in QM/ MM simulations, a nonperiodic 
water droplet model is used, and this approach has been shown to capture long-range electrostatic 
interactions sufficiently well in comparison to periodic simulations with QM/MM-Ewald 
approaches.232 Configurational sampling is required to provide information about free energies and 
can be obtained using umbrella sampling. The computational cost of performing QM/MM 
umbrella sampling with density functional theory (DFT) is quite high. Thus, a common approach 
is to perform the simulations with a computationally efficient semiempirical QM method. 
However, semiempirical methods are generally less accurate than DFT. Their accuracy can be 
improved by computing potential energies with DFT-based QM/MM calculations and then 
accounting for thermal and entropic effects by performing configurational sampling with semi- 
empirical-based QM/MM simulations. 
 
Previous QM/MM studies of class A β-lactamases have focused on the acylation78-81and 
deacylation steps82, 83, and some of these studies have helped establish likely mechanisms for β-
lactam inactivation. However, the specific contributions of the substrate in modulating proton 
transfer free energies has not been investigated. Thus, in the present work, we have combined X-
ray and neutron crystallography with QM/MM simulation to identify key factors that contribute to 
catalytic rate enhancement by a class A β-lactamase. By generating a Ser70Ala mutant of Toho-1 
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β-lactamase and obtaining a crystal structure with the substrate cefotaxime, we have captured the 
preacylation complex. This approach allowed us to scrutinize the conformations and protonation 
states of key active site residues as β-lactam hydrolysis is poised to occur. Our findings provide 
evidence in support of a concerted base hypothesis originally proposed by Mobashery and co-
workers.78 Specifically, they reveal concerted changes in the conformations of several residues 
upon substrate binding and the presence of a hydrogen bond network capable of facilitating 
cleavage of the β-lactam bond. Furthermore, our QM/MM free energy simulations show that the 
presence of the cefotaxime substrate alters the relative proton affinities of key catalytic residues, 
facilitating proton transfers prior to acylation. Recent high-resolution crystal structures of CTX-
M14, another class A β-lactamase, in complex with a conjugated penicillin233 and boronic acid 
inhibitors234 have indicated that changes in the protein microenvironment upon binding of small 
molecules can induce protonation state changes.  
 
Methods 
For experimental details see: 
 
Langan, P.S., Vandavasi, V.G., Cooper, S.J., Weiss, K.L., Ginell, S.L., Parks, J.M., and Coates, 
L. Substrate binding induces conformational changes in a class A β-lactamase that prime it for 
catalysis. ACS Catal. 2018, 8, 2428-2437. 
Simulation system setup 
The program antechamber from the AMBER 14 suite of programs235 was used to assign general 
Amber force field236 parameters for cefotaxime. AM1-BCC atomic partial charges237, 238 were 
calculated with the program sqm.239  
 
The 2.1 Å neutron structure of Arg274Asn/Arg276Asn Toho-1 β-lactamase240 was used to 
generate the apoenzyme model. The 1.1 Å X-ray structure of Ser70Ala/Arg274Asn/Arg276Asn 
Toho-1 β-lactamase with cefotaxime determined in the present study241 was used to generate the 
cefotaxime-bound model with Ala70 converted back to Ser. The ff14SB force field242 and TIP3P 
water model138 were used to describe the protein and solvent, respectively. Each system was 
solvated in a periodic box with a 20 Å margin between the protein and the sides of the box. The 
charge of the cefotaxime system was neutralized by adding a single sodium ion. No ions were 
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added to the apoenzyme system. Thus, although crystallization was carried out in high ionic 
strength buffers, all simulations were performed under low ionic strength conditions.  
 
All protonation states and active-site hydrogen-bonding patterns in the apoenzyme and 
cefotaxime-bound models were assigned directly from the corresponding neutron structures. The 
protonation states and hydrogen-bonding patterns are consistent in both structures. Unfortunately, 
it was not possible to trap the substrate without mutating a catalytic residue, in this case Ser70. 
Although it is possible that mutating Ser70 to Ala could alter active site pKa values, we do not 
expect that it would change the protonation states.  
Classical MD simulations 
Initial relaxation of the system consisted of 250 steps of steepest descent minimization followed 
by 750 steps of conjugate gradient minimization. During all MD simulations, a time step of 2 fs 
was used, and covalent bonds to hydrogen atoms were constrained to their equilibrium distances 
with the RATTLE algorithm.243 A cutoff of 8 Å was used for van der Waals interactions, and long-
range electrostatic interactions were computed with the particle mesh Ewald (PME) method.244, 245 
Each system was heated to 300 K with a Langevin thermostat over 50 ps in the canonical (NVT) 
ensemble with a 5.0 kcal mol-1 Å-2 harmonic restraint applied to all heavy atoms of the protein, 
substrate, and the active site water molecule. Next, a 50 ps equilibration was performed in the 
isothermal-isobaric (NPT) ensemble to adjust the pressure of the system to 1 atm, again with the 
same 5 kcal mol-1 Å-2 harmonic restraint. An additional 200 ps equilibration was then performed 
with a 1 kcal mol-1 Å-2 restraint on all Cα atoms, cefotaxime heavy atoms, and the active site water 
molecule. Production MD simulations were then performed in the NPT ensemble for >10 ns with 
no restraints. All classical MD simulations were performed with pmemd.  
QM model calculations 
To identify a suitable level of theory with which to describe the QM subsystem in the QM/ MM 
calculations, we performed a set of model calculations on selected amino acid side chains. The 
M06-2X global hybrid density functional246 and 6-311++G(2d,2p) basis set were previously shown 
to provide an accurate description of proton transfers between amino acids, yielding a mean 
unsigned error of 1.0 kcal mol-1 and maximum error of 1.4 kcal mol-1 for proton affinities at 0 K 
in comparison to benchmark CCSD(T)/CBS values (Table 12 in Appendix V).247 In that work, 
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geometries were optimized at the CPCM/MP2/6-311++G(d,p) level of theory. We followed the 
same procedure but reoptimized the geometries of the Asp, Ser, and Lys side chains at the CPCM/ 
M06-2X/6-31G(d) level of theory and then calculated gas-phase single-point energies with the 
larger 6-311++G(2d,2p) basis set. The resulting errors relative to the benchmark values were 0.2, 
1.4, and 1.3 kcal mol-1 for Asp, Ser, and Lys, respectively, indicating that M06-2X/6-31G(d) 
geometries and M06-2X/6-311++G(2d,2p) single-point energies provide quite accurate proton 
affinities and are expected to be useful for quantifying proton transfer energetics in the present 
enzyme system.  
QM/MM system preparation 
A spherical water droplet model was used for all QM/MM simulations. For the apo and 
cefotaxime-enzyme systems, a single snapshot was chosen near end of each classical MD 
simulation trajectory, and all water molecules greater than 36 Å from Cα of Ser70 were removed. 
The entire protein was enclosed within the spherical solvent shell. Prior to performing QM/MM 
calculations, the energy of the system was minimized for 20000 steps.  
 
For both the apoenzyme and cefotaxime-enzyme model, the side chains of Ser70, Lys73, Glu166, 
and one active site water molecule were included in the QM subsystem. Hydrogen link atoms were 
used to saturate the valences of the covalent bonds at the QM/MM boundary. The substrate was 
included in the MM region for the cefotaxime-bound model. The total charge of the QM subsystem 
was zero for both models. No cutoffs were used for the nonbonded interactions in the QM/MM 
calculations.  
Potential energy profiles 
We performed a series of restrained geometry optimizations using a generalized reaction 
coordinate approach.248 Geometries were considered converged when the RMS gradient dropped 
below 10-2 kcal mol-1 Å-1. The reaction coordinate corresponded to the Lys73 catalytic base 
mechanism proposed by Mobashery and co-workers.78 They also considered an alternative 
pathway in which Glu166 serves as the catalytic base that deprotonates Ser70 through a water 
molecule. However, this pathway was found to have a 4 kcal mol-1 higher energy barrier that the 
Lys73 general base pathway. Thus, we simply chose to focus on the Lys73 pathway in our work. 
The same atoms were used to define the reaction coordinate for both the apoenzyme and 
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cefotaxime-enzyme models (Figure 41).  
The restraint energy, U, was defined as  
U = k(w1|d1| + … + wn|dn|–d0)2 (Eqn. 2)  
where k is the force constant in kcal mol-1 Å-2, wn are the restraint weights, dn are the interatomic 
distances, and d0 is a distance offset parameter that is adjusted at each step along the reaction path. 
A force constant of 2000 kcal mol-1 Å-2 was used, and the reaction coordinate was adjusted in 
increments of 0.1 Å. We modified the program sander to allow up to six interatomic distances to 
be included in the generalized reaction coordinate. All atoms greater than 24 Å from Cα of Ser70 
were restrained during the potential energy profile calculations. All restrained geometry 
optimizations were performed sequentially in both the forward and reverse directions until smooth, 
continuous paths were obtained.  
The following interatomic distances and weights were used:  
d1 = Glu166(Oε)−water(H), w1 = -1.0  
d2 = water(H)−water(O), w2 = 1.0  
d3 = water(O)−Ser70(Hγ), w3 = -1.0  
d4 = Ser70(Hγ)−Ser70(Oγ), w4 = 1.0 
d5 = Ser70(Oγ)−Lys73(Hζ), w5 = -1.0 
d6 = Lys73(Hζ)−Lys73(Nζ), w6 = 1.0  
QM/MM free energies 
Performing Born-Oppenheimer MD simulations with a DFT description of the QM subsystem 
requires considerable computational resources. However, analogous simulations with a 
semiempirical Hamiltonian are much less computationally demanding and can provide reasonably 
accurate free energies in many cases. The PM6 Hamiltonian was developed to provide accurate 
geometries and energies of many types of molecules.249 Although proton affinities computed with 
PM6 exhibit errors on the order of 2-4 kcal mol-1 for the side chains of Lys, Ser, and Glu,250 we 
expect that performing umbrella sampling along a predefined reaction coordinate should provide 
meaningful estimates of thermal and entropic contributions. Thus, to combine the accuracy of DFT 
for the underlying energetics with the computational efficiency of PM6 for sampling, we first 
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computed DFT/MM potential energies and then added a free energy correction computed with 
PM6/MM at each reaction coordinate value:  
%! = &! 	()062-/))) + %!"#$$ 	(0)6/))) 
where  
%!"#$$(0)6/))) = %!%&	(0)6/)))–&!'( 	(0)6/))) 
For the umbrella sampling simulations, PM6/MM geometries obtained from restrained 
optimizations were used as initial structures for umbrella sampling simulations, which were 
performed at the same level of theory. We used the same reaction coordinate as for the restrained 
optimizations, but in this case the force constants for the harmonic restraints were set to 300 kcal 
mol-1 Å-2 for each simulation window. Atoms greater than 24 Å from Cα of Ser70 were restrained 
with a force constant of 5 kcal mol-1 Å-2. The time step was set to 1 fs, and the temperature was 
maintained at 298 K with a Langevin thermostat and a collision frequency of 10 ps-1. After 5 ps 
MD equilibration, we performed 25 ps production sampling at 298 K for each replica. The potential 
of mean force (PMF) for each system was obtained with the weighted histogram analysis method 
(WHAM)251 implemented in the program WHAM. Statistical errors were estimated using 
bootstrapping with 100 samples. All classical MD and QM/MM simulations were performed with 
AMBER 14.235 For the QM/MM calculations with DFT, the AMBER 14/Gaussian 09135 interface 
was used. 
Results and Discussion 
Substrate-free structures 
Previously, we have used neutron and X-ray crystallography to determine the side- chain 
orientations, water positions, protonation states, and hydrogen-bonding networks in the active sites 
of some of the reaction states of Toho-1 with both substrate-free and substrate-bound enzyme.240, 
252 In comparison to previously determined structures of the wild-type apoenzyme, the X-ray and 
neutron structures in this study show no perturbation to the active site as a result of the Ser70Ala 
mutation. In the X-ray and neutron structures of the apoenzyme, Lys73 appears in a single 
conformation oriented toward Ser130 and forming hydrogen bonds with the carbonyl group of 
Ser130 (2.79 Å, ESD 0.02 Å), Oγ of Ser130 (2.95 Å, ESD 0.02 Å), and OD1 of Asn132 (2.66 Å, 
ESD 0.02 Å) (Figure 42). The omit nuclear density maps in the neutron structure show a 
definitively protonated Lys73 in the ND3+ form in this conformation, indicating that this residue 
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is the donor group in all three hydrogen bonds. However, we note that the absence of the Ser70 
side chain in the Ser70Ala mutant could potentially alter the pKa of Lys73 and thus its protonation 
state relative to the wild-type enzyme. In addition, the pH of crystallization was slightly acidic 
(6.1), which may also have affected the protonation state of Lys73.  
Enzyme-substrate complex 
The enzyme-substrate complex is identical to the substrate-free complex with the following 
exceptions. In the X-ray structure of the enzyme-substrate complex, cefotaxime has a refined 
occupancy of 66% and Lys73 is present in two conformations, one of which is identical to its 
conformation in the substrate-free enzyme (Figure 42). The refined occupancy for the Lys73 
conformation corresponding to that found in the substrate-free complex (A conformation) is 36%, 
whereas the refined occupancy for the second Lys73 conformation (B conformation) is 64%. In 
the A conformation, Lys73 forms hydrogen-bonding interactions with the carbonyl of Ser130 (2.74 
Å, ESD 0.05 Å), Oγ of Ser130 (2.95 Å, ESD 0.07 Å), and Oδ1 of Asn132 (2.74 Å, ESD 0.05 Å) 
and is presumed to be fully protonated, as in the neutron structure of the substrate-free enzyme.  
 
In contrast, in the B conformation Lys73 interacts with the catalytic water molecule (2.89 Å, ESD 
0.03 Å), Oδ1 of Asn132 (2.76 Å, ESD 0.03 Å), and Oγ of Ser130 (3.06 Å, ESD 0.06 Å). The 
catalytic water molecule forms hydrogen bonds with Lys73 (B) (2.89 Å, ESD 0.03 Å), Oδ1 of 
Asn170 (2.81 Å, ESD 0.03 Å), and Oε2 of Glu166 (2.56 Å, ESD 0.03 Å) (Figure 42). The catalytic 
water is therefore likely to be coordinated such a way that it accepts hydrogen in a hydrogen bond 
with Lys73 and it donates hydrogen in a hydrogen bond with Oε2 of Glu166, thus providing a 
possible proton transfer pathway between Lys73 and Glu166. The B factors are particularly low 
for all atoms in the side chain of Lys73 in both X-ray structures (all are less than 10 Å2), enabling 
these discrete conformations to be visualized.  
 
Protonation states of the key catalytic residues Lys73 and Glu166 in the precovalent state of class 
A β-lactamases have been debated for decades. Lys73 has been proposed to be either cationic 
(−NH3+) or neutral (−NH2)76, which lead to different mechanisms for the formation of the acyl-





In the unprotonated form, Lys73 would act as the general base to activate Ser70 directly for the 
attack on the β-lactam ring of the substrate. A QM/MM study of TEM-1 β-lactamase with 
penicillanic acid substrate investigated the identity of the general base in the acylation step.78 That 
study provided evidence for a concerted base mechanism in which a proton is transferred from 
Lys73 to Glu166 through an active site water molecule and Ser70. The authors proposed that 
substrate binding alters the pKas of Lys73 and Glu166. The proton transfer results in a Michaelis 
complex in which all key residues, Ser70, Lys73, and Glu166, are neutral. A neutral Lys73 would 
then deprotonate Ser70 to activate it for nucleophilic attack on the β-lactam ring. Experimental 
verification of these results has been challenging due to the transient nature of the Michaelis 
complex and the high reactivity of β-lactamases. Substrate binding can alter the protein 
microenvironment and thus the pKas of catalytic residues. In β-lactamases, these effects could 
potentially help drive proton transfer in the precovalent Michaelis complex (Figure 40), 
facilitating the acylation step of the reaction.  
 
As the separately refined occupancies of the cefotaxime substrate (66%) and the B conformation 
of Lys73 (64%) are nearly equivalent, it is highly likely that the conformation of Lys73 is directly 
altered by the binding of cefotaxime in the active site cavity. Superimposing the substrate-free 
structure of Toho-1 β-lactamase Arg274Asn/Arg276Asn, which possesses Ser70, with the 
cefotaxime- bound structure described in the present work yields an RMSD for main chain atoms 
of 0.28 Å, indicating that the two structures are nearly identical. In the cefotaxime-bound structure, 
Nζ of Lys73 in the B conformation lies just 2.39 Å away from Oγ of Ser70 in the 2ZQ8 structure, 
whereas this distance increases to 3.30 Å in the A conformation. Thus, upon binding of cefotaxime, 
Lys73 moves closer to Ser70 to enable proton transfer from Lys73 to Ser70.  
 
The catalytic water molecule in the cefotaxime-bound structure of the Ser70Ala mutant is located 
2.56 Å away from Oε2 of Glu166 and 2.36 Å from Oγ of Ser70 (PDB ID 2ZQ8). This orientation 
provides a clear pathway for a proton to be transferred from Ser70 to a negatively charged Glu166 
via the catalytic water. The B conformation of Lys73 is also ideally positioned to transfer a proton 
to Ser70 simultaneously with the protonation of Glu166, which would result in the formation of a 
precovalent complex in which Ser70, Lys73, and Glu166 are all neutral. The protonation state of 
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Glu166 in the 15 K X-ray substrate-free crystal structure was deduced by comparing the difference 
in carboxyl bond lengths with their estimated standard deviations (ESDs). The unrestrained 
carboxyl bond lengths for Glu166 refined to essentially equal bond lengths, i.e., 1.26 Å (ESD = 
0.02 Å) for the Cδ−Oδ1 bond and 1.25 Å (ESD = 0.02 Å) for the Cδ−Oδ2 bond, indicating that an 
anionic Glu166 is poised to accept a proton from the catalytic water.  
To determine whether the presence of the substrate alters proton transfer energetics prior to 
acylation, we performed QM/MM free energy simulations with models of the substrate- free and 
cefotaxime-bound enzyme and compared the free energy profiles for the proton transfers in each 
system. We generated a model of the cefotaxime-bound structure by replacing Ala70 in the 
Ser70Ala mutant with the native Ser. For the substrate-free model, we used the neutron structure 
of substrate-free Toho-1 β-lactamase published previously.240,45 It has been shown that proton 
transfer from Lys73 to Glu166 via Ser70 and an active site water molecule is energetically 
favorable for TEM-1 β-lactamase with penicillanic acid as the substrate.78,38 Therefore, this 
reaction pathway was considered in the present simulations.  
 
The QM/MM optimizations indicate that the proton transfers are concerted and synchronous in 
both the apoenzyme and the cefotaxime-bound system (Figure 43), as evidenced by a single free 
energy barrier in each case (Figure 44). For the substrate-free model the estimated proton transfer 
free energy barrier is 5 kcal mol-1, with the product state (i.e., neutral Lys73 and neutral Glu166) 
being 2.5 kcal mol-1 higher in energy than the reactant state (i.e., cationic Lys73 and anionic 
Glu166). These relative free energies are consistent with the neutron crystal structure of the 
apoenzyme, in which Lys73 is cationic and Glu166 is anionic. For the cefotaxime- bound model 
we obtained a computed proton transfer barrier of 2.8 kcal mol-1 and a reaction free energy of -6.2 
kcal mol-1. Thus, the presence of the cefotaxime substrate clearly alters the relative pKas of Lys73 
and Glu166 to facilitate proton transfer from Lys73 to Glu166, as proposed previously.78 Of 
course, acylation cannot occur in the absence of substrate, but this comparison enables 
quantification of the role of the substrate toward catalyzing its own hydrolysis.  
 
In the substrate-free structure, Tyr105 also appears in a single conformation in which its phenolic 
hydroxy group forms a hydrogen bond with a water molecule (2.60 Å) that also forms a hydrogen 
bond with the main chain carbonyl of Tyr129 (2.76 Å). In the substrate-bound structure with 
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cefotaxime, Tyr105 is present in two conformations. In the first conformation (A), which has a 
separately refined occupancy of 34%, the hydroxy group of Tyr105 interacts again with a water 
molecule (2.61 Å) that also forms a hydrogen bond with an adjacent water molecule (2.80 Å). 
However, in the second conformation (B), which has a refined occupancy of 66%, the hydroxy 
group of Tyr105 forms a direct hydrogen bond with the main-chain carbonyl of Tyr129 (2.57 Å). 
In this conformation, Tyr105 forms several close contacts with the main-chain atoms of Tyr129 
and Ser130, which in turn induce a slight change in the conformation of the main chain around the 
carbonyl group of Ser130 that helps trigger the formation of the B conformation of Lys73. The B 
factors are low for most of the atoms in the side chain of Tyr105 in the cefotaxime-bound X-ray 
structure (~12 Å2 on average), which enables these discrete conformations to be visualized. The 
movement of Tyr105 is likely to be driven by the binding of the cefotaxime substrate, which has 
an identical separately refined occupancy value of 66%, due to multiple hydrophobic interactions 
between the phenol ring of Tyr105 and the dihydrothiazine ring of cefotaxime. This finding agrees 
with several earlier studies which have shown that, while not a catalytic residue, Tyr105 is 
important for catalytic efficiency.252  
Conclusions 
By using a combination of neutron and X-ray crystallography, we have determined the protonation 
states of Lys73 and Glu166 in the active site of the precovalent complex. Using occupancy 
refinement, we have observed how the binding of the cefotaxime substrate initiates several 
conformational changes from Tyr105 to Ser130 and then Lys73. This conformational change in 
the side chain of Lys73, which is directly induced by cefotaxime binding, places the enzyme into 
a catalytically competent state. Our findings are consistent with the concerted base hypothesis 
originally proposed by Mobashery and co-workers.78 They proposed that substrate binding triggers 
proton transfer from Lys73 to Glu166 through Ser70 and an active site water molecule. The 
resulting neutral Lys73 then deprotonates Ser70 to facilitate nucleophilic attack on the β-lactam 
ring. We performed QM/MM free energy simulations of the initial proton transfer steps to quantify 
the role of the substrate cefotaxime in facilitating the reaction. We found that proton transfer from 
Lys73 to Glu166 is more thermodynamically favorable when the substrate is bound. The present 
study fills in considerable detail on the structure and energetics of the proton relay network in the 
active site of a class A β-lactamase in the precovalent complex. Our structures also reveal 
concerted changes in the conformations of several residues upon substrate binding and the 
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presence of a hydrogen bond network capable of facilitating cleavage of the β-lactam bond. 
Although we did not directly observe catalysis in action, these three crystal structures two X-ray 
and one neutron supported by extensive QM/MM calculations, provide a compelling case for the 






Table 12. Proton affinitiesa (kcal mol-1) for selected amino acid side chains calculated at the 
M06-2X/6-311++G(2d,2p)//CPCM/M06-2X/6-31G(d) level of theoryb and benchmark 
CCSD(T)/CBS//CPCM/MP2/6-311+G(d,p) values.  
Amino acid M06-2X CCSD(T) Error 
Asp- 349.61 349.80 0.20 
Ser - 376.62 377.90 1.40 
Lys 226.68 228.03 1.30 
MUE   1.00 
a zero-point-exclusive proton affinity at 0 K 
b a single dihedral angle was constrained during geometry optimization in some cases to prevent 
intramolecular hydrogen bonding 






Figure 40. Catalytic mechanism of class A β-lactamase inactivation of a β-lactam substrate. A 
serine nucleophile cleaves the β-lactam bond of the substrate in two steps, acylation and 
deacylation, which lead to hydrolysis: First, the pre-covalent enzyme-substrate complex is formed 
and the acylation reaction is initiated (1). General base-catalyzed nucleophilic attack on the β-
lactam carbonyl by the serine hydroxy group proceeds through a tetrahedral intermediate (2) and 
forms a transient acyl-enzyme adduct (3). The acyl-enzyme adduct (3) undergoes general base-
catalyzed attack by the hydrolytic water molecule and forms a second tetrahedral intermediate 
during deacylation (4), which subsequently collapses to form a post-covalent complex (5) prior to 










Figure 42. Structures of substrate-free and cefotaxime-bound active sites of the Ser70Ala Toho-1 
mutant. Electron density 2Fo-Fc maps are represented at a s level of 1.0. (A, C) cefotaxime-free 
structure shown in cyan. Nitrogen atoms are shown in blue, carbon in cyan, sulfur in gold, and 
oxygen in red with the catalytic water molecule shown as a red sphere. (C) Distances (in Å) 
between Lys73 and close contacts are labeled. (B, D) The cefotaxime-bound structure is shown in 
yellow. Cefotaxime carbons are shown in green and protein carbons are shown as yellow sticks. 
(D) Both conformations are shown for Tyr105, Ser130, and Lys73. Conformations A and B are 
shown with the B conformations accommodating cefotaxime within the active site. For clarity, 

















Figure 43. Reaction path for QM/MM simulations. Reactant (left), transition state (middle) and 
product (right) states for the transfer of a proton from Lys73 to Glu166 through Ser70 and the 






Figure 44. Computed free energy profiles for proton transfer from Lys73 to Glu166 through Ser70 
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The 3D structure of a protein can be fundamentally useful to understanding its function. The most 
common way to obtain a structure of a protein in the absence of an X-ray, cryo-EM, or NMR 
structure is to use homology modeling, or the mapping of the target sequence onto a closely related 
homolog with an available structure. However, despite recent advances and efforts in structural 
biology, the 3D structure of many protein families remains unknown. Recent advances in genomic 
and metagenomic sequencing combined with coevolution analysis and protein structure prediction 
have allowed for highly accurate structural modeling of proteins previously considered intractable 
to model due to the lack of suitable templates.6, 22 Models generated by any or all of these 
approaches can then be further studied with other computational tools such as molecular dynamics 
(MD) simulations, docking of small molecule ligands to identify substrates, machine learning 
(ML) and quantum mechanical/molecular mechanical (QM/MM) free energy simulations to study 
reaction mechanisms. Here these various computational approaches were combined with predicted 
or experimentally determined structures to better understand the structure, dynamics, functions, 
and mechanisms of various bacterial proteins (Figure 1). 
Structural modeling of the HgcAB complex provides insights into the mechanism of bacterial 
mercury methylation 
 
By using metagenome-based protein structure calculations to generate models of the individual 
domains of HgcA and of HgcB valuable insights were obtained into the biochemical mechanism 
of Hg methylation in anaerobic microorganisms (Chapter I). HgcA is predicted to consist of two 
domains, the cobalamin binding domain (CBD) and a transmembrane domain (TMD). HgcB is 
predicted to have a dicluster ferredoxin fold. UV-visible spectroscopy of HgcA and HgcB 
heterologously expressed in E. coli confirmed that that these proteins do in fact bind vitamin B12 
corrinoid and iron-sulfur cofactors, respectively (Figure 2), as predicted from previous 
bioinformatics analyses. These cofactors were then incorporated into the structural models and 
used coevolution-restraints to predict how these domains assemble to form the HgcAB complex 




Based on coevolution analysis, the two domains of HgcA were not predicted to interact with each 
other, but rather both interact with HgcB (Figure 3). In addition, the TMD of HgcA did not have 
any detectable sequence homology with available crystal structures (Table 1). Furthermore, the 
interdomain contacts are not all fully satisfied, suggesting that domain motion may occur (Figure 
7). The [4Fe-4S] clusters are located far away (~15 Å) from the Co center of the corrinoid cofactor. 
Therefore, the CBD of HgcA may move closer to the [4Fe-4S] clusters for efficient electron 
transfer. The corrinoid/iron-sulfur protein (CFeSP), the closest known homolog of the CBD, has 
been shown to undergo large-scale conformational rearrangements. These rearrangements were 
observed in crystal structures upon binding to a (β/α)8 triosephosphate isomerase (TIM) barrel 
protein that acts as a methyltransferase.115 In the model of the HgcAB complex the CBD is oriented 
towards the membrane surface and would need to rearrange to accommodate a TIM barrel protein 
as a methyl donor. HgcB includes a pair of cysteine residues (Cys94 and Cys95) located at its C-
terminus. Pairs of cysteines are commonly observed in proteins and enzymes involved in metal 
trafficking and detoxification. For example, the mercuric reductase catalyzes the reduction of HgII 
to Hg0. This protein contains two Cys residues at its C-terminus that acquire HgII for transfer to 
another the pair of Cys residues in the active site active site.  
 
The mechanism of MeHg formation by HgcAB has been proposed to involve reduction of the 
corrinoid cofactor by HgcB, methylation of the Co center, and methyl transfer to a Hg substrate. 
Based on insights from our model, we propose that Cys94 and Cys95 from HgcB acquire HgII and 
deliver it to the corrinoid cofactor for methylation (Figure 12). Assuming that the reaction 
proceeds through radical ligand exchange, formation of a crosslinked HgcB-Cys94/95(Sg)–CoIII–
(Sg)Cys93-HgcA intermediate would occur. Both thiolate ligands would then be released upon 
reduction of the Co center and either of the C-terminal cysteines (Cys94/95) would be able to 
deliver [CH3Hg]+ to Cys73 from HgcB. To complete the reaction cycle an exogenous tholate (i.e. 
cysteine residue on a protein) would then liberate [CH3Hg]+ from HgcB.  
 
These mechanistic insights obtained from our structural model are consistent with known 
experimental data and will facilitate the development of hypotheses that address more detailed 
structural and functional questions which can then be tested experimentally. For example, polar 
residues identified in the model to be located at the interface of individual domains of HgcA and 
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HgcB could be mutated to determine if in vivo mercury methylation activity is reduced. When an 
in vitro methylation system becomes available, similar experiments could be performed to measure 
the effects of mutation on interprotein binding, electron transfer, or methylation kinetics. In 
addition, this work demonstrates how coevolution-based analysis can be used to predict the 
structures of protein-protein complexes. Similar approaches could be applied to identify additional 
binding partners of HgcA and HgcB (e.g., the electron donor, methyl donor, other membrane-
associated proteins). We hypothesize that an efflux pump may associate with HgcAB to enable 
rapid export of methylmercury. In the absence of sufficient sequences for coevolution analysis as 
described here to predict binding partners, deep-learning based approaches could be used for 
contact prediction (i.e. RaptorX-contact253, 254) and structural modeling (i.e. AlphaFold255 or 
DMPFold256), as these methods have been shown to produce accurate structures from multiple 
sequence alignments with fewer sequences (~100) than with conventional coevolution-based 
approaches. 
Subtle changes in the dynamics of the D243G mutant of IMPDH relieves inhibition and 
maintains catalysis 
 
Introduction of the hca pathway in E. coli resulted in only limited growth with coumarate because 
accumulation of 4-hydroxybenzaldehyde inhibited the native inosine monophosphate 
dehydrogenase (IMPDH). Engineered pathways can put a substantial burden on the host (i.e. 
inhibiting an enzyme involved in purine biosynthesis). Directed evolution can be used to select for 
mutations that alleviate deleterious interactions between engineered metabolic pathways. Here, a 
series of single point mutations in IMPDH were identified that were able to relieve inhibition by 
4-hydroxybenzaldehyde (Chapter II). Biochemical assays also confirmed that inhibition is relieved 
in the D243G mutant. This mutation is located at the N-terminal end of b11, which is near the 
NAD+ binding site where the inhibitor was predicted to bind based on docking to a homology 
model of IMPDH in the open conformation (Figure 18 and Table 8). Surprisingly, this mutation 
is located ~20 Å from the active site and did not appear to affect catalysis. 
 
To investigate how a single point mutation to an essential host protein can affect inhibitor binding 
at the distant active site while also maintaining catalysis we built a homology model of E. coli 
IMPDH in the closed conformation and ran MD simulations of the wild-type and D243G mutant. 
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In the wild-type simulations, the side chain of D243 forms stable hydrogen bonds with residues 
K87, R219, and V220 (Figure 19). In the mutant, G243 can no longer form these hydrogen bonds 
and instead interacts with Q272. Meanwhile, the catalytic dyad located on the opposite side of 
the mutation containing b-barrel remained poised for catalysis by showing only minor 
perturbations in dynamics (Figure 23). Thus, it was still not clear how the mutation propagates 
changes to the active site. 
 
To further identify changes in protein dynamics resulting from the D243G mutation, root-mean-
squared fluctuations (RMSFs) were calculated in both the wild-type and mutant (Figure 20). In 
both systems high RMSFs were observed over the entire region containing the catalytic flap. Upon 
inspection of specific interactions of flap residues, the mutation was found to lead to changes in 
hydrogen-bonding interactions with various nearby residues that results in  reorientation of a loop 
located on the flap that could be responsible for altering inhibitor binding (Figure 21 and Figure 
22). In addition, helices a2 and a8 were found to fluctuate more in the mutant than in the wild-
type (Figure 20). Helix a8 is downstream of the mutation. Therefore, the increased fluctuations 
in this region are likely due to the loss of the hydrogen bonding network D243 can form. In 
addition, N-terminal end of helix a2 and the C-terminal end of helix a8 are located near the NAD+ 
binding site. Hydrogen bonding interactions were observed between 4-hydroxybenzaldehyde and 
residues D248 and S250 located on a b-sheet just downstream of the mutation site and in close 
proximity to helices a2 and a8 (Figure 24). Taken together, changes in the structure and dynamics 
of these regions likely disrupts inhibitor access and binding to the NAD+ binding site. Follow-up 
MD simulations could be performed in the presence of the inhibitor, which would require 
straightforward force field parameterization of 4-hydroxybenzaldehyde. Additional computational 
studies could also use MD simulations to investigate the changes in dynamics of other point 
mutations that relieved inhibition and similar kinetics experiments could be used to measure 
enzyme activity in these mutants. 
Structure-based prediction of enzyme substrate scope in bacterial nitrilases 
 
Protein structures provide insight into substrate scope, or the repertoire of substrates for a given 
enzyme. 3D structures also provide information about the overall fold of the protein as well as 
domain architecture and special arrangement of residues that can be useful in determining 
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biochemical pathways and providing clues about enzyme function. Here ML was used to predict 
substrate scope for a series of bacterial nitrilases by combining structural modeling, docking, and 
physicochemical property calculations with experimental in vitro enzyme assays (Figure 32). 
Using different machine learning models our approach obtained accurate predictions of substrate 
scope for a series of aliphatic, aromatic, and arylaliphatic nitriles by including descriptors for the 
enzymes, substrates and their interactions in the models (Chapter III).  
 
Given a phylogenetic tree and sparse activity data (Figure 27 and Figure 29), it may be difficult 
to identify trends in substrate scope. In some cases, highly identical sequences can have similar 
substrate scopes (i.e., 1A1 and 1A2). However, sequence similarity is not always a good indicator 
of overlap in substrate scope, as seen in the markedly different activities of PMI28 and 1A8 (88% 
sequence identity), as subtle changes in the amino acid composition of the active site may lead to 
substantial differences in activity (Figure 26 and Figure 29). In contrast, distantly related 
sequences can have overlapping substrate scopes (i.e., 1A17 and 3WUY). Therefore, the substrate 
scope of an enzyme often cannot be accurately predicted based on inferences from phylogenic 
analysis alone. 
 
To obtain more accurate predictions of substrate scope several machine learning models were 
generated (random forests (RF), support vector machines (SVM), gradient-boosted decision trees, 
and logistic regression). RF models performed as well as, or in some cases better than, the other 
three ML methods (Figure 31). Unlike kernel-based methods (i.e., SVM), decision tree-based 
methods (i.e., RF) allow for calculation of variable importance of each descriptor. In the RF model 
the top descriptors for accurately predicting substrate scope were often those that encode 
information from the structural models and docked poses (Figure 33). 
 
As expected, small changes in sequence can cause large changes in specificity that would not be 
identified based on a phylogenetic analysis of the full sequence. In principle, our approach can 
capture these subtle effects if they lead to substantial changes in active site properties. Nitrilases 
are only one example where structure-based enzyme substrate scope prediction was applied. To 
adapt this approach to other types of enzymes the types of features used for machine learning 
would need to be carefully considered. Thus, this structure-based approach to predicting enzyme 
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substrate scope was designed to be highly modular. More specifically, physicochemical properties 
could be tailored to the enzymes of interest or calculated using different methods. For example, 
the types of properties that were used to describe the CºN bond in nitriles are highly specific to 
this system and may not be widely applicable to other cases. In addition, QM geometries and 
properties, structural modeling, and ligand docking could be performed with other software 
packages and physicochemical properties/molecular fingerprints can be calculated with freely 
available software such as rdkit.257 
 
To apply this approach to other types of enzymes, consideration also needs to be taken with respect 
to the type of machine learning methods used. The experimental assay used for nitrilase activity is 
semi-quantitative and so binary classification was used with a cutoff of 2 to allow for residual 
fluorescence in the assay results. For experimental data that is more quantitative (i.e., experimental 
binding affinities), regression may be a more suitable approach. It is also often beneficial to test 
multiple machine learning methods and evaluate their performance. Our system consisted of only 
12 proteins and 20 substrates, resulting in 240 possible pairs to be used for machine learning. This 
dataset, while small, was large enough to produce accurate binary classification models using 
logistic regression, support vector machines, and two tree-based methods, random forest and 
gradient boosted decision trees. All four methods generally had similar performance and there are 
a variety of other machine learning algorithms available. However, using deep learning-based 
methods would require much larger data sets for training. 
Overcoming antibiotic resistance 
 
Bacteria are developing various resistance mechanisms to antibiotic treatments at an alarming rate 
and resistance has been detected against every approved antibiotic on the market. Antibiotic 
resistance can develop through (i) target modification, preventing drugs from binding and 
exhibiting activity, (ii) enzymatic inactivation, leading to degradation products that lack antibiotic 
activity, (iii) altering membrane composition to prevent antibiotics from entering bacterial cells, 
and (iv) using active efflux pumps that expel antibiotics out of cells. Understanding these various 
mechanisms of antibiotic resistance is important for developing strategies to overcome multi-drug 




Overcoming antibiotic resistance to Gram-negative bacteria is challenging due to synergistic 
interactions between two barriers: the low permeability of the outer membrane (OM) and active 
multidrug efflux pumps. These barriers can be separated by using strains of Gram-negative 
bacteria that have hyperporinated OMs, lack efflux pumps, or both. Using these various strains of 
E. coli and P. aeruginosa with controllable permeability and efflux barriers the activities of β-
lactam and fluoroquinolone antibiotics were experimentally measured (Figure 35 and Figure 36). 
This activity data was then used identify physicochemical descriptors that best classify their 
relative potencies in the different strains (Chapter IV). 
 
One way to identify properties that trend with antibiotic activity is to make use of the variable 
importance calculations from tree-based methods such as RF, as other machine learning methods 
such as support vector machines are less interpretable. In addition, RF is appropriate for a dataset 
of this size, with experimental activities in the form of minimum inhibitory concentration data for 
~50 antibiotics against each of the four strains in both E. coli and P. aeruginosa. Minimum 
inhibitor concentration data is discrete rather than continuous, making it suitable for binary 
classification rather than regression.  
 
Using physicochemical properties of the antibiotics as features to build binary classification 
models using RF, we were able to identify which features were most important for generating 
accurate models of the activities in the different strains and species. The physicochemical 
properties selected by active efflux and the OM barriers were different for the two species. For P. 
aeruginosa antibiotic activity was better classified by electrostatic and surface area properties, 
whereas topology, physical properties, and atom or bond counts were important for E. coli (Figure 
38). Interestingly, active antibiotics also suffered from significant barrier effects, highlighting the 
synergy between the two barriers where optimizing for one barrier promotes strengthening of the 
other barrier. Thus, optimizing molecules with favorable physicochemical properties to overcome 
both barriers should be considered. These properties provide a set of chemical guidelines that can 
be used for development and optimization of future antibiotics. 
 
One way to restore the activity of existing antibiotics is to identify inhibitors of multidrug efflux 
pumps (EPIs, Figure 34). Similar to antibiotics, these molecules can be optimized to follow the 
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physicochemical property guidelines that promote OM permeability and minimize efflux. Using 
these existing filters in combination with ligand docking, a new class of inhibitors of E. coli 
AcrAB-TolC was identified (Figure 39). These six molecules had a shared scaffold and were 
found to potentiate antibiotic activity to varying degrees in different Gram-negative bacteria.  
 
In addition to these six molecules identified as EPIs, we have docked all ~250,000 purchasable 
primary amines from the ZINC15 database to AcrA, as compounds that contain primary amines 
have been shown to permeate the OM. Docking was done to the 29 snapshots previously described 
and at all four sites on AcrA and ~50 compounds have been selected for experimental assays to 
measure antibiotic potentiation. We have also built coevolution-based models of AdeA and AdeI, 
which are AcrA analogs in the pathogen Acinetobacter baumannii. Future work will involve 
docking our primary amine library to conformations from MD simulations of these two proteins 
to prioritize compounds for experimental testing. These experiments will include antibiotic 
potentiation assays measuring minimum potentiating concentrations to assess the ability of the top 
predicted compounds to restore antibiotic activity of a known antibiotic that would otherwise be 
effluxed from the cell in the absence of an efflux pump inhibitor. The different hyperporinated and 
efflux-deficient strains of various Gram-negative bacteria could be used to identify specific 
barriers that limit efficacy of antibiotics or efflux pump inhibitors. This information could then be 
used to guide rational design of compounds with improved properties that enhance the desired 
activity. Surface plasmon resonance or a related technique could be used to verify binding of 
compounds to AdeA or AdeI predicted by the docking calculations. 
 
Enzymatic inactivation of antibiotics is another primary mechanism of antibiotic resistance. The 
inactivation of β-lactam antibiotics, such as penicillin and amoxicillin, by β-lactamase enzymes is 
among the most extensively studied. β-lactam antibiotics fight bacterial infections by disrupting 
bacterial cell wall synthesis, resulting in cell death. A detailed understanding of this inactivation 
mechanism will inform the development of strategies for overcoming resistance to this commonly 
prescribed class of antibiotics. The first step of this inactivation reaction involves a proton transfer 
from Lys73 to Glu166 through Ser70 and an active site water molecule (Figure 40). By using a 
combination of neutron and X-ray crystallography, the protonation states of Lys73 and Glu166 in 
the active site of the precovalent (cefotaxime-bound) complex were determined (Figure 42). These 
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protonation states are consistent with the concerted base hypothesis78 where substrate binding 
triggers this proton transfer and the resulting neutral Lys73 deprotonates Ser70 to then perform a 
nucleophilic attack on the β-lactam ring of cefotaxime. Cefotaxime binding was also found to 
initiate several conformational changes in the binding site.  
 
To further investigate the role of the substrate on this initial proton transfer step and to quantify 
the role of the substrate in facilitating this reaction, QM/MM free energy simulations were 
performed on both the apo and cefotaxime-bound forms of this enzyme (Figure 43). The QM/MM 
simulations indicate that the proton transfers are concerted and synchronous in both the apoenzyme 
and the cefotaxime-bound system, as seen in the single free energy barrier in each case (Figure 
44). In the apoenzyme the estimated proton transfer free energy barrier is ∼5 kcal/mol, with the 
product state (i.e., neutral Lys73 and neutral Glu166) being 2.5 kcal/mol higher in energy than the 
reactant state (i.e., cationic Lys73 and anionic Glu166). These relative free energies are consistent 
with the neutron crystal structure of the apoenzyme, in which Lys73 is cationic and Glu166 is 
anionic. For the cefotaxime bound model the proton transfer barrier was computed to be 2.8 
kcal/mol with a reaction free energy of -6.2 kcal/mol. Thus, this proton transfer was found to be 
more thermodynamically favorable when the substrate is present and the presence of the 
cefotaxime substrate alters the relative pKa values of Lys73 and Glu166 to facilitate this reaction. 
Future work could involve using QM/MM simulations to investigate the remaining steps of this 
reaction in the presence of cefotaxime to provide additional insights into the effect of substrate 
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